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SUMMARY
The biological properties of three HSV strains were 
characterized with reference to ocular disease in the 
rabbit. Two HSV-1 strains, 17 and McKrae, and the HSV-2 
strain HG52 were studied and the following parameters were 
assessed; clinical disease; virulence; spontaneous 
shedding of HSV; induced shedding of HSV; neural latency; 
and corneal latency. Intratypic and intertypic differences 
were apparent. The HSV-1 strain 17 was pathogenic to 
rabbit eyes and neuropathogenic with increasing titres of 
inoculum. It had a low frequency of spontaneous shedding 
and an intermediate frequency of induced shedding. The 
HSV-1 strain 17 was able to establish latent infections 
within trigeminal ganglia. The HSV-1 strain McKrae was 
pathogenic to rabbit eyes and particularly neuropathogenic. 
It had a high frequency of both spontaneous and induced 
viral shedding. The McKrae strain was able to establish 
latent infections within trigeminal ganglia but differed 
in maintaining a latent infection within the cornea. The 
HSV-2 strain HG5 2 was non-pathogenic to rabbit eyes and 
non-neuropathogenic. It had a very low frequency of 
spontaneous and induced shedding. The HSV-2 strain HG5 2 
was able to maintain latent infections within the trigeminal 
ganglion.
Twelve corneas from patients suffering from herpes 
simplex keratitis were collected and analysed by light 
microscopy, electron microscopy and organ culture. Two of 
the twelve corneas released HSV after at least seven days in 
organ culture. The released virus was identified as HSV-1 
by restriction endonuclease analysis.
Primary cultures of rabbit corneal epithelial cells,
keratocytes and endothelial cells were established. The 
identity of the cells was confirmed by electron microscopy 
and indirect immunofluorescence techniques. The one step 
growth kinetics of HSV-1 in the three distinct cell types 
were established. Latent infections were established in 
the distinct cell lines in vitro using supra optimal 
temperatures. Cellular stress proteins were demonstrated 
at supraoptimal temperatures. The antiviral agent 
acycloguanosine was unable to eliminate latent HSV 
infections at the supraoptimal temperature (42°C), and the 
reactivation of HSV from acycloguanosine treated cell 
cultures was no different from the control group when cells 
were restored to 3 7°C.
Latently present genomes were detectable in epithelial 
cells following superinfection after up to 14 days at 3 7°C. 
Wild type genomes and recombinant genomes were recovered 
following superinfection.
The results presented in this thesis confirm that HSV 
can be recovered from human corneas after organ culture and 
extend this observation to HSV infected rabbits. Latent 
HSV infections can be induced in rabbit corneal cells under 
conditions of heat shock, and latently present HSV genomes 
can be detected in corneal epithelial cells after long term 
(14 day) latent infections at 3 7°C. These findings suggest 
that the cells of the cornea are able to maintain latent HSV 
infections both in vivo and in vitro, and are thus an 
additional site to neurones for HSV latency.
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1CHAPTER 1
INTRODUCTION
Classification
The current classification of herpes viruses is based 
upon biological properties. Three subfamilies of 
herpesvirus are recognised on the basis of host range, 
duration of reproductive cycle, cytopathology and the 
characeristics of latent infection. Briefly alpha herpes 
viruses including human herpesviruses 1, 2 and 3 [herpes 
simplex virus 1 and 2, (HSV-1 and -2) and varicella zoster 
virus, (VZV) ] are restricted to man in vivo, have restricted 
host range in vitro, a short reproductive cycle of less than 
24 hours causing widespread cell destruction, and an ability 
to maintain latent infections in neurones (Gilden et al. ,
19 83; Hyman et a l . , 19 83). The beta human herpesvirus 5, 
[cytomegalovirus, (CMV)] has a narrow host range and a 
reproductive cycle of greater than 2 4 hours, which slowly 
causes lytic foci. Latent infections may establish within 
secretory glands, lymphoreticular cells, the kidneys and 
other tissues. The gamma human herpesvirus 4,
[Epstein-Barr virus, (EBV) ] has a restricted host range and 
its latent infections occur frequently in lymphoid tissue, 
but may occur in other tissues (Roizman, 1985). A sixth 
human herpesvirus has been isolated recently from patients 
with the human immunodeficiency virus-2 (HIV-2) associated 
acquired immune deficiency syndrome and patients with other 
haematological disorders (Salahuddin et al ., 1986).
syn+ non syncytial
TEM transmission electron micrograph
TEMED N,NfN,N tetramethylethylenediamine
tk thymidine kinase
ts temperature sensitive
ts+ wild type for temperature sensitivity
uCi micro Curies
ug micro gram
ul micro litre
um micro metre
v/v volume per volume
Vmw molecular weight of virus induced
polypeptide
VZV Varicella zoster virus
V volt
wt wild type
w/v weight per volume
Epidemiology of ocular herpes disease
Herpes simplex virus infections are endemic throughout 
the world. Different studies have found that around 9 0% of 
the tested populations have antibodies against HSV (Buddingh 
et al. (1953), Leopold and Sery, 1963). The primary 
infection is most often asymptomatic but may be manifest as 
a pharyngitis. Infections are characteristically acquired 
in childhood and adolescence. However the pattern of 
disease may be changing, as a recent review (Anonymous,
1981) showed that the prevalence of adults with antibodies 
against HSV was declining. Smith et al. (1967) showed that 
between 3 6-4 8% of medical students and student nurses had 
antibodies to HSV-1. Glezon et a l . (19 75) reported finding 
the antibody in only 30% of students in North Carolina.
This suggests that infection in childhood may be less 
common.
Man is the natural host species for the human 
herpesviruses and no animal or insect reservoir is known. 
Disease is spread by personal contact, often unwittingly by 
an asymptomatic virus shedder. In general only one strain 
of HSV, identifiable by restriction endonuclease analysis, 
can be cultured after explantation from different sites of 
the peripheral nervous system within an individual (Lonsdale 
et al., 19 79). However the isolation of more than one 
virus strain from an individual has been reported (Buchman 
et al. , 1979 ). This variation will be reviewed later.
The most important biological properties of HSV-1 and 
-2 affecting pathogenesis of disease are the functions of 
latency and recurrence/recrudescence. These will be 
discussed in depth later.
The six human herpesviruses have all been associated
3with ocular disease; herpes simplex virus types 1 and 2 
cause primary and recrudescent disease affecting the 
anterior segment (Hogan et al., 1964), the uveal tissue 
(Patterson et a l ., 1968) and the neural cells of the retina 
(Pepose, et al. , 1985). VZV recrudescent disease causes 
significant morbidity and can result in blindness following 
an associated optic neuritis (Glaser, 1986). EBV is 
associated rarely with orbital lymphomas (Henle and Henle, 
1974), and similarly infectious mononucleosis is 
occasionally associated with a conjunctivitis (McCollum,
19 70). CMV may be acquired in utero and be manifest as a 
retinochoroiditis often associated with periventricular 
calcification (Lonn, 1972). Most adults with active CMV 
ocular disease are immunosuppressed and have a 
retinochoroiditis (Smith, 1964). Recently CMV retinitis 
has been noted as a late feature of the human 
immunodeficiency virus (HIV) induced acquired immune 
deficiency syndrome. The CMV retinitis has poor prognostic 
implications for the affected patient (Humphry et al.,
1986). The novel human herpesvirus 6 has been detected 
in the retina of patients suffering from acquired immune 
deficiency syndrome retinitis. Immunohistochemical 
techniques and the polymerase chain reaction were used to 
detect antigen and DNA .respectively ( Qavi et a l . , 19 88).
It can be seen that the clinical spectrum of ocular 
herpetic disease is wide. This thesis is confined to the 
human herpesviruses HSV-1 and -2 and their ocular effects.
Pathogenesis of ocular herpetic disease
a (i) Primary disease. A primary herpetic infection is 
characterised by a rising titre of antibodies against

FIGURE 1
A child with a primary periocular HSV infection. Herpetic 
vesicles are present around the eyelids. Primary HSV 
infections are diagnosed on the basis of a rising titre of 
antibodies to HSV.
FIGURE 2
A dendritic ulcer caused by viral replication within the 
epithelium. The ulcer, caused by loss of epithelial cells, 
stains green with fluoroscein under a cobalt blue light.
HSV. Clinically it is impossible to make an absolute 
distinction between primary and recrudescent disease, but 
the signs of primary disease may be more widespread due 
to the absence of protection afforded by antibodies 
against HSV. When the anterior segment of the eye is 
involved, a follicular conjunctivitis occurs, often 
associated with pre-auricular lymphadenopathy. Herpetic 
vesicles may be present around the eyelids (fig. 1) and 
multiple dendritic ulcers representing sites of viral 
replication may be present within the conjunctival and 
corneal epithelium. Healing usually occurs within 7-10 
days. HSV-1 and -2 can cause a primary infection. An
epidemiological study in man has shown that both HSV 
types have been separately isolated from individual 
ocular infections. HSV-2 was present in 2% of patients 
where virus was isolated, and two of the three HSV-2 
cases reported, had severe clinical disease 
(Neumann-Haefelin et al., 1978). Animal studies using 
different strains of HSV-1 and -2 show wide inter and 
intratypic strain variation in the severity of induced 
primary disease (Stevens and Cook 19 71, Oh and Stevens 
1973 and Wander et al., 1980).
(ii) Pathology of primary disease. During a primary 
pseudorabies virus infection, virus replication occurs at 
the inoculation sites before entry into the nerve endings 
(Field and Hill, 1975). HSV may replicate in corneal 
epithelium, stroma or endothelium depending upon the 
severity of disease. However since most patients have 
no history of a primary ocular HSV infection, and a 
subclinical pharyngitis is generally regarded as the site 
of primary infection (Buddingh et al., 19 53), an
alternative route for spread to and from the eye is 
required. Tullo et al. (19 82a and b) proposed that 
spread of HSV to neurones not supplying the site of 
primary infection occurs via the "back door" route, 
within the time span of the primary infection.
Following HSV inoculation to either mouse lip or cornea, 
the spread of HSV was traced from the inoculation site to 
the mandibular or ophthalmic divisions respectively of 
the trigeminal ganglion. HSV then spread to the brain 
stem (the CNS), and from there back to all divisions of 
the trigeminal ganglion. In other words HSV infection 
can occur in non ophthalmic neurones following ocular 
herpes infections and HSV infections can occur in 
ophthalmic neurones following non ocular infections. 
Goodpasture and Teague (19 23 ) observed that rabbits 
injected in mid flank with HSV developed a band-like ipsi 
lateral lesion akin to the lesion of VZV in humans. 
Simmons and Nash (19 84) suggested that this zosteriform 
spread of HSV during a primary infection might be used as 
a model of recrudescence, because clinically normal skin 
became infected with HSV via nerve endings.
Animal studies, which are to an extent artificial in 
view of the high inoculum, showed that following 
intrastromal inoculation, HSV particles were seen within 
the nuclei of epithelial cells and keratocytes after 2 
hours. Polymorphonuclear cells and lymphocytes were 
seen at the limbus within 7 hours post infection. By
day 7 there were areas of neovascularization with 
polymorphonuclear cells, plasma cells, macrophages and 
lymphocytes in the surrounding stroma. By day 3 5 
inflammatory cells were no longer present in the stroma,

FIGURE 3
(a) Epithelial disease with deeper stromal involvement. 
Scarring of the cornea is a likely consequence of this 
recrudescence.
(b) The same cornea stained with fluoroscein (green) and 
rose bengel (pink). The right edge of the ulcer stains 
with rose bengel. This sign is said to identify virus 
within cells.
FIGURE 4
(a) Disciform keratitis. The central cornea is hazy - 
replication within the endothelial cells affects cell 
function and leads to oedema in the overlying stroma.
(b) End stage HSV keratitis. The cornea is vascularize 
and opaque. Iris detail is only visible peripherally.

6although a mild cellular infiltrate persisted (Metcalf 
and Reichert 19 79). Histological studies of the 
primary disease in man do not exist, 
b (i) Recrudescent disease. After the primary infection 
HSV establishes a latent infection in the dorsal root 
ganglion. The spectrum of ocular disease resulting from 
subsequent reactivation within the dorsal root ganglion 
includes; (i) shedding of HSV in the absence of clinical
disease; (i i) epithelial disease - a dendritic ulcer
(fig. 2); (iii) epithelial disease with associated 
stromal disease - stromal keratitis (fig. 3); (iv) and 
stromal and endothelial disease possibly associated with 
uveitis in the absence of epithelial disease - disciform 
keratitis (fig. 4). HSV can be isolated from all stages 
of recrudescent disease, although an anterior chamber tap 
is required to remove aqueous humour for culture in cases 
of disciform keratitis with an associated uveitis 
(Patterson et al., 1968).
The precise pathogenesis of herpetic stromal disease and 
herpetic disciform keratitis has been a source of 
controversy for many years. Many studies have been 
designed to determine whether the in vivo response is due 
to viral replication or to an immune response.
(i i) Pathology of recrudescent disease 
The typical light microscopy findings were described by 
Hogan et al. (1964). Briefly, in dendritic ulcers, the
white cell response was non-specific, but giant cells 
were found frequently, and intranuclear inclusion bodies 
were seen rarely. Stromal keratitis with associated 
epithelial disease often resulted in; loss of epithelial
7tissue and the underlying Bowman's membrane; stromal 
necrosis; oedema and inflammatory cell infiltrate. 
Stromal necrosis could extend to Descemet's membrane. 
Perforation of the globe occurred in two of the 
ninety-nine specimens studied by Hogan et al. (1964).
In disciform keratitis necrotic zones occurred in the 
stroma within lymphocytes and polymorphonuclear cells 
present. Endothelial oedema and degeneration caused 
endothelial cell loss and the denuded areas were 
sometimes replaced by a coagulated film containing fibrin 
and inflammatory cells.
Electron microscopy studies on human corneal discs 
removed in the course of treatment for herpetic keratitis 
revealed that HSV was present in the stroma of 5 of 19 
patients at the time of graft. Four of the discs had 
associated epithelial defects and the epithelium was 
intact in the fifth (Dawson et al. , 1968a and b) . 
Additional case reports have also identified virus 
particles in a clinically quiescent failed corneal graft 
(Collin and Abelson, 1976), and in a clinically active 
cornea but HSV culture negative at the time of surgery 
(Meyers-Elliott et al., 19 80a).
Iatrogenic effects on recrudescent disease
The evolution of human herpetic disease is subject to 
modification by medical intervention in two main areas;
(i) suppression of the damaging effects of the immune 
response to HSV and the cornea by the anti inflammatory 
effect of steroids: and (ii) reduction and elimination of
virus from the cornea by anti viral chemotherapy.
In animal studies the beneficial effects of steroids in
suppressing inflammation with the consequent reduction in 
corneal scarring and visual impairment were counterbalanced 
by an extended period when virus could be isolated from 
infected eyes. (Kimura et al., 19 61; Takahashi et_al.,
19 71; Easty et al. , 19 85). However steroids did not 
increase the growth of HSV (Cooper et al., 1978). 
Histopathologically, the epithelium and stroma were more 
widely involved in infected rabbits treated with steroids 
(Kimura et al , 1961).
Specific antiviral agents that inhibit the viral DNA 
polymerase enzyme have been developed over the past 2 5 
years. They include; iododeoxyuridine (Kaufman, 19 62); 
adenine arabinoside (Kaufman et al., 19 70); 
trifluorothymidine (Wellings et al., 1972) and 
acycloguanosine (Schaeffer et al., 19 78). All these agents 
are able to inhibit HSV DNA replication and thus abort 
primary and recrudescent herpetic infections. Field et al. 
(1979) showed that acycloguanosine was incapable of 
eradicating latent HSV infections in mice.
The role of the immune system in herpes infections
The interaction between the mammalian immune system and 
herpes simplex virus during primary infection and 
recrudescent disease is complex. It is not within the 
remit of this thesis to provide a detailed review, however 
an appreciation of the respective roles of natural 
resistence, the humoral system and cell mediated immunity is 
essential for an understanding of the disease process in 
man. These three systems act separately and in concert to 
control microbiological infections.
a Natural resistance (i) macrophages. These cells are
9derived from the bone marrow and form part of the 
reticulo-endothelial system. They are widely distributed 
throughout the body. Macrophages are scavenging cells 
capable of phagocytosing virus, and are among the first 
cells encountering an invading pathogen.
(ii) natural killer cells are also derived from bone marrow 
stem cell percursors. The natural killer (NK) cells 
cause lysis of virus infected cells and require no prior 
sensitization to be effective. HSV infections enhance 
the NK cell activity (Enger et al., 19 81; Armerding et 
al. , 1981).
(iii) interferon. The interferon proteins are produced by 
leucocytes -alpha IFN; fibroblasts -beta IFN; and cells 
of the immune system -gamma IFN. They function by 
converting uninfected cells at risk of viral infection 
into resistant cells. IFN may act indirectly by 
inhibiting virus replication; by augmenting the 
efficiency of NK cells; or by activating macrophages.
Seid et al. (19 86) showed that macrophage activation was 
linked to the presence of gamma interferon released by 
T-cells. IFN may influence its own production by a 
positive feedback mechanism.
The natural resistance mechanisms play an important 
role in restricting virus replication very early in the 
infection before the humoral and cell mediated systems are 
primed (reviewed by Lopez, 19 85). 
b The humoral system. Primary herpes simplex virus 
infections are followed by a rise in the level of 
neutralizing antibodies to HSV, both in man (Buddingh et 
al., 1953) and laboratory animals (Darville and Blyth,
1982). Neutralizing antibodies are produced by the B
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cells of the immune system. Following a herpes virus 
infection the level of neutralizing antibodies tends to 
remain constant even in the presence of recrudescent 
disease (Darville and Blyth, 1982). Openshaw et al . 
(1979), showed that neutralizing antibody was able to 
reduce the virus titre of primary infections in vitro and 
in vivo, but not eliminate acute ganglionic infections. 
Neutralizing antibody permits cell to cell spread of 
virus, but inhibits extracellular spread (Notkins, 1974). 
In a small experimental series using B-cell suppressed 
mice, Kapoor et al. (19 82) demonstrated that these mice 
had a more florid primary infection in peripheral tissue 
and in the dorsal root ganglia, compared to normal mice.
A higher incidence of latent infection was also noted in 
the B cell suppressed group.
More recent studies by Simmons and Nash (19 84, 19 85) 
using the zosteriform spread model have postulated a role 
for neutralizing antibody in recrudescent disease.
Although zosteriform spread is not strictly recrudescence, 
it is similar in that centrifugal spread of virus from the 
ganglion is involved. Intravenously administered 
antibody was able to prevent zosteriform spread of HSV 
when given up to 60 hrs. post inoculation. After 60 hrs. 
HSV was present intracellularly and the effect of 
neutralizing antibody was negated. High levels of 
neutralizing antibody were required for this effect, at 
least five times higher than that normally found in 
infected mice. In view of the high antibody levels 
required for protection, the humoral immune system is 
unlikely to have a significant influence on recrudescent 
di sease.
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c Cell mediated immunity. Cell mediated immunity is
effected by thymus derived lymphocytes, T cells. A range 
of T cells exist with different inter-related functions.
T cells play roles in the elimination of virus following 
primary infections and in the control of recrudescent 
disease. Nude mice were only able to survive a primary 
HSV infection following transfer of immune T cells, 
despite previous transfer of neutralizing antibodies 
(Kapoor et al., 19 82).
The cytotoxic T (Tc) cell response is induced by live 
virus (Rouse et al., 19 83). The Tc lymphocytes are 
detectable in draining lymph nodes within 4 days of 
primary infection. Levels peak around day 6/7 and 
decline thereafter, being undetectable by day 14 (Nash 
et al., 1980a). The Tc lymphocyte acts against 
glycoproteins B, C, D and E (Eberle et al., 1981; Carter 
et al. 19 82) the response against gC is type specific 
(Eberle et al, 1981). Delayed hypersensitivity T cells 
(T-DH) are induced by live or UV inactivated virus 
introduced sub-cutaneously or intra dermally. The T-DH 
cells are detectable in draining lymph nodes within 4 
days, activity again peaks around day 6-7, and declines by 
day 12 (Nash et al. , 1980b). T helper lymphocytes (Th 
cells) augment the function of herpes primed B cells 
causing a non-specific rise in anti herpes antibodies 
(Leung et al., 1984). The supressor T cell population 
(Ts cells) contain two cell populations affecting the 
delayed hypersensitivity response (a), cells blocking the 
activation of the delayed hypersensitivity response and
(b) cells acting on the established delayed 
hypersensitivity response (Nash et al., 1981; Schrier et
HSV
T cells
Tc
B cells
Th
Bs
Ts
immunoglobulins
macrophages
monocytes
FIGURE 5
Immunological responses to HSV in mice from Nash et al. 
(1985).
.ifr +ve stimulation
_  __ _  «£> -ve stimulation
c cytotoxic
h helper
s suppressor
dh delayed hypersensitivity
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al., 19 83). The induction of suppressor T cells gives 
rise to cell populations present throughout life. This 
finding is unusual for suppressor cells and may be related 
to continued presence of antigen following recrudescent 
disease (Nash et a l ., 19 85).
A further population of B cell suppressors exist, whose 
effect is to dampen the delayed hypersensitivity response. 
The exact mode of action is unclear. The memory of cell 
mediated immunity means that detectable levels of Tc and 
T-DH cells are present within 2 days of reinfection. The 
Ts response has been already discussed. The T cells thus
act as watchmen for the immune system. The state of the
immune system in mice against HSV is summarised from the 
review of Nash et al. (1985) (fig. 5). 
d Immunopathology in herpetic stromal keratitis. The
immunological response to HSV is generally protective for 
the body, however in the localised context of the cornea 
an immunological response is often detrimental to the 
function of the cornea. Cellular invasion leads to 
disruption of the normal corneal anatomy causing scarring 
and an inability to transmit formed images to the retina.
T cells play an important role in the pathogenesis of 
stromal herpetic keratitis. Experimental studies 
performed on euthymic and athymic mice given adoptive 
transfers of HSV immune and non immune spleen cells showed 
that the T cell lymphocyte was essential in 
immuno-competent mice in the development of herpetic 
stromal keratitis (Russell et a l ., 1984). Oakes et al.
(1984) showed in experimental mice given whole body 
irradiation to depress the immune system, that T cells 
with the Lyt-1+ surface antigen phenotype were the
13
dominant mediator of antiviral protection in immune spleen 
cell reconstituted mice. Reconstituted mice and 
immunosuppressed mice had similar titres of virus present 
within the eye and trigeminal ganglion, in the 8 days 
immediately post inoculation. However at 10 days post 
inoculation all immunosuppressed mice were dead due to an 
encephalitis, whereas tissues from immune reconstituted 
mice were free of virus. Studies using monoclonal 
antibodies against specific T cell markers identified the 
Lyt-1+ T cell phenotype as the effector cell. Further 
studies showed that the Lyt-1+ T cells caused enhanced 
antibody synthesis in HSV-1 infected mice.
These studies suggest that the T cells mediating 
delayed type hypersensitivity and/or antibody synthesis 
(Lyt-1+ ) and not the cytotoxic T cells (Lyt-2 3+ ) are the 
mediators of the immune response causing virus clearance, 
e HLA antigen typing and herpetic disease. At present
there is no consensus of opinion on the importance of HLA 
antigen type and its association with herpetic disease.
In a prospective study of 2 60 HSV-1 herpes labialis 
patients compared with 606 controls, the frequency of the 
HLA-Ai antigen was increased (Russell and Schlaut 1977). 
Zimmerman et al. (1977), in a study of 46 patients with 
herpetic keratitis found that the HLA-B5 type was 
significantly more common. Meyers-Elliott et al. (1980b) 
examined 48 patients with herpetic keratitis and found a 
slight increase in the frequency of HLA-DRw3 whereas 
Jensen et al. (1984) found no significant association
between HLA type and stromal and epithelial disease in a 
study of 50 patients. The disparity in observed 
frequency of HLA types can be simply explained by the
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limited number of patients used in each study. A larger 
study with adequate controls is required to determine the 
importance of HLA type and its relationship to herpetic 
di sease.
f The protective effect of HSV infection. The immune 
system in animals and man fails to protect against 
reactivation of latent virus and subsequent recrudescent 
disease. Asbell et al. (19 84) showed that the virus 
strain within an individual where virus was recovered from 
successive infections of eyes, eyelids and mouth and then 
characterised by restriction enzyme analysis, was 
identical. A group of ten individuals was studied.
This suggests that recrudescent disease is caused by 
reactivation of the same latent virus strain within the 
trigeminal ganglion. Lonsdale et al. (19 79) 
characterised isolates recovered from superior cervical 
ganglia, trigeminal ganglia and the vagus ganglia in 
seventeen post mortem cases. Where virus was isolated 
from more than one site within an individual, it was found 
to be identical by restriction enzyme and polypeptide 
profiles.
Case reports have demonstrated that on occasion two HSV 
strains can be isolated from the same individual, even 
from the same site in recurrent genital infections 
(Buchman et al., 19 79), or two different HSV-1 strains in 
the cerebrospinal fluid coincident with HSV-1 and HSV-2 
isolates in the rectum (Heller et al., 1982), or in a 
larger series of eight patients with encephalitis; five 
patients had identical HSV strains from the brain and oral 
sites, but three had different strains at each site 
(Whitley et al., 1982). No patients had simultaneous
15
type 1 and type 2 infections.
These simultaneous isolations of HSV may represent 
shedding of the "original" latent strain plus a 
super infecting strain. Centif anto-Fi tzgerald et a l .
(1982), showed that a primary HSV infection with a 
relatively non pathogenic strain led to a decreased 
mortality and milder disease when rabbits were 
subsequently challenged with a virulent HSV strain. Only 
the HSV strain from the primary infection was recovered 
from ganglia, despite the presence of a prolonged 
superinfection in some animals. This implies that some 
protective effect is given against subsequent challenge 
with a different virus strain.
The Molecular Biology of HSV
The aim of this section is to provide background 
information, and not to provide a comprehensive review of a 
vast literature.
The Genome. HSV-1 and -2 possess a double stranded DNA 
genome with a molecular weight of around 100 x 10^, and G+C 
base compositions of 68.3% and 69%, respectively (Kieff 
et al., 1971; Wilkie, 1973; McGeoch, personal 
communication) .
The HSV genome consists of a long component of DNA 
composed of largely unique sequences, designated (Ul), and 
flanked by inverted repeat sequences, designated terminal 
repeat long (TRL ) and internal repeat long (IRl) (terminally 
redundant sequences of 0.5 x IO5 were also reported, 
designated 'a' sequences (Sheldrick and Berthelot, 1974, and 
Grafstrom et al., 1975); and a short component of DNA with 
unique sequences, (Ug) , flanked by terminal repeats, a short
16
terminal repeat (TRS ) and a short internal repeat (IRS ).
The terminal and internal long repeats can be written ab and 
b'a 1 where the "a" sequence is the redundant sequence. 
Similarly the terminal and internal short repeats can be 
written ca and a'c'.
Sheldrick and Berthelot (1974), calculated that 
recombination events between the long and short terminal and 
internal repeats could generate four isomers of the HSV 
genome differing in orientation of the unique sequences, see 
fig. 6 . Subsequent analysis of restriction endonuclease 
cleavage fragments confirmed their calculation and showed 
that the four isomers of HSV DNA were normally present at 
equal frequency (Clements et al. , 19 7 6 ; Wilkie et al. ,
1977).
Restriction Endonuclease Maps. Restriction endonuclease 
enzymes recognise specific DNA base palindromes within the 
HSV genome. The enzymes cleave the genome, producing DNA 
fragments of consistent but varying size (the number 
depending on the number of sites for the enzyme) for any 
individual HSV strain. The DNA fragments can be separated 
by size electrophoretically on agarose gel, giving a 
fingerprint characteristic to each HSV strain. The use of 
multiple restriction endonuclease enzymes in isolation, or a 
combination of two enzymes further characterises the 
fingerprint. Lonsdale et al. (1979) used restriction
enzymes to analyse HSV isolated from cadavers, and showed 
that the strains isolated from each cadaver were distinct, 
though identical (when isolated from different sites) within 
the same cadaver.
HSV genomes have been selected and isolated lacking 
Xbal restriction endonuclease sites (Brown et al ., 1984;
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FIGURE 6
Organisation of the HSV-1 genome.
The HSV-1 genome is shown to scale in prototype (P)
orientation. The long unique (Ul > and short unique (Ug) 
regions (single lines) are flanked by terminal (TR) and 
internal (IR) repeats (double lines). The a sequences (a) 
at the termini of the L and S components are represented by 
heavy vertical lines, and may be duplicated "n" or "m" times 
(a' = inverse orientation). The remainder of the long and 
short repeats are referred to as "b" and "c". Below the 
genome are mapped (i) the IE mRNAs (spliced regions are 
raised); (ii) E and L transcripts which specify the best 
known virus-encoded. proteins; and (iii) the three HSV-1 
origins of DNA replication (ORI). The four possible 
isomers of the HSV-1 genome are depicted below, where the
L and S components may be inverted (I) relative to the P
orientation as indicated. Genes in U l are numbered U^l to 
Ul 56 genes in Ug are numbered Ugl to Ugl2 (McGeoch, personal 
communication).
Abbreviations are as follows:
IE immediate-early
E early
L late
AE UL 1 2  : alkaline exonuclease
VP5 UL19 major capsid protein
tk UL2 3 thymidine kinase
gB UL2 7 glycoprotein B
MDBP Ul29 major DNA binding protein
Pol UL3 0 DNA polymerase
RR Ul3 9/4 0 ribonucleotide reductase
gC UL4 4 glycoprotein C
Vm w 6 5 UL4 8 IE stimulatory protein
gG US4 glycoprotein G
gD US 6 glycoprotein D
gE US 8 glycoprotein E
2 IK US11 gene product
ORIg origin of replication (short)
ORiL origin of replication (long)
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Harland and Brown, 1985; MacLean and Brown, 1987). The 
isolated mutants have been characterised to elucidate the 
nature of the alterations in the genomes. The isolated 
HSV-1 variants have been used in superinfection experiments 
to study the HSV genome in latency (Cook and Brown, 19 87). 
HSV-1 Sequence Determination. The HSV genome is a large 
and complex genetic system by the criteria of animal 
virology. Many of its 7 0 genes are uncharacterised by 
function and structure, while others were recognised 
originally through the existence of ts mutants or by the 
mapping of protein species as originating from particular 
regions of the genome. A complete transcript map of the 
genome now exists (Wagner, 1985; McGeoch et al., 1985,
1987; McGeoch and Davison 1986; Rixon and McGeoch, 1984, 
1985; Perry et a l ., 1986; McGeoch, personal 
communication).
Fifty-six genes were detectable in the Ul region 
(McGeoch, personal communication). Twelve genes were 
detected in the Ug re-gion (McGeoch et al. , 1985). The 
genes are evidently active during lytic infection of tissue 
culture cells as mRNAs have been detected from most of Ug. 
Current knowledge of the functions of the 5 6 Ul and the 
12 Ug encoded proteins is incomplete. The following Ug 
encoded proteins are known; VmwIE6 8 is the product of the 
immediate early gene Ugl (Hay and Hay, 1980); a protein 
kinase encoded by Ug3 has been identified by comparing the 
predicted protein sequence of an unknown gene with protein 
sequences available in data banks, using computer analysis 
(McGeoch and Davison, 1986); glycoprotein G, is the product 
of the Ug4 gene, this was determined by Frame et al. (1986), 
by raising antisera against synthetic oligopeptides
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predicted to appear in HSV encoded proteins from sequence 
data; gD and gE encoded by genes U s 6 and U s 8 respectively 
are relatively well characterised surface glycoproteins 
(Spear, 1976; Bauke and Spear, 1979; Hope et al., 1982); 
gl was identified by Longnecker et al. (1987) and Johnson
et al. (1988) mapped this glycoprotein to the Ug7 open
reading frame; 21k the product of the late gene Ugll is a 
protein that binds to double stranded DNA (Bayliss et a 1 . , 
1975; Rixon and McGeoch, 1984; and Johnson, et al. 1986); 
and last of all VmwIE12 is the product of Ugl2.
As yet little is known of the nature of the other five
encoded proteins. Seventy nine percent of Ug is occupied 
by open reading frames specifying polypeptides, and a 
further 16% appears as untranslated 3' and 5' mRNA (Rixon 
and McGeoch, 1985). After allowing for transcription 
initiation and termination signals 5 1 and 3 1 of 
transcription units only a few hundred base pairs of Ug are 
without an obvious function, illustrating the compact 
sequence utilisation of the HSV genome.
The UL , TRl , IRl , IRs ' TRS an(  ^Ug fragments have been
sequenced and many genes identified. The organisation of 
the HSV-1 genome showing the regions coding for important 
proteins is shown in figure 6 . The organisation and 
characterization of specific genes was reviewed by Wagner
(1985) .
The HSV lytic cycle.
Assembly of virions. HSV virions are composed of an 
icosahedral capsid containing 150 hexagonal and 12 
pentagonal capsomers. The capsids are contained in a 
glycoprotein and lipid envelope. The earliest steps in the 
lytic cycle are adsorption of the virion to the host cell
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plasma membrane, and penetration into the cell. The plasma 
membranes contain type specific receptor sites (Vahlne and 
Lycke, 1978). It is unclear whether HSV virions enter 
cells by fusion or by pinocytosis. Membrane fusion was 
shown by Manservigi et al. (19 77) to be related to the virus 
induced glycoprotein B (gB). Further work by Sarmiento et 
al. (19 79) showed that two HSV-1 temperature sensitive 
mutants with defects in the gB gene, adsorbed to cells but 
did not penetrate. Fusion/pinocytosis removes the virion 
envelope and releases the Herpes simplex virion to the 
cytoplasm. The virus particle migrates across the 
cytoplasm to the nuclear membrane where dissociation of the 
capsid occurs releasing HSV DNA which migrates through pores 
in the nuclear membrane (Hummeler et al., 1969). Virion 
DNA is transcribed by host cell RNA polymerase II (Costanzo 
et al., 1 9  77).
Temporal control of the viral transcription programme 
characterises the HSV-1 lytic cycle. Three groups of HSV 
genes, immediate early (IE), early (E) and late (L)
(Clements et al., 19 79) or alpha, beta and gamma (Honess and 
Roizman, 19 74) are recognised based on the kinetics of 
appearance of their gene products in the presence and 
absence of inhibitors of protein DNA synthesis.
Immediate early gene expression. The five immediate 
early polypeptides synthesised in HSV-1 infections,
VmwIE110, Vm w IE6 3, VmwIEl75, Vm w 6 8 and VmwIE12 are defined 
as those encoded by genes (IE1, IE2, IE3, IE4 and IE5 
respectively) which are transcribed and translated in the 
absence of viral protein synthesis [For simplicity the 
Glasgow nomenclature will be used throughout.] (Honess and 
Roizman, 1974; Pereira et al., 1977; and Preston et al.,
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1978). The HSV-1 genes are located as follows; IE1 and 
IE3 are diploid genes within the TRL/IRL and TRg/IRg 
segments respectively; the 5 1 termini of IE4 and IE5 are 
within TRg/IRg regions; and the coding regions are within 
Ug; the IE2 is wholly within UL (Clements et al., 19 79). 
Transcription of DNA occurs from both strands of DNA.
Post et al . (19 81) observed that a component of the
virus particle could stimulate IE gene expression.
Batterson and Roizman (19 83) suggested that the factor may 
be a tegument protein and Campbell et al. (19 84) identified 
the virion component as the major tegument protein Vmw65.
The functions of the polypeptides encoded by the immediate 
early genes are outlined below.
(i) VmwIE110. Brown et al. (1984) suggested that 
the IEl gene product may be essential for lytic growth as an 
HSV-1 mutant with an additional Xbal site in the region of 
the IEl gene in the TRL segment did not have an identical 
lesion in the IRl . This suggested that the mutation could 
not be tolerated in a homozygous form. However Stow and
Stow (19 8 6 ) constructed a recombinant virus with a deletion 
in both copies of the IEl gene. [The same deletion 
inactivates the E gene transcription stimulatory activity of 
VmwIE110 in a transient expression assay (Perry et al.,
19 8 6 )]. The recombinant virus is able to grow with reduced 
efficiency which suggests that VmwIE110 is not essential for 
lytic growth in tissue culture. The effect of the deletion 
is manifest primarily at low multiplicities of infection and 
is overcome by increasing the virus dose (Stow and Stow,
19 8 6 ). Sandri-Goldin et al. (19 83) confirmed that the 
VmwIE110 was non essential, by infecting cell lines 
containing an anti sense VmwIE110 message which reduced the
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level of VmwIEllO to less than 10%. Everett ( 1984a) used a 
co-transfection system with recombinant plasmids to show 
that VmwIE110 may be involved in the control of 
transcription. O'Hare and Hayward (1985a) confirmed that 
VmwIE110 plays a role in the stimulation of early promoters 
and suggested that the VmwIEl2 may also have a role along 
with VmwIEl75.
(ii) VmwIE63. Sacks et al. (1985) characterised four 
ts mutants with lesions in IE2. Cells infected with the ts 
mutants at non permissive temperatures overproduced VmwIEl75 
and VmwIE63, but not VmwIE110. Functional VmwIE6 3 was not 
required for the synthesis of early proteins or viral DNA 
synthesis at non permissive temperatures, however the 
expression of late genes was greatly reduced. VmwIE6 3 thus 
appears to be a polypeptide essential for lytic growth of 
HSV.
(iii) VmwIEl75. This polypeptide has been shown to be 
essential for the initial activation and continued 
expression of E and L genes (Preston, 1979a; Watson and 
Clements, 1980). Experiments using an HSV-1 ts mutant 
(ts k) with a mutation in IE3 showed that the mutant 
overproduced immediate early polypeptides but synthesised 
reduced or undetectable amounts of early and late proteins 
at the non permissive temperature. It: is thought that the 
effect of VmwIE175 is to control viral transcription by 
suppressing the synthesis of IE mRNA and activating E and L 
genes (Preston, 1979a, b; Watson and Clements, 1980).
Using cloned IE genes in transient assays the level of 
VmwIE175 was shown to determine whether IE gene expression 
was stimulated or inhibited (O'Hare and Hayward, 1985b; 
Gelman and Silverstein, 1985).
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(iv) VmwIE6 8 . Post and Roizman (19 81) have shown 
that the IE4 gene is not essential for lytic growth in Vero 
cells and Hep-2 cells. Sears et al. (1985a) further
analysed the deletion mutant of Post and Roizman (19 81) in 
rat cell lines and found that plating efficiency was reduced 
and growth was multiplicity dependent. The HSV-1 deletion 
mutant was able to establish latency in mice. Sears et al. 
(1985a) speculate that a cellular function substitutes for 
VmwIE6 8 in cells infected with the HSV-1 recombinant 
containing a deletion in the IE4 gene, and that this 
function is involved in late gene expression. The host 
cell factor complementation is cell dependent.
(v) VmwIE12. This polypeptide is non essential for 
lytic growth of HSV-1 and HSV-2 in tissue culture 
(Longnecker and Roizman, 1986; Umene, 1986; and Brown and 
Harland, 19 87) .
Early gene expression. The early group of 
polypeptides is diverse containing enzymes including 
alkaline exonuclease, thymidine kinase, DNA polymerase, 
ribonucleotide reductase and deoxypyrimidine triphosphotase; 
the major DNA binding protein Vraw13 6 and several 
glycoproteins i.e. gB, gD and gE. Early gene transcription 
peaks around 4-6 hrs. post adsorption after the appearance 
of functional IE protein in the cell. There is variation 
in the kinetics of expression of early genes. The large 
sub unit of ribonucleotide reductase may be expressed under 
IE conditions and by some mutants within the IE3 gene that 
do not otherwise express E gene products (DeLuca et al., 
1985). gD can be detected early in infection, however 
viral DNA synthesis is required for its maximal synthesis 
(Gibson and Spear, 1983; Johnson et al., 1986).
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Continued expression of VmwIEl75 throughout the lytic 
cycle was shown to be essential for the synthesis of early 
and late polypeptides (Watson and Clements, 1980). Much 
effort has been expended recently in determining the precise 
requirements for transcription of E genes and their 
subsequent translation. Everett (1984b) showed that E 
genes unlike IE genes, do not have enhancers upstream of 
promoters, thus the integrity of the whole promoter is 
essential for full activation of the gene. Co-transfection 
experiments by Sandri-Goldin et al. (19 83) examined the 
expression of HSV-1 E and L genes in the absence of IE 
functions. Transcripts of 4 genes including glycoprotein B 
and DNA binding protein were detected, however protein 
synthesis was not detectable unless VmwIEl75 was made 
available. Many of the enzymes synthesised in the early 
stage of the lytic cycle have a role in DNA replication.
HSV glycoproteins with the exception of gC are 
synthesised in the early or delayed early phase of lytic 
infection. HSV glycoproteins are incorporated into both 
nuclear and cytoplasmic membranes of infected cells (Spear 
et al., 19 70). The total number of glycoproteins specified 
by HSV is unknown. The existence of four major HSV 
glycoproteins designated gB, gC, gD and gE has been known 
for some time (reviewed by Spear, 1985; Marsden, 1987).
gB, already discussed, is involved in cell membrane 
fusion and penetration. gC has been shown to be 
inessential for infectivity (Peake et al., 1982), and in 
HSV-1 but not HSV-2 to be a receptor for complement factor 
C3b (Friedmann et al. , 1984). gD may also be involved in 
virus adsorption and penetration (Johnson et al., 1984), 
and gE interacts with the Fc region of immunoglobulin G.
24
Glycoprotein G was identified (Marsden et al. , 1984) in 
HSV-2 and its gene identified in Ug (McGeoch et al., 1987). 
The HSV-1 gG was identified by immunoprecipitation (Frame 
et al., 1986; Richman et al., 1986) and mapped to the Ug4 
open reading frame confirming the prediction of McGeoch 
et al. (1985). Glycoprotein G-2 has been shown to be non 
essential in HSV-2 using deletion variants (Harland and 
Brown, 1988). McGeoch et a l . (1985) predicted that the two 
open reading frames Ug5 and Us7 may code for transmembrane 
glycoproteins. Longnecker et al. (1987) identified
glycoprotein I and Johnson et al. (1988) ascertained that
the glycoprotein was encoded by the Ug7 open reading frame. 
Glycoprotein H was characterised and mapped to U l in HSV-1 
(Buckmaster et al., 1984).
Centifanto-Fitzgerald et al. (19 82) analysed the 
glycoproteins synthesised by different virus strains with 
defined disease patterns in rabbit corneas, i.e. epithelial 
or stromal disease. Strains secreting larger amounts of 
glycoprotein induced stromal disease rather than epithelial 
disease. Smeralgia et al. (19 82) were able to reproduce 
clinical disease patterns by injecting purified 
glycoproteins from these strains into the corneas of immune
rabbits. Thus glycoproteins clearly have a role in
generating an immune response in vivo.
Late gene expression. The kinetics of late gene
expression are not strict and genes can be subdivided into 
delayed early genes (DE), early late genes (EL), and true 
late genes (L). The efficient expression of L genes is 
dependent on viral DNA replication (Jones and Roizman,
1979), unlike the earlier DE or EL genes whose expression is 
reduced but not abolished in the absence of DNA synthesis
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(Silver and Roizman, 1985). Synthesis of HSV-1 DNA begins 
around 2 hours post absorption and peaks about 8 hours.
Late gene products can be detected 2-3 hours post absorption 
and peak by 10-16 hours; (Wilkie, 1973; Rixon et al. , 
1983). Johnson et al. (1986) studied a well characterised 
DE gene (Ug6) and its product gD; an uncharacterised L gene 
(Ugll) and its product, a 21k protein, preliminarily 
classified as a late protein; and the effects of 
phosphonoacetic acid, a viral DNA replication inhibitor upon 
them. Their results, using sensitive assays demonstrated 
that very low levels of the Ugll gene product were 
detectable under conditions designed to eliminate DNA 
replication. They speculate that late genes may be 
transcribed early in infection, but that true late promoters 
may require a high copy number achieved through DNA 
replication, before abundant expression. Johnson et al.
(1986) propose that the definition of late gene be regarded 
as functional.
Other late proteins synthesised by HSV include groups 
of DNA binding proteins, the major capsid protein UP5
(Costa et al., 1984), an assembly protein necessary for the
encapsidation of DNA (Preston et al., 19 83), and Vmw65 
(tegument protein) (Campbell et al., 1984) which stimulates 
immediate early transcription.
The expression of late genes is influenced by VmwIEl75 
(Preston, 1979a; Watson and Clements, 1980), by VmwIE63 
(Sacks et al. , 1985), and by VmwIEllO (O'Hare and Hayward,
1985a, b), which have been discussed previously.
DNA Replication and Encapsidation. The HSV genome contains 
three origins of DNA replication, one within the Ul region 
of the genome, map coordinates 0 . 4  07-0.4 29 (Spaete and
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Frenkel, 1982), and two within the reiterated sequences 
flanking Ug close to map coordinates 0.86 (IRg) and 0.9 6 
(TRg) (Stow, 1982). Deletion studies localised the cis 
acting sequences within TRg and IRg, necessary for function 
as an origin of replication, to a 1 0 0  base pair fragment 
with a 45 base pair palindromic sequence (Stow and 
McMonagle, 1983). DNA replication starts around 1-3 hrs. 
post infection and peaks at around 7-9 hrs. post infection 
(Rixon et al., 1983). Viral DNA is thought to circularize 
and then form head to tail concatemers by a rolling circle 
mechanism (Jacob et al. , 19 79) (see fig. 7). DNA 
replication generates four equimolar populations differing 
with respect to the orientation of the Ul and Ug components, 
see fig. 6 . It is thought that at least two of the genome 
populations must be involved in replication. If the genome 
template is arranged in a circular form and both isomers 
replicate, see fig. 7, then an intramolecular recombination 
event between L/S junctions plus loss of an L/S junction 
would generate all four genomic isomers (Jongeneel and 
Bachenhe imer, 1981).
The "a" sequence has been shown to be the cis-acting 
site responsible for inversion of the genome, and this 
function has been further localised to "direct repeat" 
sequences within the "a" sequence (Chou and Roizman, 1985). 
The "a" sequence also contains signals required for the 
encapsidation of viral DNA (Stow et al., 19 83). Further 
experiments by Varmuza and Smiley (1985) have localised the 
cleavage/packaging signals to a 250 base pair sub fragment 
within the terminal repeat. Only genomes of approximately 
unit length virion DNA complete the maturation process 
(Vlazny et al., 1982). Preston et al. (1983) used a ts
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FIGURE 7
DNA replication
Top HSV DNA in prototype orientation
Middle Circular structure of template DNA after end to
ligation of L and S termini.
Bottom Head to tail concatamers generated by rolling 
circle replication.
Unit length genomes cleaved at appropriately 
oriented L-S junctions, giving P and IgL isomers. 
From Varmuza and Smiley (19 85).
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mutant to show that a late polyptpeide p40 was essential for 
packaging synthesised DNA into nucleocapsids. Addison et 
al. (19 84) isolated ts mutants with lesions close to but
outside the gB gene. The ts 12 04 mutant was unable to 
penetrate the cell membrane, but when that defect was 
surmounted, and virion assembly continued, nucleocapsids 
were unable to package DNA. A second mutant ts 1208 
penetrated cells normally at non permissive temperatures 
but, was unable to package DNA. A defect in a gene 
encoding a structural polypeptide was proposed.
HSV Latency in vivo 
a The nervous system.
Latent herpes virus infections differ from lytic 
infections in that the cell and virus are able to co-exist 
for prolonged intervals, in the absence of reactivation. 
The precise mechanism of this virus/cell interaction 
remains unclear. Goodpasture and Teague (19 23) were the 
first to link primary ocular HSV infections with 
simultaneous productive viral infections in the trigeminal 
ganglia of rabbits, and Goodpasture ( 1929 ) suggested that 
the trigeminal ganglion might be a source of latent HSV 
infections. Almost fifty years elapsed before Stevens 
and Cook (19 71) showed that HSV could be recovered from 
the spinal ganglia of mice 3 weeks to 4 months post 
footpad inoculation. Virus was detected .after explanted 
tissue had been maintained in organ culture. This work 
was followed by the isolation of HSV from:- the 
trigeminal ganglia of rabbits after ocular inoculation 
(Nesburn et al., 19 72); the trigeminal ganglia of rabbits 
with a history of spontaneous ocular shedding of virus
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(Stevens et al., 1972); human trigeminal ganglia (Bastian 
et al., 1972; Baringer and Swoveland., 19 73); human 
sacral ganglia (Baringer, 1974); and animal and human 
autonomic ganglia (Price et al., 19 75; Warren et al.,
1978). Approximately 50% of the population have 
antibodies to HSV (Smith et al., 1967). The technique of 
viral superinfection was used by Brown et al. (1979), to
detect non inducible genomes in explanted human trigeminal 
ganglia. This method raised the proportion of 
individuals with detectable HSV after organ culture from 
53% to 80%, a figure closer to that of Buddingh's 
serological study.
Pseudorabies virus is transported to the sensory 
ganglia via neuronal axons following a productive 
infection at the site of inoculation (Field and Hill, 
1975). Kristensson et al. (1974) calculated that HSV 
moves along the peripheral nerves towards the cell body at 
a rate of 2-8mm/hr. This calculation is similar to the 
figure for the transport of proteins by retrograde axonal 
flow (Kristensson, 1978). The route of inoculation is 
also important in the generation of a latent infection. 
Blyth et al. (19 84) showed that inoculation of virus
through scarified skin gave a higher incidence of latency 
than subcutaneous inoculation of higher titres of virus. 
Presumably more cutaneous nerve endings were exposed to 
virus. The "back-door" route described by Tullo et al. 
(1982a) is also a means by which latent infections can 
establish in the cell bodies of neurones remote from the 
inoculation site. Despite the spread of HSV through the 
central.nervous system (CNS) and back to the dorsal root 
ganglion, the incidence of HSV latency within the CNS is
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reduced compared with latency in the peripheral nervous 
system. Tullo et al. (19 82a), reported no latent HSV 
within the CNS after culturing the brain stems of infected 
mice. However Cook and Stevens ( 1976), were able to 
isolate latent HSV from the CNS of 18% of animals, 
compared to an isolation rate of 82% from spinal ganglia, 
and Cabrera et al., (1980) produced similar figures of 5%
positive from CNS culture and 9 5% from trigeminal ganglia 
following organ culture. The latter group were able to 
detect HSV DNA sequences in the CNS of 3 0% of animals 
following DNA-DNA hybridization techniques. It is thus 
conceivable that the detected DNA did not represent the 
entire genome, and the authors concede that the sequences 
detected may be an unbalanced representation of portions 
of the genome. Stroop et al. (19 84) used in situ 
hybridization techniques with whole virus probes, and 
found that HSV-1 DNA and RNA sequences were detectable at 
very high frequency in the CNS of mice, up until 10 days 
post inoculation. Thereafter HSV-1 RNA rather than DNA 
was detected during the latent stages of infection up to 
150 days post inoculation, suggesting that only limited 
transcription occurs during latency.
Experiments by McLennan and Darby (19 80) used ts_ 
mutants to identify the neurone as the site of viral 
latency both in vivo and in vitro. Reactivation of 
latent virus was carried out at the permissive and 
non permissive temperature, viral antigens were identified 
by immunofluorescence and cells were identified 
histologically. Attempts to quantify the number of 
neurones harbouring latent HSV, using enzymatically 
dispersed dorsal root ganglia, suggested that about 1 % of
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neurones may harbour latent HSV (Walz et al. , 1976). 
Experiments by Kennedy et al. (19 83) using a double label
immunofluorescent technique showed that the proportion of 
neurones harbouring latent HSV may be as low as 0.4%.
The in situ hybridization techniques of Stroop et al.
(1984) only located HSV-1 RNA in neurones during latent 
infections. The experiments quoted above were performed 
in different in vivo and in vitro systems, 
b Peripheral tissue.
Evidence is accumulating that cells other than neurones 
may be capable of maintaining latent viral infections.
Hoyt and Billinson (19 76) reported four cases where ipsi 
lateral HSV labial infections occurred following blow-out 
fractures of the orbit. All patients had dense cutaneous 
infra orbital anaesthesia, and in two cases the infra 
orbital nerve had been severed. These findings are not 
compatible with the theory of centrifugal spread from the 
trigeminal ganglion and raise the possibility of skin 
latency. The guinea pig model of Scriba (1977), showed 
that virus was often isolated from the footpad in the 
absence of virus in the spinal ganglia. Hill et al. 
(1980) showed that 8 % of mice had virus present in 
clinically normal skin. This virus was detected after 
organ culture. Approximately 3.5% of mice demonstrate 
spontaneous HSV disease recurrences. Hill et al. (19 80) 
hypothesised that the 8 % might be shedding virus 
asymptomatically from the ganglion and that a proportion 
of them would develop clinical disease. Shimeld et al. 
(1982), isolated HSV from two of three corneal discs 
maintained in organ culture and these findings were 
expanded by Tullo et al. (1985). Cook et al., (1987)
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succeeded in isolating HSV-1 from rabbit corneas, however 
isolation of HSV-1 occurred only in rabbits infected with 
the HSV-1 strain McKrae, or HSV-l/HSV-2 recombinants whose 
genome structure is the same as that of the McKrae strain 
except for the sequence between 0.3 3 and 0.5 6 map units 
which originates from HG52 (Batra, 1987). Openshaw 
(19 83) demonstrated that HSV could be isolated from the 
posterior segment of mouse eyes after organ culture, and 
suggested that the retina, of neural origin, may be the 
site of latent infection. Al-Saadi et al. (1983) also 
demonstrated that HSV can be isolated from the mouse 
footpad after organ culture. This work has been extended 
and the findings confirmed following neurectomy and 
acycloguanosine treatment (Clements and Subak-Sharpe,
1988) .
c Maintenance of the latent state.
Much of the analysis of the latent state has been 
expressed in terms of the lytic cycle. In other words, 
analysis of the products of the lytic cycle detectable in 
tissue where HSV is presumed to be latent. A potential 
hazard to clarification, is the current functional 
definition of HSV latency, where a latent infection is 
only acknowledged after virus has been released from organ 
culture.
Temperature sensitive mutants of HSV-1 were used by 
Lofgren et al. (1977), and Watson et al. (1980) in an 
attempt to define essential viral functions necessary for 
the latent state. The initial report suggested that DNA 
replication was not essential for latency within the CNS 
or peripheral nervous system. Five ts_ mutants of HSV-1 
were studied. The second report examined an additional
32
eight ts^  mutants. The results demonstrated that the 
mutant tsK was unable to induce a latent viral infection. 
This mutant has a lesion in the IE3 gene encoding VmwIE175 
(Preston, 1979a). Other ts_ mutants which do not 
synthesise DNA after production of immediate early 
proteins were latency negative. Work by Batra (19 87) 
suggests that the ability to establish a latent infection 
is dependent upon the inoculating titre. Studies by 
Al-Saadi et al . (1983), with HSV-2 ts mutants confirmed 
that DNA replication was not essential for a latent viral 
infection either in the dorsal root ganglia of mice or in 
the mouse footpad. The VmwIEl7 5 polypeptide has been 
shown in the ganglionic neurones of latently infected 
rabbits using a monospecific antibody against the 
polypeptide. Specific antibodies against early and late 
proteins were negative (Green et al., 1981). However 
these results have not been confirmed by other workers. 
Stevens et al. (19 87) used RNA probes covering most of the 
genome to make an initial assessment of HSV-1 gene 
expression in latently infected mice. The results showed 
that only genes from the terminal repeats were expressed. 
Finer probes covering the IE genes 1-3 were used and only 
genetic information from the I El gene was detected.
Further analysis revealed that "antisense" RNA from the 
strand complementary to that encoding I El messenger RNA 
was the major species detected. The positive signal was 
localised to the nuclei of neurones. Much effort has 
been expended in determining whether the thymidine kinase 
tk gene is essential for latency. Recent experiments 
using HSV-1 recombinants with, immediate early, early and 
late regulated tk genes showed that levels of tk activity
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did not correlate directly with an ability to establish 
latent infections (Sears et al., 1985b). Tenser and 
Edris (1986) questioned the validity of the tk assay used 
in the above experiments. They suggested that the tested 
HSV-1 recombinants had an intermediate level of tk 
activity and therefore that the relationship between the 
tk gene and latency remained unclear, 
d The genome in the latent state.
Puga et al. (19 7 8 ) were able to demonstrate viral DNA in 
both acute and latent infections but mRNA only in acute 
infections. This implies that genome expression is 
severely repressed or possibly blocked during latent 
infection. Brown et al. (19 79) showed that non inducible 
viral genomes in human neural tissue were detectable 
following superinfection. Galloway et al. (1979) used 
DNA-RNA in situ hybridization to detect the presence of 
HSV mRNA in human paravertebral ganglia. Neural tissue 
from two of seven individuals had mRNA present, detected 
by non specific HSV-2 DNA probes. A further study by 
Galloway et al. (1982), used more specific probes to 
locate the areas of transcription. Transcripts of the 
left hand 30% of the genome were present in all positive 
specimens, with other regions of the long unique less 
represented, and no detectable transcripts from the short 
unique region of the genome.
Early work by Fraser et al. (1981) on HSV recovered
from human brains suggested that the viral genome may be 
present in a non integrated and linear form. However 
subsequent work by Rock and Fraser (1983, 1985), on 
experimental mice suggested that the viral DNA is likely 
to exist in the latent state either in a concatameric or
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episomal form. Puga et al. (19 84) used viral DNA probes
from the "ends" of the genome to probe DNA extracts of 
latently infected ganglia in mice. Their results 
suggested that the terminal repeats of the genome may 
undergo a rearrangement or perhaps an integration into 
cellular DNA. These results are at variance with the 
work of Rock and Fraser (1985), who detected 2M joint 
fragments but no ends, in latently infected mice. 
Efstathiou et a l . (1986) confirmed the results of Rock and 
Fraser (19 83, 1985) and showed in experimental mice and 
man that DNA loses its "ends" during latency and is thus 
arranged in concatameric or episomal form. In addition 
they found that the "endless" DNA was present in all four 
isomeric forms.
It is clear that the precise nature of the genome in 
latency is not yet understood. Most of the evidence 
presented tends to favour a static state for the virus 
where genome expression is at least partially suppressed. 
There is little evidence to support the alternative 
explanation of a dynamic state where the virus undergoes a 
chronic low grade (persistent) infection within latently 
infected tissue.
HSV Latency in vitro.
Many attempts have been made to create an in vitro 
system which mimics HSV latency, because of the difficulties 
in isolation and analysis of small quantities of viral DNA 
within neural tissue in vivo. By definition in vitro 
systems are artificial and considerable caution is required 
before extrapolating in vitro results to the in vivo 
situation.
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The first in vitro latency system was described by 
O'Neill et al. (19 72). Human embryo lung cells were 
pre-treated with cytosine arabinoside (ara-C) for 24 hrs. 
prior to infection with HSV-1, and then maintained in ara-C 
for up to 22 days. Ara-C did not eliminate HSV-1 from the 
cells, and a delay of 6 - 1 1  days post drug removal occurred 
before HSV-1 became detectable again.
A variety of different cell types have been used to 
create a more typical environment for latency. These 
include neuroblastoma cells (Vahlne and Lycke, 1978); 
transformed neural cells (Adler et al., 1978); rat foetal 
neurones (Wigdahl et al., 19 84a); human foetal neurones 
(Wigdahl et al ., 19 84b); and rabbit trigeminal ganglion 
neurones (Dunkel et a1 ., 19 84).
The most common method of inducing a latent infection 
is to pre-treat cells with an antiviral agent prior to 
infection, followed by maintenance in the presence of the 
drug for a pre-detemined time. Ara-C was used most 
commonly until 1982, thereafter bromovinyl deoxyuridine was 
used in combination with interferon (Wigdahl et a l ., 1982a, 
1983, 1984a and b) . Acycloguanosine has also been used 
(Dunkel et al. , 19 84).
Supraoptimal temperatures (greater than 3 7°C) have been 
shown to greatly reduce the synthesis of viral DNA (Crouch 
and Rapp, 1972), and temperature elevation to 42°C totally 
blocks the synthesis of viral DNA within cells (Marcon and 
Kucera, 1976). Using temperature elevation to 39.5°C, 
O'Neill (19 77) was able to extend the period of "latency" 
at the supraoptimal temperature for up to 1 2 0  days. 
Notarianni (1986) and Russell and Preston (1986) were the 
first to use temperature elevation as the sole means of
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inducing a latent infection in human foetal lung cells.
Dunkel et al. (19 84) showed that in rabbit trigeminal 
ganglion cells VmwIEl75 was detectable by immunofluorescence 
during the acute and desuppressed infections. Wigdahl et 
al. (1984a) analysed the HSV genomes present in the "latent" 
state by blot hybridization and found that both ends and 
joints were present in equimolar quantities. He suggested 
that the genome was thus present in unit lengths in a non 
integrated, non concatameric form. In this respect in 
vitro results are at variance with the in vivo results of 
Rock and Fraser ( 1983, 1985), and Efstathiou et al. (1986). 
Youssoufian et al. (19 82) studied methylation of HSV DNA
during a "latent" state induced by mitogens in a lymphoid 
cell line. Their results suggested that DNA in the 
"latent" state was heavily methylated, and that no 
methylated copies of DNA were detectable during a productive 
infection. Dressier et al. (1987) studied the methylation
pattern of HSV-1 DNA in the CNS of latently infected mice.
No extensive methylation of latent HSV-1 DNA was found in 
vivo. Russell et al. (19 87a) have attempted to define HSV 
genes required for latency in vitro. By using ts mutants, 
insertion mutants and deletion mutants with lesions in the 
VmwIE110 and VmwIE175 polypeptides, they showed that the 
lack of either protein was not enough to prevent a latent 
infection occurring in vitro. Again the in vitro results 
showing that VmwIE110 is non essential for the establishment 
of latency, contrast with the report of Stevens et al.
(1987) who found that latently infected mouse ganglia 
contain a transcript complementary to VmwIEllO mRNA in vivo. 
Further studies using in situ hybridisation have detected 
latency related RNAs in the trigeminal ganglia of rabbits,
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mice and man (Rock et al. 1987a; Spivak and Fraser, 1987; 
and Croen, 1987). More than one latency related transcript 
was detected and the genes for the latency related RNAs 
mapped in the region of the I El gene which encodes the 
VmwllO. The latent HSV-1 RNAs were found to be transcribed 
in the direction opposite to that of I El mRNA. The 
"anti sense" RNA transcripts were detectable in lytically 
infected cells but at a level approximately one-tenth that 
in latently infected cells. The precise role of the 
latency related RNAs has yet to be elucidated. The 
anti sense RNA may regulate the I El gene or it may encode a 
regulatory protein capable of suppressing the HSV-1 lytic 
cycle or interacting with cellular transcription factors.
Reactivation of HSV from latency in vivo.
The concept of trigger factors stimulating latent virus
in man is widely accepted. A variety of diverse factors 
are associated with recurrent herpetic disease including 
stress, trauma, fever, menstruation, and excessive sunlight. 
Two other conditions have been implicated in the past; 
firstly immunosuppression (already discussed), which may 
lead to an increased duration of herpetic disease through 
disruption of the immune surveillance mechanisms, although 
immunosuppression per se is unlikely to influence the 
process of reactivation; and secondly the immunosuppressant 
corticosteroid drugs.which have been shown to have no effect 
on the frequency of HSV shedding in rabbit eyes (Kibrick et
al., 1971) or mouse skin (Blyth et al. , 1976).
Two theories have evolved to take account of the known 
observations regarding HSV reactivation. The "ganglion 
trigger" hypothesis, suggests that after reactivation within
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the dorsal root ganglion the virus travels down axons to the 
peripheral site and there infects cells. This hypothesis 
is concordant with the observations of spontaneous virus 
shedding from HSV infected rabbit eyes in the absence of 
disease (Nesburn, 1967; Laibson and Kibrick, 1969; Gerdes 
and Smith, 1983; and Berman and Hill, 1985); spontaneous 
virus shedding in mice (Tullo et al. , 19 82a); and the 
induced shedding of virus following reactivation in the 
absence of disease (Laibson and Kibrick, 1967; Nesburn 
et al., 19 77; Kwon et al., 19 81). Wi ldy et al. (19 82) 
make a distinction between virus shedding in the absence of 
disease - recurrence - , and virus shedding with clinical 
disease - recrudescence - .
Hill and Blyth (1976), formulated the alternative "skin 
trigger" theory. In this hypothesis, virus reactivates 
periodically from the dorsal root ganglion and travels to 
the peripheral site. There under most circumstances, the 
virus is eliminated by the host's immune system. However 
if a breach in the peripheral site is present, perhaps 
induced by trauma, then conditions are more favourable for 
virus replication. Experiments by Shimomura et al. (19 85)
demonstrated that epinephrine iontophoresis to the corneas 
of latently infected rabbits induced reactivation of HSV 
from the trigeminal ganglia within 2 4 hrs. Iontophoresis 
is a technique for transporting ions or charged molecules 
into tissues via an electrical current. Erlanger (1954) 
suggested that the process could be used to administer drugs 
to the eye in a clinical setting, but more recently 
iontophoresis has been used in research (Hill et al., 1978; 
Kwon et al., 19 79). Iontophoresis of epinephrine has been 
shown to induce ocular shedding of HSV at high frequency
39
(Kwon et al., 1982). The effect of epinephrine on 
ganglionic reactivation is now known to be due to the 
laevo(-) stereo isomer of epinephrine (Hill et al., 1985). 
The precise role of epinephrine in triggering ganglionic 
reactivation in vivo remains unclear.
Further studies support the "skin trigger" theory.
Mild trauma to the skin of latently infected mice was 
followed by a clinical recurrence of herpetic disease 
(erythema within 2-5 days) in approximately 3 0% of mice.
HSV was isolated from the skin of 7 3% of mice with recurrent 
disease (Hill et a l . , 1978). In addition studies by 
Harbour et al. (19 83) showed that infectious HSV was 
detectable within the dorsal root ganglia supplying the 
traumatized dermatome between days 1-5 post skin trauma. 
Further work by Hill et al. (19 83) showed that recurrence of 
HSV requires an intact nerve supply. This suggests that 
peripheral stimuli induce reactivation within the ganglion, 
and that virus travels down the axon to the peripheral site 
which may or may not still be a favourable site for virus 
replication. The "ganglion trigger" hypothesis and the 
"skin trigger" theory are not mutually exclusive.
Cook et al . (19 8 6 ) took a "latency negative" HSV-1 ts 
mutant tsl whose defect is expressed late in the lytic 
infection (Gerdes et al., 19 79) (The late expression of the 
defect is paradoxical as current evidence suggests that only 
immediate early gene functions are required for latency), 
and repaired the genetic defect. The resultant virus was 
found to possess an additional ts lesion limiting its 
reactivation from latency, the defect was correlated with a 
viral replication function specific for neurones. Some 
caution is necessary in interpreting this result, as what
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the authors see as evidence of reactivation is a productive 
infection in explanted tissue i.e. replication, and it is 
possible that reactivation per se is not involved.
Host and virus factors affecting reactivation.
In man the probability of a recurrent ocular HSV 
infection was estimated to be around 50% within 2 years of 
the initial ocular HSV infection (Carroll et a l . , 1967).
More recent work showed that 3 2% of 108 patients had 
one or more recurrences between two and fifteen years of the 
initial ocular infection (Wishart et al., 1987). Both 
papers presume with little justification that the initial 
ocular HSV infection is a primary infection, when it is more 
probable that the initial ocular infection represented a 
recurrence following an asymptomatic primary infection.
Host factors including the immune system and HLA typing have 
been discussed. Harbour et al. (1981) showed that strain 
differences among groups of inbred and outbred mice were 
demonstrable when induced herpetic disease was considered. 
Intratypic variation also occurred within a mouse strain.
The effect of virus strain on spontaneous ocular 
shedding of HSV in rabbits was documented by Gerdes and 
Smith (19 83). Virus strains were regarded as having high 
or low frequency of recurrence. Inter and intratypic 
strain variation was present. The biological properties of 
latency and recurrence were not linked. Hill et al . (19 87) 
also demonstrated HSV-1 intratypic variation with induced 
viral shedding after epinephrine iontophoresis. Five viral 
strains gave no ocular shedding in rabbits after epinephrine 
iontophoresis. Co-cultivation of the trigeminal and 
superior cervical ganglia revealed that all ten strains
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tested were able to maintain a latent infection in neural 
tissue.
Reactivation of HSV from latency in vitro.
Reactivation of HSV from the "latent" state in vitro 
can be induced by removing factors suppressing virus 
replication, i.e. removing the anti-viral agent (O'Neill et 
al., 1972; Dunkel et al., 1984); or restitution of 
incubation temperature to 37°C (O'Neill, 1977; Wigdahl et 
al. , 1981, 1982a, 1983, 1984). In addition, viral 
superinfection using; HCMV (Colberg-Poley et a l . , 1979, 
1981); HSV-2 ts mutants (Wigdahl et al., 1982b); an 
intertypic HSV strain (Nilhesen et al., 1985); and HSV-1 
variants lacking Xbal sites (Cook and Brown, 1987), have all 
been used to reactivate "latent" virus in vitro.
An attempt has been made to determine viral genes 
necessary for reactivation in vitro using ts, deletion and 
insertion mutants in the IE1 and IE3 genes (Russell et al., 
1987a). HSV-2 could be reactivated by mutants which failed 
to synthesise active VmwIEl75 but not by a mutant that 
failed to synthesise VmwIE110. Caution is again required 
before drawing firm conclusions, as in vivo the dl 1403 
mutant of HSV-1 which fails to produce VmwIE110 (Stow and 
Stow, 1986) , establishes latent infections after footpad 
inoculation, and virus can be recovered after co-cultivation 
of ganglia (G. B. Clements and N.D. Stow, unpublished 
results). This suggests that a cellular factor replaces 
the transactivating effect of VmwIEllO.
Growth and characterization of corneal cells.
The cornea consists of three distinct cell types;
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epithelial cells which make up the superficial layer of the 
cornea, approximately seven cells deep, and divide 
throughout life (Davson, 1980); keratocytes, which are 
contained within the connective tissue stroma of the cornea 
occupying about 9 0 % of the cornea, and tend to be stable in 
vivo although retaining the potential for replication 
(Maumenee and Kornblueth, 1949); and endothelial cells 
which are found in a monolayer on Descemet's membrane in 
contact with the aqueous humour, and do not divide in vivo 
(Davson, 1980) (see fig. 8 ).
Microdissection techniques for the preparation and 
growth of rabbit corneal epithelial cells, keratocytes and 
endothelial cells were first described by Stocker e t .al. 
(1958) (see fig. 9). Baum et al. (1979) applied this 
method to the human cornea to obtain cultured endothelial 
cells. An alternative enzymatic method for preparing 
epithelial cell cultures was described by Gipson and Grill 
(19 82). Once pure cell lines have been established serial 
passage of corneal cells quickly yields a population of 
homologous cells suitable for experimentation. However a 
potential for inadvertent cellular contamination exists with 
the method of Stocker et al. (1958), as microdissection
techniques are used to separate the epithelial layers from 
the underlying stroma. In addition cellular morphology can 
alter with serial passage or in response to the environment 
in which cells are grown. Epithelial cells or endothelial 
cells grown in a fibronectin matrix will assume the 
morphology of fibroblasts (Hsieh and Baum, 1985). Clearly 
the identity and purity of cellular preparations should be 
established before starting experimental studies.
Ultrastructural differences have been described in vivo
FIGURE 8
Cellular layers of the cornea.
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FIGURE 9
Microdissection of the cornea for preparing cell cultures.
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by Jakus (1961) and Hogan et al. (1971). The three corneal 
cell types display recognisable morphological features such 
as size, shape, nuclear and cytoplasmic organelles.
Cell-type-specific markers also unambiguously distinguish 
epithelial cells from keratocytes and endothelial cells. 
Keratin is found only in cells of epithelial origin 
(Lazarides, 1980), whereas keratocytes and endothelial cells 
synthesise a fibronectin matrix (Yamada and Olden, 1978; 
Gospodarowicz et al., 1979). Indirect immunofluorescence 
techniques using antibodies against keratin and fibronectin 
can thus identify epithelial cells, and keratocytes and 
endothelial cells respectively.
Cultured bovine endothelial cells have been used to 
assess the cytotoxic effects of pharmacological agents 
in vitro (Jay and Macdonald, 1978). Cell cultures of 
rabbit cornea have been used to study virus/cell 
interactions by Oh ( 19 76), and Carter et al. (19 85) who 
observed the lytic cycle of HSV-1 in the three distinct 
corneal cell types.
Cell culture permits study of virus/cell interactions 
in the absence of immunological mediation.
Cellular stress proteins.
By definition the endpoint of the HSV lytic cycle is 
cell death. In the course of this destructive virus/cell 
interaction host cell directed macromolecular synthesis is 
switched off early in the lytic cycle (Sydiskis and Roizman, 
1966; Fenwick and Walker, 1978). In a latent HSV 
infection, the productive infection is aborted or directed 
to another course. The mechanism for the alteration in 
outcome is unknown, but clearly virus/cell interaction is
44
occurring. It is possible that cellular stress proteins 
may play a role in the induction and maintenance of the 
latent state, but at present the evidence for this remains 
circums tantial.
Heat shock has been shown to induce stress genes, 
manifest as chromosome puffs in Drosophila (Ritossa, 1962). 
Tissieres et al. (19 74) showed that the appearance of the 
chromosome puffs was associated with the synthesis of six 
novel proteins detectable by SDS-PAGE. A similar system 
has been described in eukaryotic cells namely chick embryo 
fibroblasts (Hightower and Smith, 1978; Kelley and 
Schlessinger, 1978). Currie and White (1981) demonstrated 
that a cellular stress protein of molecular weight 70,000, 
was synthesised in vitro in rat tissue and in vivo after 
rats were subjected to hyperthermia. The in vivo synthesis 
implies that stress proteins have a physiological role. A 
variety of other toxic stimuli including disulfiram, 
sulphydryl groups, anoxia, and viruses have been shown to 
induce cellular stress proteins (Levinson et al., 1978,
1980; Ashburner, 1982; Nevins, 1982; Collins and 
Hightower, 1982 and Khandjian and Tflrler, 1983). The exact 
function of the cellular stress response is unknown, but 
thought to be protective for the cell.
Notarianni and Preston (1982) were the first to 
demonstrate that cellular stress proteins were induced in 
chick embryo fibroblasts hy HSV using the HSV-1 tsk mutant, 
which has a lesion in the IE3 gene encoding the VmwIEl75 and 
overproduces the other immediate early polypeptides. The 
HSV-1 parental virus did not induce detectable synthesis of 
cellular stress proteins. Cellular stress proteins were 
visualised by SDS-PAGE. Further work by Russell et al.
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(1987b) has shown that it is overproduction of the abnormal 
VmwIEl75 that induces the cellular stress response in vitro. 
Truncated VmwIEl7 5 or increased amounts of normal Vm w IE17 5 
do not induce a stress response. LaThangue et al. (19 84) 
reported that a cellular stress protein, identified by a 
monoclonal antibody T156, accumulated during the HSV-2 
(strain 3 33) lytic cycle in human embryo fibroblasts and 
BHK21C13 cells. The cellular stress protein was also 
present during the cellular growth phase, in heat shocked 
cells and in cells treated with disulfiram. It is thus 
apparent that not all host cell genes are shut off following 
HSV infection. Kennedy et al. (19 85) showed that the T156 
monoclonal antibody identified a stress protein which 
accumulated during acute HSV infection, in cultured human 
neural cells.
Recent work by Patel et al. (19 8 6 ) used the monoclonal
antibody T156 to screen a lambda gtll library and for
polysome immunoprecipitation, to isolate cDNA clones derived 
from the corresponding cellular stress protein gene. Their 
results showed that HSV is capable, of transcriptionally 
inducing a cellular gene. The precise mechanism by which a 
few cellular genes are activated in the face of generalised 
repression of cellular function is as yet unknown. The 
results of Russell et al. (19 87) who used tsk which 
overproduces abnormal VmwIE17 5 to induce a stress response 
differ from work of LaThangue et al. (1984), Kennedy et al.
(1985) and Patel et a l . (19 8 6 ) who used wild type HSV to
induce a stress response. This suggests that more than one 
mechanism may induce the cellular stress response.
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CHAPTER 2
IN VIVO EXPERIMENTS
Isolation of herpes simplex virus from the cornea in 
patients with chronic stromal keratitis.
MATERIALS
Corneas. Twelve consecutive corneal graft specimens from 
clinically diagnosed herpetic keratitis patients were 
collected within 2 4 hours of surgery and transported to the 
laboratory in halanced salt solution or EFCiq (v/v ) (Eagle's 
medium 10% foetal calf serum). Corneas were received from 
throughout Scotland between April 1985 and June 1986. The 
co-operation of clinical colleagues in providing suitable 
tissue is gratefully acknowledged.
METHODS
PATHOLOGY
Corneas were processed as follows (Figure 10). One 
quarter was fixed in 2 % gluteraldehyde for several hours and 
then processed routinely for paraffin histology to assess 
pathological changes by light microscopy. Sections were 
treated with Haemotoxylin-Eosin, Periodic Acid Schiff 
(P.A.S.) and the Masson-Trichrome stains. In two of the 
specimens ( 1  and 2 ) where inflammation was conspicuous, 
additional stains for bacteria and fungi (Gram-Jenson, 
Gram-We igert, Me thenamine-Si lver) were applied (Work done by 
Dr. K.U. Loeffler and Professor W.R. lee, Tennent Institute 
of Ophthalmology, Glasgow).
ELECTRON MICROSCOPY
Tissue for electron microscopy was fixed in
EXPERIMENTAL PROTOCOL
Corneal disc 12
Organ culture 12
Light microscopy
12
8
pre culture 
post culture
Electron microscopy
pre culture 8
post culture 2
R.E. analysis 
of HSV 2
f i g u r e 10
Experimental protocol for the isolation of HSV from the
cornea in patients with chronic stromal keratitis.
Numbers to the right denote the number of corneas undergoing 
that procedure. Corneal discs were divided into eight 
wedge shaped segments.
Pre-culture - Two eighths of 12 corneas were examined by 
light microscopy and not subjected to organ 
culture
- One eighth of 8 corneas was examined by 
electron microscopy and not subjected to 
organ culture
Post-culture - Two to five eighths of 8 corneas were
examined by light microscopy after organ 
culture
- Five and six eighths of 2 corneas 
respectively were examined by electron 
microscopy after organ culture
RE - Restriction enzyme
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summarises the clinical data.
Cases 1-5 had clinically active disease at the time of 
corneal grafting, as manifest by a stromal defect down to 
Descemet's membrane. Cases 6-12 were regarded as 
clinically inactive immediately pre graft. The history of 
herpetic disease ranged from 6 months to 30 years. All but 
two patients, 5 and 8 , had required topical steroid 
preparations to the affected eye to suppress an inflammatory 
reaction in the course of their stromal keratitis. All 
patients had been treated with topical anti-viral agents at 
some time. These included idoxuridine, vidarabine, 
trifluorothymidine and acycloguanosine. Corneas were 
collected and placed in organ culture within 2 4 hours of the 
corneal graft. Only four specimens 3, 4, 8 and 10 were 
prepared outwith the first ten hours.
PATHOLOGY
A pie shaped segment (one quarter of each corneal disc) 
containing a representative piece of diseased tissue, was 
prepared and examined by conventional light microscopy.
(This work was performed by Dr. K.U. Loeffler and Professor 
W.R. Lee). Significant inflammatory cell infiltrate was 
found in seven of the twelve corneas. Four of these 
specimens, 1-4, had descemetocoeles. However specimen 5 
also with a descemetocoele had minimal inflammatory cell 
infiltrate. The correlation between clinical and 
pathological examination was poor in specimens 1 0 - 1 2 , where 
the corneas were regarded as clinically quiescent but 
histology revealed significant inflammatory cell infiltrate 
(Table lb). Specimens 1 and 2 revealed features not 
commonly found in herpes simplex keratitis viz, nuclear
Table 1 (a)
Patients with chronic herpetic stromal keratitis
Duration Anti- Time to
History of HSV Steroid viral culture
pre-graft disease treat- treat- (hours)
(years) ment ment
NS 1 Descemetocoele 3 0 + + 8.5
MJ 2 Descemetocoele 4 + + 3.0
IF 3 Descemetocoele 3 0 + + 2 3.5
BD 4 Descemetocoele 15 + + 20.0
DMcE 5 Descemetocoele 0.5 - + 1.0
JR 6 Graft (6 yrs ago) 12 + + 1.5
JG 7 Grafts (3 & 9 11 + + 7.5
yrs ago)
ML 8 Quiescent 33 - + 20.0
MF 9 Quiescent 28 + + 3.5
PW 10 Quiescent 16 + + 20.0
HW 11 Quiescent 8 + + 9.0
IR 12 Quiescent 9 + + l.Q
Patients 1-5 had active corneal disease at the time of 
surgery. Corneal ulcers were present to the level of 
Descemet's membrane (figure 8 ). All corneas had been 
treated with antiviral agents for some time prior to 
surgery. Only patient 5 did not receive topical steroid - 
therapy.
Patients 6-12 had no clinically active corneal disease 
(i.e. no ulceration, no inflamation) and were on no ocular 
medication at the time of surgery.
Table 1 (b)
Patients with chronic herpetic stromal keratitis
Active HSV E.M. E.M. Pathology
inflamation recovered performed HSV seen post culture 
(path.)
+ + - ND ND +
%  ND ND +
+ - pre - +
+ - pre - +
pre - ND
ND ND ND
- - ND ND ND
- - pre - ND
+ post + +
+ + + pre post - + +
+ - pre
+ - pre - +
pre = pre organ culture 
post = post organ culture 
ND = not done
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dust, cellular debris and necrosis of the corneal lamellae; 
bacteria or fungi could not be identified. Specimen 1 had 
been treated with tissue glue prior to grafting. (Tissue 
glue is a synthetic polymer used to "plug" a leaking 
cornea.) Specimens 3 and 4 showed features suggestive of 
active herpetic disease including inflammatory cell 
infiltrate, degeneration of stromal lamellae, multinucleate 
cells and attenuation and loss of endothelial cells on 
Descemet's membrane. Specimens 6 and 7, both of which were 
previous corneal grafts had minimal inflammatory cell 
infiltrate and no evidence of an immune rejection process. 
Specimens 8 and 9, clinically quiescent, showed evidence of 
previous herpetic disease; loss of Bowman's membrane, loss 
of stromal organisation with fibrous replacement, and in 
specimen 9, a break in Descemet's membrane with a 
granulomatous reaction at its ends causing a fan shaped 
splitting of its lamellae, fig. ll(a-c). This relatively 
unusual feature is known to be associated with longstanding 
herpetic keratitis (Naumann, 1980, and Hogan et al. , 1964). 
Specimen 10 (Fig. 12(a-c) and specimen 11 showed features 
suggestive of active herpetic disease.
ORGAN CULTURE AND RESTRICTION ENDONUCLEASE ANALYSIS 
Organ culture was performed on five/eighths or 
three/quarters of each cornea. Tissue was maintained in 
organ culture for up to 28 days. Herpes simplex virus was 
cultured from only two of the twelve corneas, specimens 9 
and 10. Virus was isolated from three of six segments 
after 7 days (two segments positive) and 9 days (three 
segments positive) in organ culture, in specimen 9; and 
from one of five segments after 7 days in organ culture in

FIGURE 11
Specimen 9.
(a) gap in Descemet's membrane (PAS X 80)
(b) granulomatous reaction at the end of Descemet's 
membrane (Masson X 3 20)
(c) lamellar split in Descemet's membrane (PAS X 320)
FIGURE 12 
Specimen 10.
(a) corneal epithelium, irregular in thickness and 
architecture (H and E X 30)
(b) multinucleate cells with swollen keratocytes 
(Masson X 120)
(c) numerous foamy macrophages, multinucleate cells, 
lymphocytes and polymorphs within the stroma 
(Masson X 70)
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specimen 10. All other segments from these and other 
corneas were negative. The isolates from the two corneas 
were shown to be HSV-1 by restriction endonuclease analysis 
(see fig. 13). The EcoRI digests show that the k and 1_ 
bands run together in specimen 10. The Hpal digests show 
that the k and 1 bands of specimen 9 run together. Both 
isolates are thus distinct from each other and from HSV-1 
strain 17.
ULTRASTRUCTURAL STUDIES
Corneal tissues pre and post organ culture were 
examined including segments releasing and not releasing HSV 
in.an attempt to identify HSV particles within corneal 
tissues. (Tissues were prepared and sectioned by Mrs. D. A.
Aitken. ) A total of seven specimens (one/eighth of each
corneal disc) were examined ultrastructurally immediately 
pre-culture. These segments were not subjected to organ 
culture and included one segment from specimen 1 0 , whose 
"co-segment" subsequently released HSV after organ culture. 
No HSV particles were seen in the segments not subjected to 
organ culture, however features typical of active 
inflammation were seen, including disturbance of the normal 
stromal architecture and macrophages engulfing dead cells 
(Table lb) .
Figure 14 shows a negative co-segment from specimen 10 
after 14 days in organ culture. Epithelial cells are 
migrating down the sides of the tissue hLock towards the 
tissue culture plate, and healthy keratocytes are present 
within the stromal lamellae. A total of eight specimens 
were subjected to histological examination post organ 
culture. In the main, epithelial and endothelial cells
FIGURE 13
Restriction endonuclease profiles for specimens 9 and 10, 
compared with profiles from HSV-1 strain 17 and HSV-2 
strain HG52. The enzymes Xbal, EcoRI and Hpal were used. 
The HSV-1 strain 17 profiles are labelled. Restriction 
endonuclease maps for the genome HSV-1 strain 17 are shown 
in figure 31.
Xba I 
HG52 10 9 17
EcoR I 
HG52 10 9 17
Hpa I
HG52 10 9 17
-; 5um
FIGURE 14
Specimen 10.
, (a) A culture negative co-segment after 14 days
in organ culture. Epithelial cells are migrating 
down the side of the tissue towards the tissue 
culture plate (a). The stromal lamellae are 
evident (b) (E.M. x 4,500). Enlarged area shown
in figure 14 (b) - (c).
(b) Vesicles within specimen 10. No viral structures 
are apparent (E.M. x 77,000).
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were absent, and keratocytes were often well preserved. 
Inflammatory foci were often present, though other sections 
had well preserved corneal architecture. There was no 
evidence of active herpetic disease.
The three segments of specimen 9 which released HSV 
after organ culture on days 7 and 9, were subjected to 
detailed ultrastructural examination after 14 days in organ 
culture. Similar studies were performed on the culture 
positive segment and a culture negative segment of specimen 
1 0 , on day 1 1 ; and on the remaining three culture negative 
pieces of specimen 10, on day 14.
HSV particles were only seen in segments that had been 
organ culture positive. N o .epithelial cells or endothelial 
cells were present, although both Bowman's layer and 
Descemet's membrane were evident. Nearly all cells 
examined showed effects of viral synthesis. It was 
possible to observe many of the steps of viral synthesis 
within the corneal tissue. Electron micrographs showing 
stages in the formation of virions after organ culture are 
shown in figures 15-19. These micrographs were obtained 
from specimens 9 and 10.
Figure 15 shows a virion about to enter or exit a 
keratocyte by fusion or pinocytosis. Precise 
interpretation of a dynamic process in a static micrograph 
is impossible. The characteristic morphological changes of 
a host cell after transcription of virion DNA by host cell 
RNA polymerase II are shown in figure 16; they include 
margination and condensation of host cell chromatin (Nii et 
al., 1968). Infecting virion structural components or 
immediate early viral proteins (Dargan and Subak-Sharpe, 
1983), or a host cellular stress response may play a role in
FIGURE 15
Specimen 10.
A virion (a) about to enter/exit a cell by fusion/ 
pinocytosis. Stromal lamellae (b) in cross section are seen 
superiorly (E.M. x 212,000).
FIGURE 16 
Specimen 9 .
A keratocyte with margination and condensation of host cell 
chromatin at the nuclear membrane (a). A variety of
i
nucleocapsid structures are present within the nucleus
(b) core containing nucleocapsid (c) empty nucleocapsid 
(E.M. x 21,000).
o liim
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the induction of these structures (Dewey et al., 1971). 
Nucleocapsid forms representing different stages of 
maturation are shown in figure 17. An empty capsid without 
core, incapable of encapsidating viral DNA is shown.
Electron dense fibres appear to be penetrating the 
nucleocapsids, figure 18, and the fibres are thought to 
represent supercoiled DNA (Ni i et al. , 1968, Friednann et 
al. , 1977 and Puvion-Dutilleul et al. , 1982). Envelopment 
of nucleocapsids occurring at the inner nuclear membrane is 
shown* in figure 19.
DISCUSSION
* HSV was isolated from two of twelve herpetic corneas 
subjected to organ culture. HSV was isolated from three of 
six segments in specimen 9 , and from one of five segments in 
specimen 10. The HSV was typed by restriction endonuclease 
analysis and found to be HSV-1. The DNA of each isolate 
had its own distinct restriction endonuclease pattern. The 
isolation of HSV from herpetic corneas independently 
confirms the results of Shimeld et al. (19 82) and Tullo et 
al. (1985), in Bristol, however the frequency of isolation, 
two out of twelve, differs markedly from the published 
results, six out of nine. Since 1985 the Bristol series 
has been expanded and current figures for HSV isolation 
after organ culture stand at ten positives out of forty 
(Shimeld, personal communication). The reduced frequency 
of isolation may be accounted for by better recognition and 
treatment of virus induced disease within the cornea in the 
human population, thereby reducing or eliminating virus from 
corneal cells; and by the fact that inclusion/exclusion 
criteria became less rigorous as the study progressed
FIGURE 17
Specimen 9 .
A keratocyte within the stromal lamellae. Core and capsid 
sub units are present within the nucleus (a). An empty 
capsid without a core is present (b). Stromal lamellae (c) 
surround the keratocyte. (E.M. x 28,000).
FIGURE 18 
Specimen 9 .
Electron dense fibres penetrating nucleocapsids and attached 
to the central core (a), this is thought to represent 
encapsidation (Nii et al., 19 6 8 ). This appearance was 
found only once. (E.M. x 122,000).
1 0  urn
FIGURE 19
Speciihen 9 .
Nucleus with marginated chromatin showing:
Top right A mature enveloped virion within the
cytoplasm (a).
Bottom centre A virion which has acquired the inner nuclear 
membrane and is acquiring an outer nuclear 
membrane (b).
Bottom left Reduplication of the nuclear membrane (c)
(E.M. x 350,000).
omm
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(Shimeld, personal communication). The isolation of virus 
within a cornea is sporadic, in other words not every 
segment will release HSV within a positive cornea.
Shimeld, Tullo and Easty (personal communication) observed 
that virus tended to be recovered from clinically diseased 
tissue.
The pathological responses of the human cornea to a 
toxic stimulus from whatever source are limited. Four 
corneas, specimens 3, 4, 10 and 1 1 , showed immediately post 
graft,' pathological changes, suggestive of an active 
herpetic infection. Of these only specimen 10, said to be 
clinically quiescent pre graft, yielded HSV on organ 
culture. Other specimens, notably 1 and 2 but also 12, 
showed evidence immediately post graft, of an active 
inflammatory process, which was not characteristically 
herpetic. Another two specimens, 8 and 9 , showed evidence 
of long standing though inactive herpetic disease 
immediately post graft (specimen 9 released HSV on organ 
culture) .
It is thus clear that the inflammatory response, per se 
does not correlate with an ability to recover HSV from organ 
culture. The human immune response to herpetic keratitis 
is complex and has been covered in the introduction, but 
briefly it is T cell mediated. Meyers-Elliott et al.
4
(1980a) demonstrated viral antigens by immuno-perodixase 
electron microscopy in the cornea of a patient with active 
keratitis. Viral antigen was present in the keratocyte 
nucleus, on keratocyte nuclear membranes and in degenerating 
keratocytes. Henson et al. (19 74) used human 
immunoglobulin G against HSV to localise viral antigens in 
cultured rabbit corneal cells infected with HSV. Viral
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antigen was found at the nuclear membrane on areas of focal 
plasma thickening resembling the envelope of HSV, and on 
enveloped virus particles. Unenveloped virus particles did 
not react with labelled antibody. This suggests that the 
humoral immune response is mounted against HSV induced 
structures present after viral DNA synthesis has occurred, 
and thus viral replication is an important step in the 
evolution of chronic stromal and/or disciform keratitis.
The subsequent immune response continues against HSV induced 
cellular antigens which may explain the presence of an 
immune response in the absence of infectious HSV.
HSV has been demonstrated previously in ultrastructural 
studies performed on corneal discs when viral disease was 
clinically active. Epithelial disease was generally 
co-existent with stromal disease but HSV was rarely isolated 
(Dawson et al. , 19 6 8a and b; Jones et al. , 19 77). 
Meyers-Elliott et al. (19 80a) demonstrated viral antigens 
within a herpetic cornea but found that structurally 
complete enveloped viral particles were rarely seen, 
suggesting that an abortive non-replicating infection only 
occurred in keratocytes. Mature virus particles were 
demonstrated by Collin and Abelson (1976), in a clinically 
quiescent failed corneal graft, but the detection of 
infectious HSV was not reported.
Our ultrastructural studies link the detection of HSV 
by organ culture with the presence of HSV on ultrastructural 
examination, and show that the steps outlining most of the 
sequence of virion assembly were demonstrable within 
keratocytes. Epithelial and endothelial cells were not 
observed, presumably because virus replication had already 
occurred within them causing lysis, or because they had
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migrated to the tissue culture plate during organ culture. 
The ul trastructural studies performed immediately post 
graft, on the five corneas with active disease did not 
reveal HSV structures, however only one eighth of each 
cornea was examined by this method. This contrasts with 
the results of Dawson et al. (1968a) who found HSV particles 
in the corneal stroma of five out of nineteen corneas 
examined by electron microscopy. Four of his five positive 
specimens had epithelial defects, at the time of surgery, 
but no virus isolates were recovered from swabs taken prior 
to surgery. The five positive corneas (Dawson et al.
1968a) received ocular steroids prior to surgery, however 
only one of the five was documented as being treated with an 
antiviral agent. This does not necessarily mean that the 
others did not receive antiviral treatment pre operatively. 
It is conceivable that current antiviral agents achieve 
better corneal penetration and are thus more able to 
eliminate virus deeper within the cornea. Alternatively 
the pre operative antiviral treatment given to patients in 
my series may have eliminated HSV from the patients with 
descemetocoeles prior to surgery. Both positive corneas in 
my series were regarded as clinically inactive at the time 
of surgery and had not been treated with antiviral agents.
The recovery of infectious HSV from human corneas after 
organ culture raises questions on the state of HSV within 
the human cornea; is it latent, persistent, or newly 
arrived from a neural source? The evidence cited in the 
introduction and this study support the hypothesis that HSV 
may indeed by capable of maintaining a latent infection 
within a non-neural cell type.
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CHAPTER 3
IN VIVO EXPERIMENTS
MATERIALS
Viruses: HSV-1 Glasgow strain 17 syn+, Brown et al. (1973),
HSV-1 strain McKrae (From Dr. J.M. Hill, Iouisiana State 
University, New Orleans, La., USA) (Williams et al. , 1965) 
and HSV-2 strain HG52 Timbury (19 71) were used in animal 
expe riments.
Cells: BHK2 iC^ 3  cells (MacPherson and Stoker, 1962) derived
from a fibroblastic line of baby hamster kidney cells were 
used for growth of virus, and screening for virus.
Tissue culture media: BHK2 1 C1 3  cells were grown in Glasgow
modified Eagle's medium supplemented with 100 units/ml 
penicillin, lOOug/ml streptomycin, 0.2 ug/ml amphotericin 
and 1 0 % calf serum, 0 .0 0 2 % phenol red and 1 0 % calf serum 
(EC1 0 ).
Versene (0.6mM EDTA in PBS, 0.0 02% (w/v) phenol red) and
trypsin (0.25% (w/v)(Difco) in Tris saline were used for the
washing and removal of cell monolayers during passaging or
setting up cells for growth of viruses.
PBS 1 70mM NaCl, 3.4mM KCl, lOmM Na2 HP04 , 2mM KH2 PC>4 (pH 
7.2 ) .
Tris saline 14 0mM NaCl, 3 0mM KCl, 2 80mM Na2 HP 0 4 , lmg/ml 
glucose, 0.0 015% (w/v) phenol red, 2 5mM Tris HCl (pH 7.4), 
100 units/ml penicillin, lOOug/ml streptomycin.
Enzymes: Restriction enzymes were obtained from Bethesda
Research Laboratoris (BRL).
Radiochemicals; Radio isotopes, 3 2p orthophosphate (carrier 
free) were obtained from Amersham International.
Solutions:
(i) EFCxq Glasgow modified Eagle's medium supplemented
with antibiotics as before plus 1 0 % (w/v) foetal calf 
serum.
(ii) EFC2 5  Glasgow modified Eagle's medium supplemented
with antibiotics as before plus 2 5 % (w/v) foetal calf 
serum.
(iii) General restriction endonuclease buffers.
Low salt Medium salt High salt
Tris HCl lOmM pH 7.5 lOmM pH 7.5 lOmM pH 7.5
NaCl - 5 OmM lOOmM
MgCl2 lOmM lOmM lOmM
DTT1 ImM ImM ImM
10X stocks of these buffers were prepared, autoclaved 
and stored at -20°C.
Reaction volumes of 3 Oul contained DNA in a solution 
with a final concentration of 1 x reaction buffer, 1 0 0  
ug/ml bovine serum albumin, and the appropriate 
restriction enzyme at approximately 1 unit per ug DNA. 
(iv) RNase mixture. 1ml distilled H 2 O and lOOug RNase A + 
250 units of RNase Tl. The mixture was freshly 
prepared and boiled for 1 0  minutes prior to use.
(v) 10X E buffer. Tris 43.6g/L, NaH2 PC>4 H2 0 , 46.8g/L Na 
EDTA 3 .7 g/L , H20 1 litre.
(vi ) Restriction enzyme stop (R.E. stop) mixture.
lOul of the following mixture was added to stop 
digestion of DNA; 2g Ficoll, 0.54g EDTA, 10ml 10X E 
buffer, 1 0 ml H 2 O, plus bromophenol blue to colour. 
Animals; New Zealand white female rabbits less than six 
months old and between 1.5-2 kg were obtained from Hyline 
Rabbit Farms. Rabbits were kept apart in individual cages.
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Only the left eye of any animal was used in experiments. 
Animals were monitored scrupulously, and any animal showing 
evidence of pain or systemic illness was humanely destroyed. 
Iontophoresis apparatus: A system was devised fcy
Mr. W. Davies (Department of Medical Physics, Western 
Infirmary, Glasgow), to administer an ionised solution of 
epinephrine to the eye by way of an electrical current 
(Figure 20). The design was based on the system of Kwon et
al. (1981), such that a fixed current of 0.8 mAmps was used 
and a voltage of around 7V depending upon the integrity of 
the connection between electrode and epinephrine solution.
An automatic timer was incorporated into the apparatus to 
allow the iontophoresis to run for 8 minutes. The circuit 
was arranged in series so that four animals might be treated 
simultaneously. Practical problems dictated that three 
animals were the optimum number. The circuit was arranged 
so that the cathode was applied to the animal's shaved 
trunk, and the anode was in contact with the epinephrine 
solution (see figure 2 1 ).
Iontophoresis eye cup: A cylindrical well with an expanded
flanged end was produced by Mr. J. IVkcfarlane (Department of 
Ophthalmology, Vfestern Infirmary, Glasgow) and copied from 
an original well of Kwon et al. (19 81). The flanged end 
was bevelled to the approximate curvature of a rabbit's 
cornea. This arrangement permitted the well to sit on the 
cornea with the eyelids over the flange, thus creating a 
partially closed system and minimising loss of drug 
solution. The wells were made of nylon which allowed them 
to be autoclaved and re-used.
Electrodes; The anode electrode was formed by a small strip 
of aluminium foil. The cathode electrode was an ECG
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electrode supplied by Cambmac Instruments Ltd.
Chemicals; (a) anaesthetics Ketamine supplied by
Parke Davis and Co.
Xylazine supplied by 
Bayer UK Ltd.
(b) iontophoresis Epinephrine (adrenalin)
supplied by Sigma Chemical 
Co.
(c) killing animals Expiral supplied by
Ceva Ltd.
METHODS
Tissue cell culture; BHK21C13 cells were passaged in 8 0 oz 
roller bottles and kept in an atmosphere of 9 5% air, 5% CO 2  
at 3 7°C.
Virus preparation; BHK2 1 C-L3 cells in 8 0 oz roller bottles 
were infected with HSV-1 strain 17 or strain McKrae, or 
HSV-2 strain HG52 at an m.o.i. of 0.003 pfu/cell (10^ pfu 
per bottle) in 4 0 mis ECiq- Virus infected cells were 
incubated at 31°C for 3-4 days until extensive cytopathic 
effect (CPE) had developed. Cells were removed by shaking 
into the medium and pelleted (MSE Cbolspin, 2,000 
rpm/10min/4°C). Supernatant medium was further centrifuged 
(Sorvall SS34 rotor, 12K rpm/2 hr/4°C) to concentrate cell 
released virus (CRV), which was sonicated and stored at 
-7 0°C. The pelleted material from the low^-speed 
centrifugation was sonicated in a small volume of 
supernatant medium for recovery of cell-associated virus 
(CAV). Cell debris was removed by further low speed 
centrifugation and the virus solution sonicated and 
centrifuged again if necessary. Supernatant containing CAV 
was stored at -70°C.
FIGURE 20
Iontophoresis apparatus.
FIGURE 21
Three anaesthetised animals undergoing iontophoresis of 
epinephrine. The cylindrical wells containing epinephrine 
are loosely held by clamps.
. ijj/ k .  ' i»«i» ( M L  -A
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The CRV and CAV fractions were checked for sterility 
(on blood agar plates) and titrated on BHK2 1 C1 3  monolayers 
in the presence of human serum, as described by Brown et al. 
(1973) .
Inoculation; Outbred New Zealand white rabbits were 
inoculated with either HSV-1 strain 17 (Brown et al. , 1973), 
HSV-1 strain McKrae (Williams et al. , 1965) or HSV-2 strain 
HG52 (Timbury, 1971). The left eye was infected by placing 
50ul of a virus suspension in the lower cul-de-sac and 
massaging over the closed eye for approximately 1 minute.
The virus inoculum ranged from 10^ pfu - 5 x 10^ pfu. 
Scarification: Prior to inoculation, as above, rabbits were
anaesthetised. The cornea was traumatised fcy applying 10 
linear incisions followed by a further 1 0  perpendicular to 
the first series, using a 26 gauge needle.
Anaesthesia: Rabbits were anaesthetised using intra­
muscular injections of xyalazine, 4mg/kg and ketamine 2 0 
mg/kg in combination. When rabbits were anaesthetised on 
three consecutive days, a degree of tolerance often occurred 
by the third day. It was thus necessary to increase the 
dosages to achieve anaesthesia.
Sampling of the pre ocular tear film: A solution of EFC^o
was used. Both eyes were sampled. 0.1ml of EFC^q was 
dropped into the lower cul-de-sac and massaged over a closed 
eye for 3 0 seconds approximately. 0.5ml of EFC^o was then 
poured over the cornea and allowed to collect in the lower 
cul-de-sac. The fluid was removed with a pipette and the 
process repeated twice using the same 0.5ml of EFCgo* This 
procedure was not foolproof as a rabbit might occasionally 
pull away causing loss of the ocular washing. In that 
event the procedure was repeated. The sample of pre-ocular
Table 2
Lesions Score for HSV-1 Infections in Rabbit Eyes
Corneal epithelium
0.0 = Normal.
0.1-0.9 = Superficial punctate ulcerations.
1.0-1.9 = One or more dendritic ulcerations.
2.0-2.9 = Geographic ulcerations (less than 7 5% of cornea
involved).
3.0-4.0 = Geographic ulcerations (more than 7 5% of cornea
involved).
Stroma
0 . 0 = Normal.
0.5 = Mild oedema; not diffuse; no haze.
1 . 0 = Mild oedema; slight haze.
2 . 0 = Oedema and haze; diffuse.
3.0 = More oedema; cloudy, can see anterior chamber.
4.0 = Severe oedema; very cloudy, cannot see anterior
chambe r.
Add 1.0 if descemetocoele formation , perforation,
or neovascularization is present.
Iris:
0 . 0 = Normal.
0.5 = Mild hyperemia.
1 . 0 = Hyperemia.
2 . 0 = Marked hyperemia, beginning oedema, folds seen
in iris.
3.0 = Marked oedema; excessive hyperemia.
4.0
=
Fibrinous iritis.
Conj unctiva:
0 . 0 — Normal.
1 . 0  - = Mild hyperemia.
2 . 0 = Severe hyperemia
Add 1.0 if chemosis is present.
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tear fluid was dealt with in one of two ways.
(i) During primary infections, sonication then storage at 
-7 0°C for titration,
(ii) division of sample between two 5 0mm plates of BHK2 1 C^ 3  
cells for viral screening post iontophoresis.
Clinical scoring of rabbit eyes during primary infection:
An established clinical scoring system table, devised by 
Kwon et a l . (19 79) was used to assess the appearance of the 
rabbit eyes (see Table 2). The tissues assessed clinically 
were corneal epithelium, corneal stroma, iris and 
conjunctiva. The rabbits were examined with a flashlight 
torch and fluoroscein dye to determine whether corneal 
ulceration was present. A magnifying loupe was used 
initially to examine corneas in greater detail. This 
technique proved difficult and was abandoned.
Iontophoresis: Rabbits were subjected to iontophoresis of a
0 .0 1 % solution of epinephrine for 8 minutes on three 
consecutive days. The cathode was attached to the shaved 
trunk of the animal and the anode was placed in the solution 
of epinephrine. A direct current of 0.8 mAmp, 7V was 
applied. The tear film of. the rabbits was sampled prior to 
iontophoresis to determine whether spontaneous shedding of 
HSV was occurring and for 8 to 10 days after the first 
iontophoresis procedure to determine whether induced 
shedding was occurring.
Killing of animals; Rabbits were killed humanely by one of 
two methods, (i) intravenous injection of Expiral 
2 0 0 mg/1 .5 kg body weight, (ii) rabbits were stunned and then 
bled by severing jugular arteries and veins. This 
permitted dissection of the central nervous tissue in a 
bloodless field.
62
Dissection of animals: Rabbit eyes and trigeminal ganglia
were removed in the animal house, then dissected in a 
laminar flow hood.
(i ) Removal of eyes; a limbal incision was made to the 
conjunctiva through 3 60°; extra ocular muscles were 
isolated and divided; the optic nerve and vessels were 
divided freeing the globe; the globe was placed in EFCio 
prior to dissection of the cornea.
(ii) Dissection of cornea; each cornea was removed from 
the globe with scissors at the limbus; the cornea was 
divided into six pie shaped wedges which were placed in 
organ culture.
(iii) Removal of trigeminal ganglia; a midline incision was 
made in the rabbit skin over the skull and flaps were 
reflected; connective tissue was divided and bone exposed; 
the vault of the skull was removed using a bone punch and 
scissors; the frontal and middle cranial fossae were 
cleared of cerebral tissue and nerves were divided; the 
middle cranial fossa was exposed and the trigeminal nerve 
root was divided; the trigeminal cave was opened using 
scissors to divide bone; the trigeminal ganglion was 
exposed and removed; the contralateral ganglion was treated 
identically.
(iv) Dissection of trigeminal ganglia; the ganglia were 
maintained in EFCqo f°r a short time prior to dissection; 
the ganglia were divided into six segments and placed in 
organ culture.
Screening for latent HSV by organ culture: At time of
death, the rabbits showed no clinical evidence of active 
infection and were not shedding virus that was detectable by 
sampling the pre-ocular tear film. The technique of
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homogenizing a portion of tissue and plating out to screen 
for an active infection in either corneas or trigeminal 
ganglia was not employed. The dissected corneas and 
trigeminal ganglia were maintained in EFC2 5  at 31°C or 37°C 
in 5% CO 2 - separate organ cultures within a 96 well 
microtitre plate. Each filled well was surrounded by empty 
wells to eliminate cross contamination. The incubated 
cultures of corneas and ganglia were each screened regularly 
post explantation by removing lOOul of supernatant medium 
onto semi-confluent BHK2 1 C1 3  cells, incubating for 4 days at 
31°C and examining for plaques or cytopathic effect after 
staining with Giemsa stain. Organ cultures were generally 
screened daily for 14 days then twice weekly up to 2 8 days. 
Restriction endonuclease analysis; Lonsdale (19 79).
bhk21c13 ceH s were seeded into Linbro wells at 5 x 10^ 
cells per well in 500ul of phosphate free Glasgow modified 
Eagle's medium with 1% calf serum (PIC), and grown at 3 7°C 
overnight. The medium was then removed and 0.1ml of virus 
suspension (containing approximately 5 x 10^ pfu of virus) 
was added to the Linbro well, and allowed to absorb at 3 7°C 
for 1 hour. Cells were then washed with 800ul PIC, and 
450ul of PIC added to each well. Linbro plates were 
incubated for 2 hours at 31°C, before adding 5 0uCi3 2p_ 
orthophosphate (Amersham, carrier free) to each well in 50ul 
PIC. The incubation was continued for 4 8 hours at 3 1°C.
When cytopathic effect was evident, DNA was harvested 
by adding 0.5ml 5% (w/v) sodium dodecylsulphate. The 
mixture was removed with Eppendorf tips and transferred to 
conical plastic 15ml centrifuge tubes (Falcon) and allowed 
to stand at 3 7°C for 10 minutes. Saturated phenol 1ml was 
then added to each tube and inverted several times. The
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mixture was left for 5 minutes at room temperature and the 
same time on ice. The mixture was centrifuged (2,0 00 
rpm/10 mins/4°C). The aqueous phase was removed to a glass 
centrifuge tube and the nucleic acids precipitated by 2 mis 
of ethanol. A further 10 minute spin at 2,000 rpm pelleted 
the DNA. The supernatant was discarded and the tubes 
inverted and drained. The nucleic acids were re-suspended 
by gentle shaking for 2 hours in a 3 7°C waterbath, with 
200ul of H 2 O containing 25ul of RNase.
The re-dissolved nucleic acids (lOul) were transferred 
to a 2.5cm Whatman's no. 1 filter paper disc and air dried. 
The discs were given three washes in 5% trichloracetic/0.1 
ml sodium tetrapyrophosphate, three washes in absolute 
ethanol and then air dried. The discs were placed in 5% 
toluene PPO and counted for 1 minute in a scintillation 
counter. Samples containing equal counts were added to the 
appropriate restriction enzyme buffer mix including 1 % 
bovine serum albumin, water and sufficient restriction 
enzyme to give a complete digest in 4 hours at 3 7°C; total 
volume 3 Oul. The reactions were stopped by the addition of 
lOul R.E. stop.
Digests were analysed after overnight electrophoresis 
40mV, on agarose gels of suitable strength. Gels were air 
dried onto glass plates and exposed to film for 12-4 8 hours.
RESULTS
Data is presented in tabulated form and groups of 
animals are identified by a series of letters and numbers to 
permit their course to be followed. Each group of animals 
did not necessarily follow an identical protocol. This was 
necessitated by the restriction on animal house space and
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the difficulties encountered in working with small numbers 
of rabbits.
EXPT. (1) group A(i) 3 rabbits; infecting dose
5 x 105 pfu/eye HSV-1 strain 17. 
group B(i) 3 rabbits; infecting dose
5 x 10^ pfu/eye HSV-2 strain HG52. 
Clinical scoring; The clinical scoring system was not in 
use during experiment 1 , and animals were simply examined 
and a clinical impression of the eye was noted. The three 
animals inoculated with HSV-1 strain 17 [A(i)], had evidence 
of herpetic eye disease including dendrites and conjunctival 
inflammation, which was maximal around day 7, and almost 
completely resolved fcy day 13. The group B(i) animals had 
no clinically discernible evidence of ocular herpetic 
infection.
Titration: Group A(i); the average titration from the
animals on days 1 - 1 0  post inoculation is presented in figure 
2 2.
Group B(i); a few viral plaques were detected from 2 
rabbits on days 1 and 2 respectively post inoculation. No 
other virus was detected from this group.
Mortality; group A(i); one animal at 21 days post 
inoculation. This was quite unexpected and not attributed, 
by us, to the herpetic infection.
Group B(i); none.
Spontaneous shedding; days 4 0-60 
Group A; none 
Group B; none.
Iontophoresis: days 61-6 3 (inclusive). No HSV shedding 
was induced in either group A(i) or B(i) after iontophoresis
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FIGURE 22
Average titration of primary infection with HSV-1 strain 17.
o -----o group A (i) infecting dose
5 x 1 0  ^ pfu/eye
A ---------------A  group A (ii) infecting dose
'' 1 0  ^ pfu/eye
A  —  —  —  —A. group A (iii) infecting dose
1()6 pfu/eye
Symbols on the Y axis indicate the infecting dose. Rabbits 
that died within 10 days of inoculation in groups A (ii) 
and (iii) are not included in the average titrations.
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of epinephrine.
Latency: One animal of group A(i) released virus from the
left trigeminal ganglion after 3 days of organ culture and 
from the right trigeminal ganglion after 6 days of organ 
culture. The other surviving animal in this group did not 
release latent HSV. (It is likely that inexpert dissection 
was to blame!) The group B(i) animals were not dissected 
as it was thought unlikely at that time that there would be 
latent infection. Similarly corneas were not organ 
cultured for HSV.
EXPT. (2) group A(ii) 8 rabbits; infecting dose
107 pfu/eye HSV-1 strain 17.
Clinical scoring: The average clinical score from the
animals on days 1-10 is shown in figure 2 3. The clinical 
scores from the rabbits destroyed on day 8 because of 
encephalitis and excoriation are not included in the average 
clinical scores but shown separately.
Titration: The average titration of HSV-1 from the left
eyes of animals is shown in figure 2 2. All animals had 
detectable virus in the right eye within the 1 0  days 
post-inoculation. The amount of virus was minimal, except 
in three animals; the animal that died on day 13 from 
presumed encephalitis had HSV shedding from the right eye at 
a titre of 1 0  ^ pfu/ml between days 8 and 1 0 ; the animal 
with the excoriated ear destroyed on day 8 shed virus from 
the right eye on days 7 and 8 at a titre of 7 x 1 0  ^ pfu/ml; 
and the animal destroyed on day 3 0, had shed HSV at a titre 
of lO-^-lO^ pfu/ml between days 6 and 10. The rabbits 
destroyed on day 8 because of encephalitis and excoriation 
are not included in the average titrations.
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FIGURE 23
Average clinical score of primary infection with HSV-1 
strain 17.
Group A (ii) The rabbit destroyed on day 8 (encephalitis) is 
not included in the average scores but is shown separatelyA 
The rabbit destroyed on day 8 (excoriation) is not included 
in the average score but is shown separately*
Group A (iii) The rabbit destroyed on day 8 (encephalitis) 
is not included in the averge scores but is shown 
separatelyA The rabbit destroyed on day 10 (excoriation) is 
not included in the average score but is shown separately^
▲ ^  group A (ii) infecting dose
10? pfu/eye 
A  group A (iii) infecting dose
10^ pfu/eye
A"
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Mortality: Five out of eight rabbits in this group died or
were killed because of severe disease within 1 month of 
inoculation. One animal was destroyed because of an 
encephalitis 8 days post inoculation, and another was found 
dead 13 days post inoculation presumably due to 
encephalitis. Three other animals were destroyed because 
of severe ocular disease with adjacent lid, skin or ear 
infection and excoriation.
Spontaneous shedding: The three surviving animals were 
monitored for spontaneous shedding for 4 weeks, 5 days out 
of 7, from days 21-46. One animal shed virus spontaneously 
for 3 days between days 2 3-2 5, from the left eye. 
Iontophoresis: Applied days 85-87 post inoculation. No
rabbits shed virus after iontophoresis including the 
spontaneous shedder. Further iontophoresis treatments were 
performed on days 126-128 post inoculation with negative 
results, and on days 147-149 post inoculation when an animal 
that had not shed virus spontaneously, had detectable HSV in 
the ocular washings on the 4th and 6 th day after the first 
iontophoresis treatment, highest titre 2 . 8  x 1 0  ^ pfu/ml.
EXPT. (3) group A(iii) 8 rabbits; infecting dose
10^ pfu/eye HSV-1 strain 17.
Clinical scoring: The average clinical score from the
animals on days 1-10 post inoculation is shown in figure 2 3. 
Titration: The average titration from the left eyes of
animals is shown in figure 2 2. The rabbit destroyed 
because of encephalitis on day 8 , shed HSV-1 from the right 
eye in significant amounts (not titrated but extensive 
c.p.e. on culture plates) between days 5 and 7.
Mortality: One rabbit was destroyed on day 8 because of an
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encephalitis, another was destroyed on day 10 because of 
severe ocular disease with lid excoriation.
Spontaneous shedding: Animals were sampled for 2 0 days, as
in experiment 2, between days 18 and 4 3. No rabbits shed 
virus spontaneously.
Iontophoresis: Two animals shed HSV after iontophoresis;
the first animal within 2 4 hours of the first treatment, 
detected on one day only, 102 pfu/ml; the second animal 
within 4 8 hours of the first treatment for five consecutive 
days, peak titre on day 3 of shedding 2 x 10^ pfu/ml. 
Iontophoresis was applied on days 48-50 inclusive. Further 
iontophoresis treatments were repeated on days 59-61 and 
days 8 0-82 with negative results.
EXPT. (4) group C(iv) 7 rabbits; infecting dose
105 pfu/eye HSV-1 strain McKrae. 
Clinical scoring: The average clinical score from the
animals on days 1-10 post inoculation is shown in figure 2 4. 
Titration; The average titration from the left eye of 
animals is shown in figure 2 5.
Mortality; Two animals were found dead in their cages on 
days 10 and 18 post inoculation, respectively. One animal 
was destroyed on day 8 with an encephalitis, and another was 
destroyed on day 2 0 post inoculation because of its poor 
condition. A fifth animal was destroyed on day 5 3 post 
inoculation because of severe ocular disease.
Spontaneous shedding: One of the three surviving rabbits
shed virus spontaneously for one day within the 2 0 day 
period between days 19 and 4 4.
Iontophoresis: The two surviving animals had iontophoresis
of epinephrine between days 65 and 67 inclusive. Both
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FIGURE 24
Average clinical score of primary infection with HSV-1 
strain McKrae.
j  _______ || group C (iv) infecting dose
10^ pfu/eye
The clinical score of each animal is indicated on each day 
by a • . Considerable variation in the clinical score 
exists among animals. The maximum and minimum ranges are 
indicated ty dashed lines.
10a ------------------ 1------------------- 1-------------------1-------------------1----------------1
2 4 6 8 10
Time (days post inoculation )
FIGURE 25
Average titration of primary infection with HSV-1 strain 
McKrafe.
J  j  group C (iv) infecting dose
10^ pfu/eye
Symbol on the Y axis indicates the infecting dose.
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animals shed HSV-1 for 4 8 hours on the fourth day after 
first iontophoresis. The titres were 5 x 10^ pfu/ml and 
>104 pfu/ml.
EXPT. (5) group B(v)a 3 rabbits; infecting dose
5 x 10^ pfu/eye HSV-2 strain HG5 2 
(unscarified) 
group B(v)b 3 rabbits; infecting dose
5 x 10^ pfu/eye HSV-2 strain HG5 2 
(unscarified) 
group B (v )c 3 rabbits; infecting dose
5 x 1()6 pfu/eye HSV-2 strain HG5 2 
; (scarified)
group B(v)d 3 rabbits; infecting dose
5 x 10^ pfu/eye HSV-2 (scarified) 
Clinical scoring; The average clinical score from each 
group of animals on days 1-10 post inoculation is shown in 
figure 2 6.
Titration; The average titration from the left eyes of the
animals in each group is shown in figure 2 7.
Mortality; A rabbit from group B(v)d was found dead 18 days 
post inoculation.
Spontaneous shedding: Animals were not screened for
spontaneous shedding.
Iontophoresis; Eleven surviving animals had iontophoresis 
with epinephrine between days 2 7-29. One rabbit from group 
B(v)c shed detectable virus 72 hours after first 
iontophoresis. One rabbit from group B(v)d shed detectable 
virus 72 hours after first iontophoresis, which was 
detectable for the following 72 hours.
Latency; All rabbits from group B(v)a, and two of the three
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FIGURE 26
Average clinical score of primary infection with HSV-2 
strain HG52.
A- • — .... .....A group B (v) a infecting dose
5 x 10^ pfu/eye (u)
▲ --------------- ▲ group B (v) b infecting dose
; 5 x 10^ pfu/eye (u)
□—  --  — - — □ group B (v) c infecting dose
5 x 10^ pfu/eye (s)
■--------- group B (v) d infecting dose
5 x lO^ pfu/eye (s)
(u) - unscarified
(s) - scarified
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FIGURE 27
Averse titration of primary infection with HSV-2 strain 
HG52.
A  • • • • group B (v) a infecting dose
-
5 x 10^ pfu/eye
-------------A group B (v) b infecting dose
5 x 10^ pfu/eye
□—  — —  -----  □ group B (v) c infecting dose
5 x 10^ pfu/eye
■---- ________ ■ group B (v) d infecting dose
5 x 10^ pfu/eye (s)
(u) - unscarified
(s) - scarified
t
Symbols on the Y axis indicate the infecting dose.
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rabbits from group B(v)b were sacrificed between days 4 3 and 
45 post inoculation. The third rabbit from group B(v)b was 
sacrificed on day 5 8 post inoculation. Trigeminal ganglia 
and corneas were explanted, randomly divided and screened 
for latent HSV. No HSV was detected. This result from 
the trigeminal ganglia was very surprising, and suggested 
that dissection was inadequate. The technique was 
therefore re-demonstrated. It appeared that trigeminal
nerve root rather than ganglion was being explanted.
The five remaining animals in groups B(v)c and d were 
sacrificed and tissues explanted for screening on day 59. 
Left trigeminal ganglia from animals in group B(v)c shed 
virus for the first time on days 8, 11 and 18 respectively. 
No right ganglia shed virus. No corneas shed virus. The 
left ganglia from both animals in group B(v)d shed virus on 
day 8 post explantation. No right ganglia or corneas shed 
virus.
EXPT (6) group A(vi) 4 rabbits; infecting dose
5 x 10^ pfu/eye HSV-1 strain 17 
(unscarified) 
group B(vi) 3 rabbits; infecting dose
5 x 107 pfu/eye HSV-2 strain HG5 2 
(unscarified) 
group C(vi) 4 rabbits; infecting dose
5 x 105 pfu/eye HSV-1 strain McKrae 
(unscarif ied)
Clinical scoring; The average clinical score from each 
group of animals on days 1-10 post inoculation is shown 
in figure 28.
Titration: The course of the primary infection was not
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FIGURE 28
Average clinical score of primary infection with HSV-1 
strains 17 and McKrae and HSV-2 strain HG52.
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group C (vi)
infecting dose 
5 x 10^ pfu/eye 
HSV-1 strain 17 
infecting dose 
5 x 10^ pfu/eye 
HSV-2 strain HG5 2 
infecting dose 
5 x 10^ pfu/eye 
HSV-1 strain McKrae
titrated. Virus was present in the ocular washings of all 
animals on day 7, post inoculation.
Mortality; An animal from group A(vi) was put down on day 
16 post inoculation because of severe excoriation and 
scratching of the left lower lid. A rabbit from group 
C(vi ) was put down on day 31 because of a necrotising 
keratitis.
Spontaneous shedding; Animals were sampled for spontaneous 
shedding between days 2 0-29 post inoculation. Spontaneous 
shedding of HSV occurred, in one animal of group A(vi) and 
one animal of group B(vi) both on day 27 post inoculation 
and for one day only.
Iontophoresis; Animals were subjected to iontophoresis of 
epinephrine on days 29-31. No rabbits from groups A(vi) or 
B(vi) including the spontaneous shedder, shed HSV after 
iontophoresis. The three surviving animals in group C(vi) 
all shed HSV 7 2 hours after first iontophoresis for a 
further 7 2 hours, 2 4 hours and 48 of 9 6 hours respectively. 
Iontophoresis of epinephrine was repeated on days 6 7-69 on 
the three animals inoculated with the HSV-1 strain McKrae. 
Two of the three animals shed ocular HSV 9 6 hours post 
iontophoresis, one for 7 2 hours, the other only on one day. 
No ocular shedding of virus was detected in the third 
rabbit. The technique of iontophoresis of epinephrine thus 
gave partially repeatable induced reactivation (two out of 
three) and ocular shedding with the HSV-1 strain McKrae. 
Latency; Group A(vi); two animals shed virus from the 
explanted left trigeminal ganglion on days 6 and 10 post 
explantation. Another animal shed HSV from the right 
trigeminal ganglion on day 12 and the left ganglion on day 
22 post explantation. The fourth animal in the group first
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shed from the left on day 10 and the right on day 2 8 post 
explantation. All corneas were negative.
Group B (vi ); virus was shed from the left ganglion on 
days 15 and 22 in two rabbits, and from the left on day 7 
and the right on day 13 in the third animal. All corneas 
were negative.
Group C(vi); see table 3.
Virus was shed from all left ganglia and three right 
ganglia. Virus was also detected from the left cornea of
animal 3. This animal was sacrificed on day 31 because of
a necrotising keratitis. However ocular washings for the 2 
days prior to death were negative for HSV.
EXPT (7) group C(vii) 14 rabbits; infecting dose
5 x 10^ pfu/eye HSV-1 strain McKrae 
(unscarified)
Clinical scoring; Animals were examined on days 5 and 10 
post inoculation for evidence of clinical ocular herpetic 
disease. All animals had clinical evidence of herpetic 
disease on days 5 and 10.
Titration: Primary infections were not titrated. Clinical
disease was regarded as positive proof of infection. 
Mortality: Seven of the fourteen animals died within
14 days of the primary infection, six of them from 
encephalitis. The seventh had severe excoriation of the 
lower lid and was put down. An eighth animal was moribund 
on day 2 7 post inoculation and was put down.
Spontaneous shedding: Animals were sampled for 15 of 17
consecutive days. All animals shed virus on at least two 
separate occasions, often for more than one day. Animals 
were sampled between days 2 4 and 41 post inoculation.
Table 3
Group C(vi):
Detection of latent virus after organ culture (days 
post-explantation)
ANIMAL
1 2 3 4
s (L )TG 8 10 6 17
I (R) TG 28 24 - 10
T (L)C - - 24 -
E (R)C — — — —
L = left 
R = right 
TG = trigeminal ganglion 
C = cornea
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Iontophoresis: Animals were subjected to iontophoresis 
between days 4 6-4 8 post inoculation. One shed HSV within 
48 hours of first iontophoresis, the other five animals shed 
virus within 7 2 hours of first iontophoresis.
Latency: All left trigeminal ganglia released HSV-1 into
the supernatant medium between 4 and 7 days after 
explantation. Two right trigeminal ganglia released HSV-1, 
5 and 7 days after explantation, but no corneas released 
HSV-1 after explantation.
RESTRICTION ENDONUCLEASE ANALYSIS
The HSV-1 strain 17 and strain McKrae were analysed 
simultaneously using seven restriction endonuclease enzymes, 
namely; Hindlll, EcoRI, Hpal, BamHI, PvuII and Xbal. The 
method of Lonsdale (19 79 ) was used throughout. The Xbal, 
Hindlll, EcoRI and PvuII digests were run on a 0.6% agarose 
gel. The BamHI, Hpal and Kpnl digests were run on a 1%
gel. The results are presented in figures 29 and 3 0.
Restriction endonuclease maps for the above enzymes and 
HSV-1 strain 17 are shown in figure 31.
Analysis:- Xbal profiles, no sites lost and no discernable 
fragment size differences.
Hindlll, the m/n site in McKrae compared to 17 is lost from 
the Ug region.
The following bands are missing:
m Ug 0.83 - 0.88 map units
n . Ug 0.88 - 0.914 map units
f_ (.i+m) . TRL + IRg
c (d+m) irl + IRg
The following new bands are formed:
m( 4. 5 ) + n (2 .9 ) total 7.4 band running with h/i
FIGURE 29
Restriction endonuclease analysis of the genomes of HSV-1 
strain 17 and strain McKrae using Hindlll, PvuII and EcoRI 
enzymes. Maps for the genome of the HSV-1 strain 17 are 
shown in figure 31.
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FIGURE 30
Restriction endonuclease analysis of the genomes of HSV-1 
strain 17 and strain McKrae using Xbal, BamHI and Hpal 
enzymes. Maps for the genome of the HSV-1 strain 17 
are shown in figure 31.
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FIGURE 31
Restriction endonuclease maps for the genome of HSV-1 strain 
17 using the enzymes Xbal, Hindlll, EcoRI, Bglll, Hpal, Kpnl 
and BamHI.
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m+n + ]^(7.0) total 14.4
m+n + d(18) total 25.4
EcoRI, no sites lost.
Fragment size differences:
_1 Ul smaller
k IRg smaller
n Ug larger
PvuII, no sites lost 
Fragment size differences:
'~e Ug larger
f Ul larger
n Ul smaller
« w IRg larger
BamHI, no sites lost.
Fragment size difference:
a
n
s or t
UL
IRS+Ug
smaller
larger
smaller
larger
band runs below d/e 
bands runs with a/b
approx. 0.1 x 106 
approx. 0.1 x 10^ 
approx. 0.1-0.2 x 10^
approx. 0.1 x 10^ 
approx. 0.2-0.3 x 10^ 
approx. 0.1 x 10^ 
approx. 0.1 x 10^
approx. 0.5 x 106 
approx. 0.1 x 10^ 
approx. 0.1-0.2 x 10^ 
approx. 0.1 x 10^or z IRg 
Hpal, no sites lost.
Fragment size differences:
Some size alterations in the opqrs group, probably the 
changes are in the _i, o, or r terminal fragments. 
pqrs UL
o TRl
DISCUSSION 
Primary infections
(i) Clinical scores: The three strains of HSV used in 
experiments are all capable of inducing ocular herpetic 
disease. The HSV-1 strain 17 induced ocular disease at the
lowest m.o.i., 5 x 10^ pfu/eye, expt. 1. The ocular signs 
were maximal on day 7 and almost completely resolved by day 
13. When the m.o.i. was increased to 10^ pfu/eye, expt. 2, 
and 10? pfu/eye, expt. 3, the ocular signs were maximal on 
day 8, and diminishing thereafter (fig. 23). This figure 
also shows that the higher m.o.i. did not lead to more 
severe ocular disease, confirming the results of Wander et 
al. (1980). The HSV-2 strain HG52 induced no discernible 
ocular disease at 5 x 105 pfu/eye, expt. 1. When higher 
m.o.i". *s were used, expt. 5, ocular disease occurred, 
however there was minimal difference in the clinical 
appearance of eyes infected at 5 x 10^ pfu/eye or 5 x 107 
pfu/eye (fig. 26). The severity of ocular disease was 
increased when HSV-2 strain HG52 was inoculated onto a 
scarified cornea. Scarifying the cornea presumably allows 
virus to adsorb to a greater number of cells, and also 
increases the initial depth of viral penetration within the 
cornea. Infection thus becomes established, superficially 
and deeply. The clinical course of eyes infected with the 
HSV-1 strain McKrae at a m.o.i. of 10^ pfu/eye, expt. 4, is 
shown in figure 2 4. The signs of infection were maximal on 
day 7 and diminish thereafter. This was broadly similar to 
the results with the HSV-1 strain 17. Within an 
experimental group of animals the clinical score varied 
widely. This is demonstrated in figure 2 3 where animals 
that died of encephalitis or were destroyed because of 
excoriation were recorded individually. The clinical 
scores of all animals in experiment 4 are shown in figure 
2 4. A considerable range existed between the minimum and
maximum clinical score after day 3 post inoculation.
Larger numbers of animals would be required to determine
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significant trends.
When the three strains of virus were used at m.o.i. 's 
capable of inducing ocular disease and minimising mortality, 
expt. 6, the HSV-1 strains gave a similar disease score.
The HSV-2 strain HG52 had a much reduced clinical score 
despite the m.o.i. being 1 log greater than the HSV-1 strain 
17 and 2 logs greater than the HSV-1 strain McKrae (fig.
28). The ability of the HSV-2 strain HG52 to cause ocular 
disease was limited in comparison with the two HSV-1 
strains, however HG52 is known to be less pathogenic than 
most HSV-2 strains.
Intertypic and intratypic strain variation is well 
documented. Oh and Stevens (19 73) have suggested that 
HSV-2 strains were more pathogenic to the eye. This
contrasts with the findings above.
ii) Titrations; The average ocular titration for each 
group of animals during the first 10 days post-inoculation 
in experiments 1-3 for HSV-1 strain 17 is shown in figure 
22. In experiments 1 and 3 at the lower m.o.i. 's, virus 
appears to be present in the ocular washings in increasing 
amounts after a lag phase of 2 4-4 8 hours. At the highest 
m.o.i. 107 pfu/eye, expt. 2, the amount of virus recovered 
from the eye decreases steadily after inoculation. Figure 
27 shows the average titration of virus in the first 10 days 
post inoculation with HSV-2 strain HG52, expt. 5. The 
average titration for the McKrae strain during primary 
infection is shown in figure 2 5. Two peaks in the McKrae 
curve are obvious on days 3 and 8; these were caused fcy a
high titre of virus being found in the eye of one animal,
which caused the average to be raised. No relationship 
between m.o.i., and/or scarification is obvious using the
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HSV-2 strain HG52.
As the infection progresses, the clinical score 
correlates poorly with the virus recoverable from ocular 
washings. The clinical score takes account of more 
widespread disease within the corneal stroma and the iris, 
whereas ocular washings only collect virus produced 
superficially by corneal and conjunctival epithelium. 
Mortality: The mortality of animals inoculated with HSV-1
strain 17 does not increase in relation to the multiplicity 
of infection, Ihble 4. For these purposes mortality refers 
to death from encephalitis within 3 0 days post inoculation. 
The HSV-2 strain HG52 has a low incidence of mortality 
irrespective of m.o.i. The mortality rate for rabbits 
infected with HSV-1 strain McKrae ranged from 0-50%.
The infecting doses used were 10^ and 5 x 10^ pfu/eye.
The mortality rates for the McKrae strain are similar to 
the results of Berman and Hill (1985). Encephalitis was 
occasionally preceded try the shedding of virus from the 
non inoculated right eye, expts. 2 and 3. A total of nine 
animals out of 6 6 were put down humanely because of severe 
excoriation around the lower lid. Scratching may have been 
caused by discharge from the eye (although care was always 
taken to keep animals clean) or perhaps fcy spread of virus 
to the surrounding skin via zosteriform spread (Simmonds and 
Nash 1984) .
Spontaneous shedding: Spontaneous shedding of HSV in the
tear film of rabbit eyes has been documented (Nesburn et 
al., 1967, laibson and Kibrick 1969, and Berman and Hill 
1985). The largest study of spontaneous ocular shedding of 
HSV in rabbits was performed by Gerdes and Smith ( 19 83). 
Cumulative data from experiments 1-7 is presented in Table
Table 4
Cumulative Data: Experiments 1-7
Mortality within one month of inoculation due to 
encephalitis.
Viral Strain
-
A (17ts+syn+ ) B (HG5 2) C (McKrae)
105 3/7* (iv)$
Multiplicity
of
5x10^ 0/3 (i ) 0/3 (i) 0/4 (vi) 
7/14 (vii)
Infection
106 1/8 (iii)
pfu/eye 5x106 0/4 (vi ) 0/6 (v)
107 2/8 (ii)
5xl07 1/6 *.( v )
0/3 (vi)
* Number of deaths/number of animals inoculated. 
$ Experiment number
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5. The small number of animals used in experiments, and 
the infrequent samplings for spontaneous shedding do not 
permit any valid comparison with the results of Gerdes and 
Smith (19 83). Their results suggested that both the McKrae 
strain and the 17 strain had high frequencies of spontaneous 
shedding with 5.3% and 2.4% respectively of positive 
cultures for the total number of cultures taken. The HG5 2 
strain had a very low frequency of spontaneous recurrence at 
0.15%. The spontaneous shedding results from my 
experiments (1 - 6 ) give a frequency of spontaneous shedding 
for the 17 and McKrae strains considerably less than that of 
Gerdes and Smith ( 19 83). The spontaneous shedding result 
from experiment 7 give a considerably higher frequency.
No valid conclusions can be drawn from this series of 
experiments. The importance of spontaneous ocular shedding 
of HSV was noted by Shimomura et al. (19 83) who observed 
that latently infected rabbits that shed virus spontaneously 
could be induced to shed virus at a much higher frequency 
and for a longer duration than animals that had not shed 
virus spontaneously. Spontaneous shedding proves that both 
HSV latency and reactivation mechanisms are operating. 
Induction of virus shedding after iontophoresis: The
induction of ocular shedding of HSV-1 following 
iontophoresis of epinephrine into the rabbit eye was 
described by Kwon et a l . (1981). The iontophoresis of 
epinephrine reactivates latent HSV within the trigeminal 
ganglion, and infectious virus can be quantified from cell 
free homogenates of the ganglion after iontophoresis 
(Shimomura et al., 1985).
The cumulative results from experiments 1-7, Ihble 6 , 
suggest the HSV-1 strain 17 is capable of induced
Table 5
Cumulative Data: Experiments 1-7
Spontaneous viral shedding.
Viral Stra in
- A (17ts+syn+ ) B (HG5 2) C (McKrae)
1 0 5 1/60* (iv)$
Multiplicity 
of
5x105 0/40 (i) 0/60 (i) 30/90 (vii)
Infection
1 0 6 0 /l 2 0  (iii>
pfu/eye 5x106 1/30 (vi)
1 0 7 3/60 (ii)
5xl07 1/30 (vi)
* Number of days viral shedding/number of days sampled. 
$ Experiment number
Table 6
Cumulative Data; Experiments 1-7 
Iontophoresis induced viral shedding.
Vi ral Strain
- A (17ts+syn+ ) B (HG52) C (McKrae)
1 0 5 2 / 2 * 4$
Multiplicity
of
5xl05 0/3 (i) 0/3 (i) 3/3 (vi) 
2/3 (vi) 
6 / 6  (vii)
Infection
1 0 6 2 / 6 (iii)
pfu/eye 5x106 0/3 (vi) 1 / 6  (v)
1 0 7 V 3 (ii)
- 5x107 1/5 (v) 
0/3 (vi)
* Number of animals shedding virus post iontophoresis/ 
number of animals undergoing iontophoresis.
$ Experiment number
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reactivation and ocular shedding following iontophoresis of 
epinephrine. However the results were not repeatable as 
subsequent treatments failed to induce ocular shedding of 
virus. The rabbits of the 17 strain that shed virus 
spontaneously did not have iontophoresis induced virus 
shedding. The picture for the HSV-2 strain HG5 2 is 
similar, but the frequency of induced reactivation is lower.
In contrast the HSV-1 strain McKrae had a 100% 
frequency of induced reactivation in the three groups of 
rabbits subjected to iontophoresis. The process was 
repeatable in two out of three rabbits, experiment 6 .
Induced shedding of ocular HSV-1 was therefore produced in 
some animals that failed to shed virus spontaneously.
A recent study by Hill et al. (19 87) concluded that the 
17 strain had a low frequency of spontaneous reactivation 
and shedding, 3.3%, but a high frequency of induced 
shedding, 67%. The study was based on six survivors from 
twenty animals bilaterally inoculated through a scarified 
cornea.
Latency in neural and extra neural tissue: HSV was always
recovered from all left trigeminal ganglia explanted and 
then screened for latent HSV, irrespective of whether or not 
the animal had a spontaneous or induced reactivation of 
ocular virus shedding during life, Thble 7. This implies 
that HSV was always present in the ganglia during life, and 
thus potentially available for reactivation. Failure to 
spontaneously shed virus or failure to shed virus after the 
iontophoresis of epinephrine, suggests that epinephrine is 
not the sole stimulus to reactivation, and that viral 
genetic differences are involved in view of the intra- and 
intertypic strain variation. Virus from right trigeminal
Table 7
Cumulative Data; Experiments 1-7 
Virus latent in left trigeminal ganglion
Viral Strain
A (17ts+syn+ ) B (HG5 2) C (McKrae)
1 0 5 4 / 4 * 0  (vi)$
Multiplicity
5x105 1 / 1  (i) 6 / 6  (vii)
of
Infection 1 0 6
pfu/eye 5xl06 3/3 (vi) 3/3 (v)
p-oi—i
5xl07 2 / 2 (v)
3/3 (vi )
* Number of positive left trigeminal ganglia/number 
of animals.
$ Experiment number
o Not included are negatives which occurred as a result of 
inexpert dissection. Details available in results 
section.
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ganglia was also detected from animals in group A(i) one 
rabbit; group A(vi) two rabbits; group B(vi) one rabbit; 
group C(vi) three rabbits and group C(vii) two rabbits. 
Animals were not inoculated via the right eye. It is 
likely that HSV reached the right trigeminal ganglion during 
the course of the primary infection, with virus spreading 
from the left eye to the left trigeminal ganglion, through 
the central nervous system to the right trigeminal ganglion. 
The spread of virus may stop there, or it may continue to 
the right eye as happened with several rabbits who had an 
encephalitis, expts. 2 and 3. A similar route of spread 
was postulated by Tullo et al. (1982a and b) , to explain 
latent HSV in non ophthalmic divisions of the trigeminal 
ganglion after ocular inoculation. Two other explanations 
have to be considered for spread to the right trigeminal 
ganglia; the animals may cross-infect between right and 
left eyes by scratching; and the mucous membranes of the 
eyes are in continuity via the nasolacrimal tear passages 
and nasopharynx.
The McKrae strain of HSV-1 was also recovered from the 
left cornea of one rabbit, expt. 6 , after 2 4 days in organ 
culture. This animal had a severe necrotising keratitis 
and was put down because of this. However ocular washings 
for the two days prior to death were negative. In addition 
virus was recovered from the left trigeminal ganglion after 
only 6 days of organ culture. HSV has been recovered from 
other non neural sites after explantation and culture, 
namely mouse skin (Hill et al., 1983), mouse footpads 
(Al-Saadi et al. , 1983), and ocular posterior segments in 
mice (Openshaw, 1983) in latently infected animals. HSV 
has also been recovered from human corneas after
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explantation and culture (Shimeld et al. , 19 82, Tullo 
et al. , 1985 and Cook et al. , 1986). Batra ( 1987) 
confirmed that HSV-1 strain McKrae was recoverable from the 
corneas of latently infected rabbits. Virus was always 
recovered later from the corneal explants than from the 
trigeminal ganglion explants. The observation has been 
repeated using an HSV-1 McKrae/HSV-2 HG52 recombinant whose 
genome structure is McKrae except for the sequence between 
0.33 and 0.56 map units (Cook et al. , 1987).
In summary the HSV-2 strain HG5 2 is not pathogenic to 
rabbit eyes, and is not neuropathogenic. It has a low 
frequency of spontaneous reactivation and ocular shedding 
for. a HSV-2 virus, and a very low frequency of induced 
reactivation after iontophoresis of epinephrine. The HSV-2 
strain HG52 is able to maintain latent infections within the 
trigeminal ganglion. The HSV-1 strain 17 is pathogenic to 
rabbit eyes, and is neuropathogenic. It has a low 
frequency of spontaneous reactivation, and an intermediate 
frequency of induced viral reactivation, which is unreliable 
in terms of repeatability. Latency is established within 
the trigeminal ganglion. The HSV-1 strain McKrae is 
pathogenic to rabbit eyes and particularly neuropathogenic, 
even at the lowest m.o.i. tested (10^ pfu/eye) . It has a 
high frequency of both spontaneous and induced viral 
reactivation. Induced reactivation is repeatable. The 
McKrae strain is able to maintain latent trigeminal ganglion 
infections. The McKrae strain appears to differ in that it 
has a limited ability to maintain a latent infection within 
the cornea. These three viruses, particularly the HSV-1 
strain McKrae and the HSV-2 strain HG52 with distinct 
biological properties will provide
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useful tools in determining regions of the genome 
responsible for reactivation and neuropathogenic. Batra 
(1987) has constructed McKrae XHG52 recombinants to study 
latency reactivation differential. Thompson et al. (19 83, 
1985) utilized intertypic recombinants from the HSV-1 strain 
17 and HSV-2 strain HG52, to locate the neuro-vi rule nee 
region of the genome to between 0.71 and 0.74 map units in 
the HSV DNA sequence. Recent work by Halliburton et al. 
(1987) using 31 different HSV-1 X HSV-2 intertypic
recombinants is less definite about the location of the
genes for neurovirulence and suggests that this biological 
function may be under multigenic control.
Restriction endonuclease analysis; Only limited mapping 
data is available for the HSV-1 strain McKrae from Gerdes 
and Smith (19 83), who reported the loss of the following 
17 strain defined sites in the McKrae strain: Hindi II m/n,
Kpnl c/x and a Hpal k site. My restriction endonuclease 
results confirm the loss of the Hindi II m/n site in the
short unique section but show a similar Hpal map with no
site losses. No sites are lost with the other enzymes 
tested, EcoRI, PvuII, BamHI and Xbal, although fragment size 
variation exists. Batra ( 1987) has made a more detailed 
examination of the Kpnl site differences and confirmed the 
loss of the Kpnl c/x site and the Kpnl d/z site. The 
McKrae strain also had an additional Kpnl site in TRl and
irl.
Variation in restriction maps between HSV-1 strains is 
predictable. Correlating different biological properties 
and relating them to virus genes, and DNA sequences 
represents the work of a lifetime.
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CHAPTER 4
IN VITRO EXPERIMENTS
Growth and characterization of rabbit corneal cells in vitro 
MATERIALS
Rabbits: Young female animals 3-6 months old and weighing
between 1.5-2kg were obtained from Hyline Rabbit Farms. 
Outbred New Zealand white rabbits were used.
Dissection of the cornea was performed using a Griffin 
dissecting microscope.
Media: Epithelial cells were grown in Glasgow modified
Eagle's medium plus 10% (v/v) foetal calf serum, 
supplemented with penicillin/streptomycin 1 0 0  units/ml, and 
L-glutamine 1% (v/v) ( EFC^q ) • Keratocytes and endothelial 
cells were grown in 20 mM Eepes buffered Dulbecco's medium 
plus 1 0 % (v/v) foetal calf serum supplemented with 
penicillin/streptomycin 100 units/ml, and L-glutamine 1% 
(v/v)(DFC1 0 ). Epithelial cells were stored in Eagle's 
medium 65%, supplemented as above with penicillin/ 
streptomycin and L-glutamine, foetal calf serum 25% (v/v) 
and glycerol 10% (v/v). Keratocytes were stored in 
Dulbecco's medium 65% (v/v), supplemented as above with 
penicillin/streptomycin and L-glutamine, foetal calf serum 
25% (v/v) and glycerol 10% (v/v).
Glasswear: Cells were grown in 2 5cm2, 8 Ocm^ and 175cm2
plastic tissue culture flasks supplied by Nunclon.
Antisera : Monospecific rabbit antiserum against human 
plasma fibronectin was obtained from Bethesda Research 
Laboratories. Polyspecific guinea pig anti keratin 
antiserum was obtained from Miles Scientific. Antibody 
binding was visualised with sheep anti rabbit IgG,
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conjugated to fluoroscein, supplied by Wellcome, and rabbit 
anti guinea pig IgG conjugated to fluoroscein, supplied by 
Miles Scientific.
Electron microscopes: A Jeol T2 00 scanning electron
microscope and a Philips 301 transmission electron 
microscope were used (Work done by Mrs. D.A. Aitken, Tfennent 
Institute of Ophthalmology).
METHOD
Cells: Rabbit corneal cells were prepared by the
microdissection method described by Stocker et al. (1958). 
Briefly, the eyes of freshly killed rabbits were 
ennucleated. Corneal explant cultures were prepared within 
a laminar flow hood. The cornea was separated from the 
globe by a circumferential incision 1 mm within the limbus 
and then anchored to a sterile dissecting block, epithelial 
surface face down. Descemet's membrane with its attached 
endothelial cells was peeled from the underlying stroma, 
divided and placed in a 25cm2 tissue culture flask 
containing medium. Endothelial cells grew from Descemet's 
membrane. A cleavage plane was formed in the stroma close 
to the epithelium, and the superior stromal tissue 
containing keratocytes was removed, divided and placed in 
medium. The remaining tissue which consisted largely of 
epithelium was treated similarly, fig. 9. Secondary 
cultures were obtained by splitting confluent primary 
cultures 1:2 with trypsin/versene. Cultures were grown at 
37°C in a humidified incubator with 5% CC>2 »
Growth kinetics of cells: Suspensions of rabbit corneal
epithelial cells, keratocytes or endothelial cells at 
passage no. 3, were seeded at 1 0  ^ cells onto 3 5mm plastic
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tissue culture plates (Nunclon). Cells were grown at 3 7°C 
in a humidified incubator with 5% CC>2 , and harvested after 
1, 3 or 6 days in culture. Cells were counted on a 
haemocytometer.
Storage and recovery of cells: Secondary cultures were
prepared for storage by harvesting a large tissue culture 
flask (1 7 5 0 1 1 2 ), and suspending the cells 5 x 1 0  ^
approximately, in 5mls of EFC^o or DFC10- The suspension 
was spun at 2,0 00 rpm for 5 minutes and the cells 
resuspended in 1ml of storage medium. Cells were then 
frozen slowly in an insulated box at -70°C for 24 hours 
before transfer to -170°C. Cells were recovered by rapid 
thawing in a 3 7°C water bath. The cells were then 
resuspended in appropriate medium and grown at 3 7°C.
Indirect immunofluorescence: Indirect immunofluorescence
was performed following methods described by Kennedy et al. 
(1983). Cultures of the three corneal cell types grown on 
12mm glass coverslips were studied. Cells were fixed in 
methanol for 10 minutes at -20°C before incubation with 
antikeratin antiserum. Coverslips were washed three times 
in phosphate buffered saline (PBS) then incubated either 
with monospecific rabbit anti fibronectin antiserum (diluted 
1:30) or polyspecific guinea pig anti keratin antiserum 
(diluted 1:5) for 3 0 minutes at 3 7°C. Coverslips were 
washed another three times in PBS, and then exposed to the 
appropriate fluoroscein labelled secondary antibody, sheep 
anti rabbit lgG (diluted 1:20) and rabbit anti guinea pig 
lgG (diluted 1:20) for 30 minutes. Coverslips were washed 
a further three times in PBS then once in distilled water. 
Coverslips incubated with anti fibronectin antiserum were 
then fixed in 5% glacial acetic acid with 9 5% ethanol
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(acid-alcohol). Appropriate controls including omission of 
the primary antibody and the labelled secondary antibody 
were employed. The fluorescent staining of cells was 
assessed when coverslips were examined under a Leitz 
Ortholux fluorescent microscope equipped with 
epi-illumination and phase contrast optics.
Electron microscopy of corneal cells: Epithelial cells,
keratocytes and endothelial cells were seeded onto 3 5mm 
plastic tissue culture plates containing 1 2 mm glass 
coverslips. The coverslips were processed for scanning 
electron microscopy, critical point dried, gold coated and 
examined in a Jeol T200 scanning electron microscope. A 
total of 40 coverslips were examined by scanning electron 
microscopy (SEM). The plastic plates were prepared for 
transmission electron microscopy (TEM). After dehydration 
the monolayer was removed by dissolving the plate in 
propylene oxide prior to embedding in araldite. Sections 
were examined using a Philips 301 transmission electron 
microscope. A total of 2 0 tissue culture plates were 
prepared and each cell type was represented a least six 
times. Sections of 8 0nm were cut at 2 Oum intervals through 
the tissue blocks for TEM.
RESULTS
Establishing explant cultures and cellular growth kinetics: 
Epithelial cells migrated rapidly from the explanted tissue 
and began to divide on the surface of the tissue culture 
flask. Only a few explants failed to adhere to the flasks 
and establish cellular growth within a few days. By 
contrast stromal cultures were slow to establish as stromal 
tissue was poorly adherent to the tissue culture flask.
87
However when secondary cultures were established, the 
doubling time (time taken for cells to increase their number 
2 -fold) for epithelial cells and keratocytes was 18 hours. 
The adherence of Descemet's membrane with attached 
endothelial cells, to the tissue culture flask was 
intermediate. Endothelial cells migrated rapidly from 
Descemet's membrane onto tissue culture flasks, but the 
doubling time was prolonged to 5 days, and with successive 
passage, cellular contact became less and cells increased in 
size. Cellular growth kinetic experiments were performed 
in duplicate, fig. 32 (endothelial cells excepted).
In my hands, epithelial cells and keratocytes survived 
up to 1 2  serial passages, and were successfully recovered 
after 9 months in storage. Endothelial cells survived 
eight serial passages, but were not stored.
Electron microscopy of corneal cells: (Electron micrographs
were prepared by Mrs. D.A. Aitken. ) Cells were prepared 
for SEM or TEM after 2 days in tissue culture. The 
preparations showed marked homology within a cell type, 
and the morphological features were consistent in the large 
number of sections viewed both by SEM and TEM. Epithelial 
cells on SEM were small (25um) spindle shaped cells lacking 
contact inhibition. The nuclear and cellular outlines were 
poorly defined, figure 3 3a. By TEM the cells were cuboidal
and stratified, figure 3 3b. Small cytoplasmic processes
were present in some cells forming microplicae, figure 3 3 c. 
The cytoplasm contained small mitochondria, rough 
endoplasmic reticulum and numerous vesicles which are a 
common feature of cultured cells. Keratin filaments 
condensed to form desmosomes at sites of cell contact, 
figure 3 3 d.
FIGURE 32
Average cellular growth curves.
T&p epithelial cells
Middle keratocytes
Bottom endothelial cells
Suspensions of cells at passage nunber 3 were seeded at 10^ 
cells onto 3 5mm tissue culture plates. Cells were grown 
at 3 7°C in a humidified incubator with 5% CO2 and harvested 
after 1, 3 or 6 days in culture. Cells were counted on a 
haemocytometer. Experiments were run in duplicate
(endothelial cells excepted) .
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FIGURE 33
Epithelial cells.
(a) Top left
(b) Top right
(c) Bottom left
(d) Bottom right
Small spindle shaped cells lacking 
contact inhibition (SEM x 3,800) 
Stratification of cuboidal cells 
(TEM x 5,000)
Abundant vesicles (a) and formation 
of microplicae (b) (TEM x 11,800) 
Aggregation of keratin filaments 
forming desmosomes (a)
(TEM x 11,800)
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FIGURE 34
Keratecytes.
(a) Top left
(b) Top right
(c) Bottom left
(d) Bottom right
Cells showing prominent nuclei (a) 
with nucleoli (b) and overlapping 
cytoplasmic processes (c)
(SEM x 3,000)
Two cells at right angles 
(TEM x 6,000)
Dilated profiles of rough 
endoplasmic reticulum (arrows)
(TEM x 40,000)
Nucleoli (a) within prominent 
nucleus (b) (TEM x 9,500)
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FIGURE 35
Endothelial cells.
(a) Top left
(b) Top right
(c) Bottom left
(d) Bottom right
Portion of a large endothelial cell 
(SEM x 3,000)
Small Golgi (a) surrounding large 
central nucleus (b) (TEM x 6,000) 
Dense fibriller matrix forming 
thickened basement membrane (a) 
and micropinocytotic vesicles (b) 
(TEM x 15,000)
Higher magnification of matrix, 
intracellular and extracellular 
component (arrows) (TEM x 22,5 00)
lum
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On SEM keratocytes (35um) were flattened. The nuclear 
outline was clearly visible, and nuclei contained several 
prominent nucleoli, fig. 34a, and TEM fig. 34d. Cellular 
processes radiated in an irregular manner, fig. 34a. By 
TEM the keratocytes were orientated at right angles to each 
other and cellular processes were abundant, fig. 3 4b. 
Cytoplasmic organelles were sparse, consisting mainly of 
large profiles of rough endoplasmic reticulum and small 
mitochondria with swollen cristae, fig. 34b, c.
Endothelial cells were large and polygonal on SEM.
The cell size was variable (60-100um), fig. 35a. Contact 
between cells was rare. Organelles consisted of a few 
mitochoad^-ia, some rough endoplasmic reticulum, small Golgi 
close to the nucleus and micropinocytotic vesicles, fig.
35b, c. A dense matrix was deposited at the basal aspect 
of the cells. This appearance was peculiar to the 
endothelial cells and probably represented primitive 
Descemet's membrane, fig. 35b, c. d.
Indirect immunofluorescence studies; Epithelial cells and 
keratocytes at passage no. 8, and endothelial cells at 
passage no. 4, were seeded onto glass coverslips 2 days 
prior to examination. The use of cell specific markers 
allowed the screening of larger numbers of corneal cells 
than was possible by electron microscopy. The appropriate 
controls using primary antibody and secondary antibody in 
isolation; and primary antibody and secondary antibody 
together against the inappropriate cell types were performed 
to ensure _that there was no cross reactivity (data not 
shown). Epithelial cells (keratin+) showed perinuclear 
fluorescent staining corresponding to the cytoplasmic 
location of keratin filament bundles (Cook et al. , 1987).
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Around 7 5% of epithelial cells were weakly positive or at 
background fluorescence. However no fluorescent staining 
above background was detected when epithelial cells were 
tested with antisera and conjugate against fibronectin.
Approximately 80% of keratocytes and endothelial cells 
were strongly positive using indirect immunofluorescence 
against fibronectin. The fibronectin matrices of the 
keratocytes and endothelial cells were identified by the 
cell surface fibronectin, figs. 3 6 and 3 7. The endothelial 
cells were sparse on the coverslips and no intercellular 
matrices were demonstrated. Neither the keratocytes nor 
endothelial cells reacted positively with anti keratin 
antibodte.s._.and conjugate.
DISCUSSION
Other authors have described techniques for the 
isolation of corneal epithelial cells, keratocytes and 
endothelial cells. The identity of their cell cultures was 
ascertained either by light microscopy or by ultrastructural 
studies on a single cell type (Stocker et al. , 19 58; Baum 
et a l ., 1979 and Gipson and Grill, 1982). Light microscopy 
distinguished endothelial cells from epithelial cells and 
keratocytes morphologically, but differences between 
epithelial cells and keratocytes are harder to establish.
The dissection technique of Stocker et al. (19 58) has the 
potential for inadvertent contamination of a cell line when 
separating stroma with its keratocytes, from epithelium.
The identification of the rabbit corneal cell lines was 
performed in two ways. Ul trastructural examination showed 
microplicae and desmosomes in epithelial cells (Gipson and 
Grill, 1982) and demonstrated stratification and a lack of
FIGURE 36
Fibronectin4- keratocytes with fluorescent staining of cell 
walls-r-and. intercellular matrix (oil immersion X 1,200).
FIGURE 37
Fibronectin4- endothelial cells showing cell surface 
fluorescence (oil immersion X 1,200).
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contact inhibition (Newsome et al., 1974). Keratocytes 
showed dilated cisternae of endoplasmic reticulum and 
prominent nucleoli (Newsome et al., 19 74). The endothelial 
cells were polygonal and covered a large surface area 
(Perlman and Baum, 1974). Ultrastructural studies permit 
only a small proportion of cells to be examined. Indirect 
immunofluorescence techniques were used to screen larger 
numbers of cells. Antibodies against keratin and 
fibronectin identified epithelial cells, and keratocytes and 
endothelial cells respectively. The purity of the cell 
lines was confirmed by this method.
The cellular doubling times for the three corneal cell 
types gxpwn without extracellular matrices or growth factors 
were similar to the results of other groups (Carter et al. , 
1985; Hsieh and Baum, 1985). The slow growth of 
endothelial cells prevented the accumulation of sufficient 
cells for storage, but epithelial cells and keratocytes were 
successfully stored at -170°C.
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CHAPTER 5
IN VITRO EXPERIMENTS
HSV-1 persistence and latency in rabbit corneal cells
in vitro
MATERIALS
Growth of viruses: Virus stocks were grown and titrated as
before. Strains of HSV-1 used were HSV-1 strain 17 (Brown 
et al. , 1973), and the X2 variant of strain 17 which lacks 
the Xbal sites at 0.0 7 map units and 0.6 3 map units (Brown 
et al. , 1984). The HSV-1 strain 17 particle:pfu was 10:1. 
The X2 variant particlerpfu was 5:1.
Cells: ^ JRabbit corneal epithelial cells, keratocytes and 
endothelial cells whose purity and morphology were confirmed 
by indirect immunofluorescence and electron microscopy, 
as described before, were used.
Acycloguanosine: Acycloguanosine (Schaeffer et a1., 1978)
is phosphorylated by the herpes specified thymidine kinase. 
The triphosphate of acycloguanosine is inhibitory to viral 
DNA polymerase. Acycloguanosine was used in lOuM 
concentrations to treat cell cultures, and eliminate lytic 
infection. Acycloguanosine was supplied hy the Wellcome 
Medical Division.
Radiochemicals: Radiochemicals were obtained from Amersham
International. L-[3 5 S] methionine was used to label 
proteins; the specific activity was variable with storage, 
fresh stocks were usually about 1300 Ci/m mol.
[32p]-dCTP and dGTP (3 000 Ci/m mol) were used to label 
nick-translated viral DNA probes.
are given below.
7..5% 5%
1 2 mis 4 mis
1 2 mis 6 mis
24 mis 14 mis
300 ul 2 0 0 ul
2 0 ul 1 0 ul
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Gels: (i) polyacrylamide gels were prepared using the method 
of Marsden et al. (19 76). The recipes for the 7.5% single 
concentration gel and the 5% stacking gel   
30% acrylamide/bisacrylamide
resolving gel buffer/stacking gel buffer   
distilled water 
1 0 % ammonium persulphate 
Temed 
Solutions:
(i) Polyacrylamide gel buffers; tank buffer 6.3 2g of
Tris HC1, 4g of glycine and lg of SDS made to 1 litre 
■JSL 1th deionised water.
Resolving gel buffer; 18.15g of Tris HCl and 0.4g of
SDS made to 100ml and pH 8.9.
Stacking gel buffer; 5.9g of Tris HCl and 0.4g of
SDS made to 10 0ml and pH 6.7.
(ii) Polyacrylamide gel fix/stain; a mixture of methanol, 
water and acetic acid in the ratio of 50/43/7 (w/v) 
containing 0.2% w/v Coomassie brilliant blue.
(iii) Polyacrylamide gel destain; a mixture of methanol, 
water and acetic acid in the ratio of 5 0/880/70.
(iv) Acrylamide; 30% acrylamide solution (+ 5% linker) - 
2 8.5g acrylamide and 1.5g N-N' methylene 
biacrylamide. These were made up to 100ml and 
filtered through a Whatman nunber 1 filter prior to 
use.
(v) Boiling mixture; 1ml stacking gel buffer, 0.8ml 25% 
SDS, 0.5ml 2-B mercaptoethanol, 1ml glycerol and 
0..02 5m1 of a saturated solution of Bromophenol blue. 
This was diluted 1 part in 3 parts with distilled
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water and if necessary the pH adjusted by the 
addition of NaOH to give a blue colour.
(vi) Gel soak I; 2 0 0mM NaOH, 6 0 0mM NaCl.
(vii) Gel soak II; 1M Tris HCl (pH 8.0), 0. 6 M NaCl.
(viii) SSC; 0.15M NaCl, 0.015M trisodium citrate (pH 7.5). 
(ix) Denhardt's buffer (50X); 1% Ficoll (w/v), 1% solid
BSA (w/v), 1% polyvinyl pyrrolidone (w/v).
(x) Hybridization buffer; 15% 2OX SSC (v/v), 10% 5OX 
Denhardt's buffer(v/v), 1% 100X salmon sperm DNA 
(v/v), 1% 1M Tris HCl (pH 7.5) and 7 3% H 2 0.
METHODS
One ste-p-^growth experiment; Confluent plates of BHK2 jC;l3 
cells (1 0  ^ cells), corneal epithelial cells (1 0  ^ cells), 
keratocytes (1 0  ^ cells), and corneal endothelial cells 
(5 x 1 0  ^ cell), were infected with HSV-1 strain 17 at a 
multiplicity of infection (m.o.i.) of 1 0  plaque forming 
units (pfu)/cell. After absorption for 1 hour at 3 7°C the 
cultures were washed twice in PBS plus 5% (v/v) calf serum 
(PBSC5 ) and overlaid with ECgg- various time intervals
between 0 and 2 4 hours the infected cells were harvested 
into 1 ml of medium and virus released by sonication. 
Samples were stored at -7 0°C and virus titres measured by 
plaque assay on BHK 2 gCg3 cells.
Lytic infection in corneal cells and acycloguanosine 
treatment; Four confluent cultures of epithelial cells at 
passage number 6 and keratocytes at passage number 8 
(approximately 1 0 6 cells/flask), were each infected at a 
m.o.i. of 1 pfu/cell. Virus was absorbed for 1 hour at 
370c then cultures were washed twice with PBS. Epithelial 
cells were incubated at 3 7°C for 2 4 hours; with medium
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containing lOuM acycloguanosine (ACG) , with medium 
containing ACG pre-incubated at 4 2°C for 4 8 hours; with 
control medium, or with control medium pre-incuba ted at 4 2°C 
for 4 8 hours. Keratocyte cultures were treated similarly. 
The cultures were harvested after 24 hours and the yield of 
cell associated virus was determined fcy titration on 
BHK2 1 CP3 cells.
Non productive infections in corneal cells I: Twenty-four
confluent cultures of each corneal cell type were grown in 
25cm2 flasks (approximately 10^ cells/flask) at 37°C. The 
cells ranged from passage nos. 5-8 (epithelium); passage 
no. 12 (keratocytes); or passage nos. 5-8 (endothelium). 
Cultures jtfere maintained at 41.5°C for 2 4 hours prior to 
inoculation. Eight flasks of each of the three cell types 
were inoculated at m.o.i.'s of 0 .0 1 , 0 . 1  and 1 . 0  pfu/cell in 
lOOul of medium. Virus was absorbed for 4 5 minutes at 
41.5°C. The cultures were then overlaid with the 
appropriate medium which was changed every third day. At 
weekly intervals after inoculation two cell cultures at each 
m.o.i. and of each cell type were transferred to 3 7°C. The 
medium was supplemented with 5% (v/v) human serum for the 
first five days at 3 7°C. Human serum was added to 
neutralize any residual extracellular virus.
Assay for infectious virus I: The presence of infectious
virus was determined by two methods; (1 ) observation of 
viral plaques on corneal cell cultures; (2) assay of 0.5ml 
corneal cell supernatant on BHK2 1 C1 3  cells. After a 45 
minute absorption period at 3 7°C the cell monolayer was 
overlaid with EC;lo and incubated for 4 8 hours at 3 7°C. 
Cultures .were stained with Giemsa and examined for viral 
cytopathic effect. Cultures were scored as positive for
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virus ( + ) or negative (-). The amount of virus released 
was not quantified. The assays were performed daily for 
two days after inoculation, and then every third day when
the medium was changed.
Non productive infection in corneal cells II; the effect of
ACG treatment: Forty-four confluent cultures each of
epithelial cells, passage no. 8 , and keratocytes, passage 
no. 7, were grown in 2 5cm2 flasks (approximately 10^ 
cells/flask) at 37°C. Cultures were maintained at 42°C for 
24 hours prior to HSV-1 inoculation. (As 4 2°C was not 
detrimental to cell viability it was considered a more 
stringent temperature to eliminate virus replication.)
The cultures of each cell type were divided into two groups 
of 22 flasks; A - treated with lOuM ACG, and B - ACG free 
control. Flasks 1-10 were infected at a m.o.i. of 0. 0005 
pfu/cell, flasks 1 1 - 2 0  were infected at a m.o.i. of 0 . 0 0 1  
pfu/cell, while flasks 2 1  and 2 2  were not infected with 
vi rus (MI).
From day 0, (day of inoculation) the medium was changed 
every second day and assayed for infectious virus (using 
method 2 only) until the experiment was concluded. On day 
10 post infection the 2 2 flasks of group A of each cell type 
had ACG added to a concentration of lOuM. Fresh ACG was 
added with each change of medium between day 10 and 15 to 
the group A flasks. On day 15, flasks 1 and 11 from groups 
A and B were superinfected at 3 7°C. The remaining twenty 
flasks were transferred to 3 7°C where medium was changed and 
assayed every second day until day 29 (see fig. 38). 
Superinfection; The X2 variant of HSV-1 strain 17 (Brown et 
al. , 1984-)'was used for superinfection. Both ACG treated 
and untreated cultures were superinfected either on day 15,
FIGUREUj-B.,
Experimental protocol for non productive infection in 
corneal cells II; the effect of ACG treatment.
Figure 38
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$
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f
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Day 0 Infection
Day 10-14 ACG to A
Day 15 Superinfection (2 cell cultures) 
Transfer to 3 7°C
Day 29 Super in feet ion 
DNA extraction
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the day of transfer from 42°C to 3 7°C, or on (fey 29 after a 
fourteen day incubation at 37°C. The cultures were 
super infected with X2 at a m.o.i. of 0.005 pfu/cell or 0 01 
pfu/cell ( 1 0  times the original m.o.i. with strain 17).
After absorption for 1 hour and removal of unabsorbed X2 
virus, incubation was continued at 37°C for 24 hrs. The 
cultures were harvested, virus was released fcy sonication 
and samples were stored at -7 0°C.
Restriction endonuclease analysis of progeny virus from 
superinfection experiments: Virus samples from
superinfected cultures were titrated on BHK2 1 CX3 cells with 
the overlay medium containing human serum. A large number 
of single, well separated plaques were picked individually 
into 0.5ml PBS 5% calf serum and sonicated. 0.2ml of the 
single plaque samples was used to infect 1 0  ^ BHK2 1 C-L3 cells. 
Progeny virus was harvested from these cultures after 4 8 
hrs. at 3 7°C and used for restriction endonuclease analysis.
Restriction enzyme analysis was carried out using the 
Linbro well method described fcy Lonsdale (1979). Confluent 
cells were infected in the presence of 3 2 p at an approximate 
m.o.i. of 10 pfu/cell and incubated at 31°C for 48 hrs.
^ P  labelled viral DNA was treated with restriction 
endonucleases at concentrations sufficient to give complete 
digestion in 4 hrs. at 3 7°C. The generated DNA fragments 
were separated fcy overnight electrophoresis on agarose gels 
°f appropriate concentration and after drying the gels were 
exposed to XS1 film. HSV-1 strain 17 DNA and the X2 
variant DNA were used as controls.
DNA-dna hybridization;
(i) DNA extraction. DNA was extracted from half the 
cultures which had failed to shed infectious virus
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after 14 days at 3 7°C. The method used was as 
described by Stow et al. (1983).
Medium was removed from the cultures and the cells 
lysed with buffer (0.6% SDS, ImM EDTA, lOmM Tris pe 
7.5) plus 5 OOug/ml pronase for 4 hrs. at 37°c. NaCl 
was added to a final concentration of 2 00mM. After 
sequential extraction with phenol, phenol + chloroform 
and chloroform the DNA was precipitated with ethanol 
at -20°C. The DNA was redissolved in Tris/EDTA 
containing lOug/ml RNase/Tl and digested for 2 hrs. at 
37°C. Samples of DNA were digested with the BamHI or 
Hpal restriction endonuclease. Digested samples were 
run overnight on agarose gels of appropriate 
concentration in 1XE buffer. Following gel 
electrophoresis DNA was visualized fcy staining in 
ethidium bromide (lug/ml) prior to examination under 
UV light.
(ii) Transfer of DNA to nitrocellulose. The transfer of 
DNA fragments from agarose gels to nitrocellulose 
membranes was performed fcy the method described fcy 
Southern (1975). After electrophoresis the DNA was 
denatured fcy soaking the gel for 4 5 mins. in Gel 
Soak I, and then neutralized fcy soaking in Gel Soak II 
for 4 5 minutes. The gel was transferred to a glass 
plate wrapped in 2 sheets of Whatman 3MM paper 
moistened with 10XSSC. The plate was supported in a 
tray of 2 litres of 10XSSC. Care was taken to ensure 
that no air bubbles were present between the 3MM paper 
and either the plate or the gel. A sheet of 
nitrocellulose paper was floated on the surface of the 
10XSSC until it soaked from beneath, then it was
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applied to the gel surface. All air bubbles between 
the gel end filter were removed. Two moistened 
sheets of 3MM paper cut lo the same size as the filter 
were placed on top of the nitrocellulose followed by a 
weighted stack of paper towels. DNA fragments 
transferred from the gel to the nitrocellulose 
overnight maintaining their original spatial 
arrangement. The filter was dried at room 
temperature and baked in a vacuum oven for 2 hours,
(iii) Nick translation of DNA. In vitro labelling of DNA 
with 32P deoxyribonucleoside triphosphates was done 
essentially as described by Rigby et al. (1977).
Nick translated DNA was made from total HSV-1 DNA, 
from recombinant plasmid pGX8 containing HSV-1 BamHI k 
(Davison and Wilkie, 1981) and from recombinant 
plasmids pGX121, 122, 123 and 134 containing the HSV-1 
Kpnl b, c, d and m fragments respectively.
Nick translation reactions were set up on ice and 
typically contained 0.5ug DNA in a volume of 3 Oul of 
the following solution: lul BSA, 3ul 10XNT buffer,
2.25ul 0.2mM dATP, 2.25ul 0.2mM dTTP, 2ul 3 2 P-dCTP,
2ul 3 2 P-dGTP, lul DNase 10"4 mg/ml, lul DNA polymerase 
1 and H 2 O to a final volume of 3 Oul. The reaction 
mixture was incubated at 15°C for 9 0 minutes. After 
incubation the mixture was made up to 5 Oul with 
distilled water and the labelled DNA precipitated 
twice with 0.1 volume 3M NaAc and 0.75 volume 
isopropanol on dry ice for a minimum of 3 0 minutes.
The radioactivity of the probe was monitored using a
portable beta counter.
(iv) Hybridization. Nitrocellulose strips were pre soaked
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in sealed polythene hags with lOmls of hybridization 
buffer for 2 hours at 75°C. Radioactively labelled 
probes were used to detect homologous sequences in the 
single stranded DNA immobilized on the nitrocellulose. 
Nick translated probe DNA was denatured by heating at 
100°C for 2-3 mins. in 8 0% (v/v) formamide. The hags 
containing the pre-incuba ted nitrocellulose strips 
were drained and the denatured probes added in lOmls 
of fresh hybridization buffer. The nitrocellulose 
strips were hybridized for 4 8 hours at 75°C in a 
shaking water bath. The nitrocellulose filters were 
then extensively washed for 2 hours at 60°C in a 
shaking water bath in 10% 20XSSC, 10% SDS and 0.5%
1.0M Na 2 HPC>4 pH 7. The sheets were air dried and 
autoradiographed.
Preparation of corneal cell protein gels;
(a) Radiolabelling of cells. Growth medium was removed 
from confluent 3 5mm plates of epithelial and keratocyte 
cells and the cellular monolayers washed twice with PBS. 
Methionine free Eagle’s medium plus 2% (v/v) calf serum was 
added. After 4 hours lOu Ci of  ^5g methionine was added to 
each culture for a further two hours. Control cultures 
infected with HSV-1 strain 17 at a m.o.i. of 20 pfu/cell 
were labelled with 35g methionine for 24 hours. Disulfiram 
0.3uM was added to the cell growth medium at 3 7°C to obtain 
radiolabelled stress protein markers (Levinson et al. ,
1978). After incubation, labelling medium was removed, 
monolayers were washed with ice cold PBS and cells disrupted 
with 0 . 2 5m 1 s of boiling mix diluted 1 in 3 with distilled 
water. The infected cells were then solubilised hy 
incubation at 6 O^C for 10 minutes. The sample (0.01ml) was
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then spotted onto a Whatman number 1 filter disc, which was 
washed twice in ice cold TCA (10 minutes each) and rinsed 
with absolute alcohol. The amount of radioactivity in the 
air dried disc was estimated in the usual way. The 
radioactive content in each sample was standardized using 
diluted boiling mix as diluent so that each contained the 
same amount of radioactivity per unit volume.
(b) Electrophoresis. Samples of cell extracts were loaded 
into preformed wells in the stacking gel. Electrophoresis 
was started at 4 0mAmps and left for 3-4 hrs., until the 
Bromophenol blue dye front emerged from the end of the gel. 
At this time the gel was removed and fixed/stained for 1 hr. 
at-, room ^temperature, following which they were destained and 
rehydrated fcy the addition of several changes of destain 
over a 24 hr. period. The gel was then dried onto paper 
using a BioRad gel slab dryer, operating under a vacuum of 
30mm Hg. The dried gel was sandwiched between glass plates 
against Agfa-Gevaert Xray films. The autoradiograph was 
then developed in an X-omat industrial film processor.
RESULTS
One step growth kinetics of HSV-1 in three corneal cell 
types: Single cycle growth experiments were performed in
epithelial cells, keratocytes and endothelial cells using 
BHK2 1 C1 3  cells as a control. The experiments were run in 
duplicate. The results are presented in fig. 39. HSV-1 
strain 17 replicated efficiently in the three corneal cell 
types, however distinct differences were observed. In 
BHK2 1 C1 3  cells viral growth showed a four-hour eclipse 
phase, a- plateau of virus production within 2 4 hrs. and a 
yield of around 100 pfu/cell. The viral growth curve was
FIGURE 39
One step growth curves of HSV-1 strain 17 in corneal cells.
— Top left BHK21C13 cells
Top right epithelial cells
Bottom left keratocytes
Bottom right endothelial cells
Cells were infected at m.o.i. 10 pfu/cell, after absorption 
for 1 hour at 3 7°C the monolayers were washed twice with PBS 
C5, overlaid with EC10 and incubated at 3 7°C. Cultures 
were harvested at the times indicated and the virus titre 
measured fcy plaque assay on BHK21 C13 cells.
Horizontal bars indicate the range of values.
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similar in epithelial cells but the eclipse phase was 
prolonged to six hours. Virus growth in keratocyte and 
endothelial cells showed a prolonged eclipse phase of eight 
hours, and a slower rate of growth. Both curves were still 
in the logarithmic phase at 24 hours suggesting that virus 
production had yet to reach a maximum.
Non productive infections in corneal cells I: Two assay
methods (see Methods) were used to determine the presence of 
infectious virus. There was 8 7%, 79% and 77% correlation 
between the two assay methods in the epithelial cells, 
keratocytes and endothelial cells respectively. The 
results presented are based on method (2 ) - the corneal cell 
culture supernatant assay on BHK2 iC^ 3  cells.
The three corneal cell types were infected with HSV-1 
strain 17 at various low m.o.i.'s at 41.5°C. At weekly 
time intervals up to 2 8 days cultures were transferred to 
37°C. At the start of the experiment there were 
twenty-four cultures of each cell type. Cells were able to 
divide at 41.5°C, so when cells became over-confluent the 
cultures were split 1:2. The progeny cultures continued in 
the experiment increasing the original number of cultures 
(Table 8 a-c).
Infectious virus was detected in all cultures on the 
first day post inoculation and in most cultures on the 
second day post inoculation. Focal cytopathic effect, 
observed fcy rounding of cells was seen to some extent in all 
cultures after HSV-1 infection. At higher m.o.i.*s (0.1 
and 1 . 0  pfu/cell) cell death was sometimes overwhelming by 
the seventh day, leaving no surviving cells. This was 
marked in keratocyte and endothelial cells, but was less 
noticeable in epithelial cells where a snail number of
Course of non productive infections in corneal cells.
TABLE 8(a) EPITHELIUM
Time of vi rus
Culture Culture No. of PI LI Reacti- release after
number death days at vation HS removal at
41.5°C failure 37°C (days)
1 * 7 + 3
2 7 + 3
3 14 + 2
4 14 + 2
5 2 1 + 6
6 2 1 + 9
7 28 +
a 28 + 2 >
9 A+$ 7 + 3
9 B 7 + 3
10 7 + 3
1 1 14 +
1 2 14 +
13 2 1 + 3
14 2 1 +
15 28 +
16 28 + 2
17t C< 7
18 7 + 3
19 14 + 4
2 0 14 + 4>
2 1 2 1 + 9
2 2 2 1 + 3
23 28 + 2
24 28 + 2
PI = Persistent infection 
LI = Latent infection 
HS = Human serum
Course of non productive infections in corneal cells.
TABLE 8 (b) KERATOCYTES
Time of virus
Culture Culture No. of PI LI Reacti- release after
number death days at vat ion HS removal at
41.5°C failure 37°C (days)
1A* $ 7 + 3
IB 7 + 3
2A 7 + 3
2B 7 + 3
3A + 14
3B + 14
4A + 14
4J3 + 14
5A 21 +
5B 21 + 6
6A 21 +
6B 21 + 6
7A 28 +
r-lB _ 28 +
8A 28 +
8B 28 + 5
9 + 7 + 6
10 7 + 11
11 14 + 13
12 14 + 2>
13 + 21
14 + 21 -
15 + 28
16 + 28
17t 7 + 9
18 7 + 23
19 14 + 7
20 + 14
21 + 21
22 21 + 1>
23 28 + >
24 + 28
PI = Persistent infection 
LI = Latent infection 
HS = Human serum
Course of non productive infections in corneal cells.
TABLE 8(c) ENDOTHELIUM
Time of virus
Culture Culture No. of PI LI Reacti- release after
number death days at vation HS removal at
41.5°C failure 37°C (days)
1* 7 + 9
2A$ 7 + 3
2B 7 + 3
3 14 +
4 14 + 2
5 2 1 + 6
6 2 1 + 9
7 28 + 2
r 28 +
9A+ 7 + 3
9 B 7 + 3
10 7 + 3
11 C< 14
12 14 + 2
13 A " 2 1 +
13B C 2 1
14 2 1 + 3
15 28 + 2
16A + 28
16B + 28
17+ C 7
18 7 + 9
19 14 + - . 7
20 + 14
21 + 21
22 21 + 3
23 28 + 5
24 28 + 2
PI = Persistent infection 
LI = Latent infection 
HS = Human serum
Footnotes: * Cultures 1-8, m.o.i. 0.01 pfu/cell 
+ Cultures 9-16, m.o.i. 0.1 pfu/cell 
j Cultures 17-24, m.o.i. 1.0 pfu/cell 
$ A or B: Cultures were split 1:2 on day 13
< C: cell death occurred due to contamination 
> Cultures shed virus at 3 7°C in the presence of 
human serum; keratocyte culture 2 3 did not 
shed any other virus at 3 7°C
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surviving cells were able to divide and re-form confluent 
monolayers. Over confluent cell monolayers were 
sub-cultured 1:2 on day 13 post inoculation. An anomalous 
finding was cell death in keratocyte cultures 3A, 3B, 4A and 
4B. Their parent cultures 3 and 4, inoculated at the 
lowest m.o.i. (0 . 0 1  pfu/cell) were sub-cultured on day 13.
On day 14 the progeny cultures were transferred to 3 7°C and 
medium was replaced fcy medium supplemented with 5 % human 
serum. The cells had not settled onto the culture flasks 
by day 14 and were removed with the medium. Other 
keratocyte cultures 5A-8B, sub-cultured on day 13, but left 
undisturbed at 41.5°C until day 16, settled and ultimately 
be came^conf lue nt (Table 8 b).
Persistent infection, defined as the presence of 
infectious virus in the supernatant medium at 41.5°C, after 
the immediate period post infection, was detected in one 
epithelial cell culture infected at 0 . 0 1  pfu/cell, and four 
epithelial cell cultures infected at 0.1 pfu/cell. The 
infection appeared to be partially suppressed in that it did 
not succeed in destroying cellular monolayers until cells 
were transferred to 3 7°C. No infectious virus was detected 
in surviving keratocyte and endothelial cell cultures 
maintained at 41.5°C for up to 2 8 days post infection (Table 
8 a-c).
Latent infection was defined as absence of infectious 
virus in the supernatant medium at 41.5°C, but detectable 
infectious virus in the supernatant medium after transfer to 
37°C. All cell types proved capable of releasing 
infectious HSV after human serum was removed at 3 7°C.
By 'day 40 post infection, all surviving epithelial 
cells had released infectious virus, but five keratocyte and
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three endothelial cell cultures at 3 7°C had failed to 
release virus up to 2 0 days after human serum removal. The 
eight cultures that failed to release infectious virus at 
37°C were defined as reactivation failures (Table 8 b and c) . 
The release of infectious virus was quicker from epithelial 
and endothelial cells than from keratocytes after human 
serum was removed.
Superinfection I: An attempt was made to recover non
inducible virus genomes from the reactivation failures fcy 
superinfection. The X2 variant was used at a m. o.i. of 5
pfu/cell with the intention of assuring that every cell in 
the flask was infected. Cultures were harvested after 4 8 
hours. All cultures were contaminated at 48 hrs., and were 
therefore Arcton sterilized. The sterilized stocks were 
then titrated and 5 0 plaques picked from each stock. A 
total of 189 plaques from the eight reactivation failures 
were analysed fcy Xbal restriction endonuclease analysis.
(50 plaques from keratocyte culture 5A; generally 2 0 
plaques from the other flasks.) All analysed plaques 
showed the X2 profile. This line of investigation was not 
pursued for three reasons; firstly despite Arcton 
sterilization post-contamination, the possibility remained 
that novel bands might be from the contaminating organism; 
secondly the superinfection m.o.i. was too high resulting in 
a ratio of supe rinf ecting virus to input virus of 5 00 or 5 0 
to 1; and thirdly harvesting after 4 8 hours probably 
permitted multiple rounds of virus replication by the 
superinfecting strain, thereby overwhelming the original 
input virus. These factors were all corrected in the 
subsequent series of superinfection experiments.
Cellular stress proteins: Supra-optimal temperatures induce
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the synthesis of cellular stress proteins. Other agents 
including Disulfiram, transition series metals and 
sulphydryl reagents induce the synthesis of cellular stress 
proteins (Levinson et al. , 1978, 1980). Figure 40 shows 
the effect of temperature elevation on protein synthesis in 
rabbit corneal epithelial cells and keratocytes.
Disulfiram 0.3uM was added to the cell growth medium at 3 7°C 
to obtain radiolabelled stress protein markers. In mock 
infected keratocytes and epithelial cells, incubated at 
41.5°C there was increased synthesis of proteins having 
approximate molecular weights of 9 0,000, 75,000 and 43,000. 
Novel proteins, having approximate molecular weights 7 0,0 00, 
63,-0 00^^53,0 00 and 4 5,0 00 also appear to have been 
synthesised.
Many characteristic herpes simplex virus proteins were 
detected after 2 4 hours in both keratocytes and epithelial 
cells infected at 2 0 pfu/cell and maintained at 3 7°C; 
however these were absent at 41.5°C. The herpes simplex 
virus infected cells at 41.5°C had similar protein profiles 
to the mock infected cells at 41.5°C.
Lytic infection in corneal cells and ACG treatment: 
Epithelial cell cultures and keratocyte cultures gave virus 
yields of 3 . 5  x 1 0 ® pfu/flask and 2 . 0  x 1 0 ® pfu/flask in 
control medium. After 2 4 hours no cell associated virus, 
was detected from the cultures incubated with 1 OuM ACG. 
Similarly epithelial cell cultures and keratocyte cultures 
gave no virus yield when treated with medium containing lOuM 
ACG that had been pre-incubated at 4 2°C for 4 8 hrs. prior to 
the lytic infection at 37°C. The control epithelial cell 
culture and keratocyte virus yields were 2 x 1 0  ^ pfu/flask 
and lO^ pfu/flask respectively.
FIGURE 40
Protein synthesis in rabbit corneal epithelial cells and 
keratocytes. Cultures were mock infected (MI), treated with 
0.3uM disulfiram (D) , or infected with herpes simplex virus 
at 20 pfu/cell (HSV). Cultures were maintained at 3 7°C or
4 1 . ,
CD Increased synthesis of cellular stress proteins 
Synthesis of novel stress proteins 
^  Synthesis of HSV induced proteins
Approximate molecular weights of HSV proteins are given on 
the near right of the last track. Approximate molecular 
weights of stress proteins are given on the far right.
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Non productive infections in corneal cells II: The
experimental protocol is summarised in figure 3 8 . The 
essential differences from the series I experiments were;
(1 ) lower m.o.i's were used; (2 ) medium was changed and 
assayed for infectious virus every second day; (3 ) an 
incubation temperature of 4 2°C was used to induce the non 
productive infections (other experiments, see series III, 
had indicated the importance of maintaining the incubation 
temperature; where the temperature had dropped to between
40°C and 41°C a low grade infection had occurred); (4) ACG
was applied to half the cell cultures.
The results of the infection in epithelial cells are
shown in-^Table 9a and b, and in keratocytes in Table 10a and 
b. The tables allow the course of infection within an 
individual flask to be followed. The cumulative 
information is presented in graphic form in figures 41 and
42. In both groups A and B of epithelial cells and 
keratocytes, infectious virus was detected on the first and 
second day post infection and in one case on the fourth day. 
In four of the epithelial cell cultures no infectious virus 
was detectable on the days immediately post infection and in 
three of these none was detected subsequently.
Virus was not detected in the culture medium of any of 
the infected cultures between day 4 and day 15. On 
transfer to 37°C on day 15, cultures 1 and 11 in each group 
were immediately super infected. The remainder were
monitored for infectious virus up to day 29. Of the 
group A epithelial cells 8 cultures released virus at 3 7°C 
and 10 remained negative. Of the group B epithelial 
cultures,-' 11 released virus and 7 did not. Similarly in 
keratocytes group A, 11 became positive while 7 remained
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E^itheJ^lal, cells; non productive infections
□— — ___□ ACG treated cells
B " non ACG treated cells
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Ke r a tocy£es; non productive infections II.
 □ ACG treated cells
a-   ■ non ACG treated cells
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negative and in group B, 12 were positive and 6 negative.
The range of first detection of virus was day 17 to 2 7.
Some cultures shed virus for several consecutive days until 
the cell sheet was totally destroyed e.g. culture 19 
epithelial cells B. Others shed detectable virus on one 
occasion only e.g. culture 13 keratocytes A.
Treatment of the infected cells with lOuM ACG for the 5 
days at 4 2°C prior to transfer to 3 7°C did not significantly 
change either the frequency or rate of spontaneous 
reactivation at 3 7°C although reactivation seemed to occur 
slightly earlier in the cells that had not been treated with 
ACG.
Sup&rinf&j^tjon II - the isolation of latent wild type 
genomes and recombinants; Cultures 1 and 11 of groups A and 
B of both keratocytes and epithelial cells were 
superinfected with the X2 mutant virus on day 15 immediately 
after transfer from 42°C to 37°C. The Xbal and six other 
restriction endonuclease maps of Glasgow strain 17 are shown 
in Fig. 31. Superinfection was at a m.o.i of either 0.005 
pfu/cell or 0 . 0 1  pfu/cell, such that the m.o.i. of 
superinfection was 1 0  times that of the initial infection. 
The superinfected cultures were harvested after a further 2 4 
hrs. incubation at 3 7°C and the progeny virus released by 
sonication and then titrated. From each of the progeny 
virus samples 4 8 single plaques were isolated (making a 
total of 384), grown into small plate stocks and their DNA 
analysed using the restriction endonuclease Xbal. All 48 
plaques from epithelial flask Al had the Xbal profile of the 
superinfecting mutant X2 (Fig. 4 3, track 4). From 
epithelial' flask All, 1 of the 4 8 plaques had a novel 
profile (Fig. 43, track 3). The 48 plaques from epithelial
FIGURE 43
Autoradiographs of Xbal restriction digests of viral DNA 
Tabeldred-with 32p# Glasgow strain 17 (lane 1); recombinant 
3 (lane 2); recombinant 1 (lane 3 ) ; X2 (lane 4); Strain 17 
(lane 5); recombinant 2 (lane 6 ).
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FIGURE 44
Autoradiographs of restriction digests of viral DNA labelled 
with 32p. lanes 1-3 Xbal/Hindlll; lanes 4-6 Xbal/Hpal; 
lanes f-9 Xbal/KpnI.
Glasgow strain 17 (lanes l f 4, 7); recombinant 2 (lanes 2,
5, 8 ); X2 (lanes 3, 6 , 9).
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flask Bl had the X2, Xbal profile but from flask Bll, 6 
isolates had Xbal profiles different from X2. Three had 
the strain 17 wild type Xbal profile (Fig. 43, tracks 1 and 
5), 2 had the same profile as shown in Fig. 43, track 3, and 
one had a second novel profile (Fig. 43, track 6 ). The 192 
plaques from the keratocyte cultures showed Xbal profiles of 
the superinfecting X2 virus.
This shows that superinfection of the epithelial cells 
allowed retrieval of the original input 1 7+ wild type virus 
genome and in addition that recombination occurred between 
the resident genomes and the superinfecting genomes. The 
Xbal profile in Fig. 43, track 3 shows missing b, c and g 
bands ajid the regained d and e bands. This means that in 
All and Bll recombinants were generated containing the Xbal 
site at 0.6 3 map units but still missing the 0.07 map unit 
site (Recombinant 1). The profile in Fig. 43, track 6 
shows a new band running between Xbal and Xbal £. To 
characterise this isolate further, Xbal/HindlII, Xbal/Hpal 
and Xbal/Kpnl double digests were carried out. For 
reference the Hindlll, Hpal and Kpnl restriction 
endonuclease maps are given in Fig. 31. Figure 4 4 shows 
the Hindlll/Xbal digest in which the new isolate 
(Recombinant 2 ) is compared to wild type strain 17+ and the 
superinfecting X2 virus. The Xbal sites at 0.29 and 0.45 
map units cut the HindiII a fragment to give three new a 1 
fragments. The other Xbal sites do not affect the HindiII 
profile. It can be seen in Fig. 44, track 2 that in 
Recombinant 2 the Hindlll d band is missing and the joints 
containing d, i.e. b and c are also missing. Three new 
bands. ca^ n be seen: a 1.5M band running above g, a 0.2 5M
band running with _f and a 0.5M band running with d and e.
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This is due to a new Xbal site at approximately 0.74 map 
units giving rise to 1M and 0.5M fragments of approximately 
the same size i.e. 1 0  x 1 0  ^ mol. wt. and the new joints of 
mol. wt. 18.5 x 106 and 14.5 x 106 . The Xbal/Hpal digest, 
Fig. 44, track 5 shows a missing s band and confirms the 
position of the new Xbal site. The two expected new bands 
are too small to be seen on this gel. As expected the 
Xbal/Kpnl digest of Recombinant 2 shows a missing g fragment 
and two new fragments of mol. wt. 6 x 1 0  ^ and 1 x 1 0 6 formed 
by the new Xbal site (Fig. 44, track 8 ) .
Superinfection with X2 has therefore generated a genome 
containing the 0.29 and 0.45 map unit sites and a novel Xbal 
site _ at^g* 74 maP units (Recombinant 2).
Flasks which had survived to day 29 without shedding 
virus were also superinfected with the X2 mutant of strain 
17 at 3 7°C. These were epithelial A flasks 3, 4, 12 and 16 
epithelial B flasks 2, 3 and 12; keratocyte A, flasks 2, 3, 
14 and 16 and keratocyte B, flasks 2, 3, 16 and 17. The 
DNAs from 48 progeny plaques each from epithelial flasks A12 
and B12; and 9 6 plaques each from keratocyte flasks A14 and 
B16 were subjected to restriction endonuclease analysis by 
Xbal.
From the epithelial A12 progeny 4 5 plaques showed the 
X2, Xbal profile, 2 showed a wild type profile and 1 a 
profile indicating a recombinant with the Xbal d/e site at 
0.63 map units regained (Fig. 43, track 3). From B12, 47 
of the progeny plaques had the superinfecting X2 profile and 
one had a profile indicating a further recombinant (Fig. 4 3, 
track 2). It can be seen that the b and g bands have been 
regained^ The profile denotes a recombinant with a 
regained 0.07 Xbal site, but with the 0.63 site still
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missing (Recombinant 3).
Each of the 19 2 plaques isolated from the keratocyte 
cultures showed a DNA profile equivalent to the 
superinfecting X2 virus. Neither recombinants nor 
reactivated input virus was detected.
DNA-DNA hybridization I: In addition to the superinfection
experiments, cells which had failed to shed infectious virus 
up to 29 days post infection were probed for viral DNA using 
the Southern blotting technique. Total DNA was extracted 
as described in materials and methods from the epithelial A 
flasks 9, 10, 17 and 20; epithelial B flasks 9 and 20; 
keratocyte A flasks 4 and 20 and keratocyte B flasks 4, 9 
and~20._^ Reconstruction experiments were set up using the 
epithelial cells and the keratocytes infected at m.o.i.'s of 
5, 1 and 0.001 pfu/cell and the DNA extracted after 2 4 hrs. 
incubation at 3 7°C. The probes used were ^2p labelled nick 
translated total strain 17+ wild type DNA and the BarnHI k 
joint fragment containing the s and q end fragments 
(Fig. 31). The results for the keratocyte B group which 
are representative are shown in Fig. 4 5. Using both the 
total HSV-1 DNA and the BamHI k fragment, viral DNA could be 
detected in the reconstruction controls of epithelial cells 
and keratocytes infected at m.o.i.'s of 5 and 1 pfu/cell but 
not at 0.001 pfu/cell. No viral DNA could be detected in 
any of the other epithelial and keratocyte culture DNAs 
tested.
DNA-DNA hybridization II; Further experiments were 
performed to determine the origin of the novel Xbal site 
located at 0.74 map units. The probes used were 32P 
labelled-nick translated total wild type DNA f rom the strain 
17; the Kpnl b fragment containing the 0.07 Xbal site; the
110
Kpnl m fragment containing the 0.29 Xbal site; the Kpnl c 
fragment containing the 0.45 Xbal site and the Kpnl d 
fragment containing the 0.63 Xbal site. The results are 
shown in figure 4 6 .
The Kpnl b fragment detects the Hpal !L, m, o and _r 
fragments; the Kpnl m fragment detects the Hpal i_ fragment; 
the Kpnl c fragment detects the Hpal b and h fragments and 
the Kpnl d fragment detects the Hpal e and f_ fragments.
All probes hybridize to their expected sites, which suggests 
that the new Xbal site arose because of a point mutation, or 
perhaps because of a small deletion/insertion. There is no 
evidence to support a recombination event involving one of 
the pre-existing Xbal sites.
i
FIGURE 45
Autoradiograph of nitrocellulose blot strips containing 
BamHI restriction fragments of strain 17 DNA to which DNA 
probes have been hybridized. The probes were total HSV-1 
DNA (lanes 1-3) and the BamHI k fragment (pGX8 ) (lanes 
4-11). Whole virus joint and end fragments were detected 
in lytically infected cells ( 5 and 1 pfu/cell) using the 
above probes. Viral DNA was not detected in latently 
infected cells.
Lane 1 KA21 Keratocyte flask lytic infection 
m.o.i. 5 pfu/cell 
Lane 2 17 strain HSV-1 wild type (lug DNA)
Lane 3 KB4 latent viral infection
Lane 4 As lane 2
Lane 5 As lane 3
Lane 6 KB9 latent viral infection 
Lane 7 KB2 0 latent viral infection
Lane 8 As lane 1
Lane 9 KB21 keratocyte flask lytic infection 
m.o.i. 1 pfu/cell 
Lane 10 KA22 keratocyte flask lytic infection 
m.o.i. 0 . 0 0 1  pfu/cell 
Lane 11 KB2 2 keratocyte flask mock infection
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FIGURE 46
Autoradiograph of nitrocellulose blot strips containing Hpal 
re-stiri:©%ian fragments of strain 17 (lane 1) and recombinant
2 (lanes 2-5). The probes were HSV-1 DNA (lane 1); the
Kpnl b fragment (lane 2); the KphI m fragment (lane 3); the
Kpnl c fragment (lane 4); the Kpnl d fragment (lane 5).
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DISCUSSION
The isolation of herpes simplex virus from explanted 
human corneas (Shimeld et al., 1982; Tullo et al., 1985;
Cook et al., 1986) raises the question of whether the cell 
types found in the cornea are capable of supporting a latent 
or persistent viral infection. Separate cultures of rabbit 
corneal epithelial cells, keratocytes and endothelial cells 
whose purity was defined both morphologically and by cell 
specific markers were used to analyse the relationship 
between corneal cells and HSV. The three cell types were 
used initially to study the lytic cycle of HSV-1 and
secondly to establish an in vitro latency system in cells
where the. virus is known to occur in vivo.
Previous in vitro latency models have used HEL-F cells 
and cytosine arabinoside (O'Neill et al., 1972), rat foetal 
neurones and BVdUR plus interferon (Wigdahl et al., 1983), 
and human foetal neurones and BVdUR plus interferon (Wigdahl 
et al., 1982a) to examine virus and cell specific functions 
related to latency. All these systems employed viral 
inhibitors. Darai et al. (1975) and Marcon and Kucera 
(19 76) showed that detectable HSV-2 DNA synthesis was 
blocked at the supraoptimal temperature of 4 2°C.
Temperature elevation alone has been shown to induce latent
viral infection in HEL-F cells (.Russell and Preston, 1986; 
Russell et al., 19 87a). A permissive temperature of 3 7°C 
was chosen, the corneal temperature of the rabbit is 3 5°C i_n 
vivo. The in vitro latency system described in this thesis 
is solely dependent on manipulation of temperature to induce 
and reactivate latent HSV-1 infections. The in vitro 
latency system was used to determine whether peripheral 
cells, from the cornea which is a known focus of recurrent
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disease in man, are capable of supporting a latent HSV 
infection.
During the lytic cycle, the virus growth rate was 
fastest in epithelial cells and closely resembled that in 
control BHK21C13 cells. The growth rate was intermediate 
in keratocyte cells and slowest in endothelial cells. 
Experiments by Carter et al. (19 85) using corneal cells 
infected with HSV at lower m.o.i.s suggested that virus 
titres reached their maximum in 2 4 hours and remained 
relatively constant until 72 hours. It can be concluded 
that corneal epithelial, keratocyte and endothelial cells 
are capable of efficiently supporting HSV replication.
—  The...three corneal cell types were capable of 
replication under heat shock conditions. Subculture 
infected cultures 1:2 at 41.5°C did not induce detectable 
reactivation. The multiplicity of infection was found to 
be critical in the in vitro latency system; when 0 .1 ,
1 . 0  pfu/cell was used, a very large proportion of cells were 
killed in the seven days immediately post infection. This 
effect was overwhelming in some keratocyte and endothelial 
cell cultures leaving no surviving cells. The findings 
were comparable with the results of O'Neill et al. (1972) 
who found that the inoculating m.o.i. was critical to ensure 
surviving cells. Wigdahl et al. (19 82a) successfully 
increased the m.o.i. using a combination of the antiviral 
drug BVdUR and interferon to treat cells prior to infection 
with HSV.
Epithelial cells were the only cell type to exhibit 
persistence, defined as a detectable chronic low grade viral 
infection, insufficient to destroy the cellular monolayer at 
41.5°C. The three corneal cell types were able to support
11 3
a latent HSV infection, defined by absence of infectious 
virus in supernatant medium at 41.5°C assayed on BHK21C13 
cells, but presence of infectious virus in supernatant 
medium at 3 7°C assayed on BHK21C13 cells. Virus was 
obtained more quickly from epithelial cells and endothelial 
cells than keratocytes at 3 7°C.
Corneal cell types have different properties of 
replication in vivo; epithelial cells divide and are shed 
throughout life whereas keratocytes have replicative 
potential but tend to be stable, and endothelial cells have 
limited if any replicative ability in vivo (Davson, 19 80; 
Maumenee and Kornblueth, 1949). It is established that HSV 
latency-^occurs in non dividing neurones, in vivo, both in 
man (Bastian et al. , 1972; Baringer and Swoveland, 1973); 
and in animals (Stevens and Cook, 1971; Stevens et al. , 
1972). Wigdahl et al. (1984a) showed in an in vitro system 
that neurones were capable of supporting more latent HSV 
genomes, per haploid cell, than HEL-F cells.
In our in vitro system, keratocytes and endothelial 
cells which are non dividing in vivo were capable of 
maintaining a latent HSV infection. Epithelial cells were 
also capable of maintaining an in vitro latent HSV-1 
infection, but in addition epithelial cells demonstrated 
some persistent HSV infection at 4 1.5°C. No surviving 
epithelial cell cultures failed to release infectious HSV 
upon transfer to 3 7°C, in contrast to keratocyte and 
endothelial cell cultures where eight cultures in total did 
not release infectious virus at 3 7°C. It is possible that 
non inducible herpes simplex virus was present in these 
cultures-and might have been detected by viral 
superinfection experiments. It is evident that the
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phenotype of the cell affects the outcome of both lytic and 
latent infection of corneal epithelial cells, keratocytes 
and endothelial cells in vitro.
Only temperature elevation or reduction was used to 
induce latency or trigger reactivation in our in vitro 
system. Heat shock induces stress proteins (Tissieres 
et a l ., 1974). Notarianni and Preston (1982) and Russell
et al. (19 87b) have shown that stress proteins are induced 
by the immediate early proteins of HSV. In our system most 
cellular stress proteins were induced fcy heat shock. It 
was not possible to ascertain whether additional proteins 
were induced in any of the three cell types infected at low 
m.o^i. with HSV. However it is clear that cellular stress 
proteins were present at 41.5°C when HSV was latent and were 
much reduced in intensity at 3 7°C when virus was able to 
reactivate.
Acycloguanosine (ACG) was used to distinguish latent 
and persistent viral infection in the second series of 
experiments. The nucleoside analogue 9 - (2-hydroxy ethoxy 
methyl) guanine (acycloguanosine) has been shown to be an 
effective and extremely selective antiviral agent blocking 
the replication of several herpes viruses both in vitro and 
in vivo in a number of animal models (Elion et al. , 1977; 
Schaeffer et al., 1978). If low levels of replicating 
virus were present in corneal cell cultures at 4 2°C, 
incubation in the presence of ACG would eliminate such virus 
and upon transfer to 3 7°C there would be no release of 
infectious persistent virus. However if the virus genomes 
were present in a latent form inaccessible to the drug ACG, 
treatment would be expected to have no effect and upon 
transfer to the permissive temperature there would be
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release or reactivation of virus.
It has been shown by Schaeffer et al. (1978) that the 
ID5 0  of ACG on the ICI strain of HSV-1 as measured by plaque 
reduction on Vero cells was O.luM. ACG (lOuM) was 
effective in blocking the lytic cycle of HSV at 3 7°C in 
rabbit corneal epithelial cells and keratocytes.
Incubation of ACG at 42°C for 4 8 hours did not inactivate 
the effect of ACG on a subsequent lytic infection at 3 7°C.
The time interval between medium changes in the in vitro 
latency system was 4 8 hours. Compared to Schaeffer et al. 
(1978), we used a 100 fold higher concentration of lOuM as 
being optimal for virus inactivation without a cytotoxic 
e f f e e t . T h e  presence of this high ACG concentration for 5 
days prior to transfer to 3 7°C did not affect the number of 
cultures shedding virus, nor did it significantly alter the 
onset of first virus release or the duration of shedding. 
This finding applied to both epithelial cells and 
keratocytes and to both infecting multiplicities. It 
appears therefore that rabbit corneal keratocytes and 
epithelial cells are both capable of supporting a latent 
infection. The latent infection was induced and maintained 
by incubating cells at 4 2°C. At 4 2°C the virus genomes are 
probably non-replicating and therefore inaccessible to the 
action of ACG but they must retain the potential to initiate 
replication within 48 hrs. of shift to 3 7°C.
Superinfection experiments were performed to determine 
whether it was possible to reactivate virus from latently 
infected cultures before spontaneous virus release. To 
maximise the chance of both reactivation of resident HSV 
from the -corneal cultures and recombination between resident 
and superinfecting genomes, we chose to superinfect the
116
latently infected cells with the X2 mutant of HSV-1 strain 
17 (Brown et al., 19 84). The X2 mutant has lost the Xbal 
sites at 0.07 and 0.63 map units and was constructed by 
recombination between two viruses each lacking a single 
site. The viruses with the individual site losses were 
isolated by enrichment selection with Xbal. The removal of 
the site at 0.0 7 map units is due to a base change or 
deletion or insertion of less than 150 base pairs. The 
site loss at 0.6 3 map units is due to a 150bp deletion.
Xbal analysis of the progeny from cells superinfected 
on day 15 immediately after transfer to 3 7°C showed that of 
19 2 plaques analysed from the epithelial cultures, 185 had 
the^_prof_ile of the superinfecting virus and 7 had Xbal 
profiles differing from the superinfecting virus. Three 
had the Xbal profile of the original infecting virus and 
were either true reactivants or recombinants and 4 had 
profiles indicative of recombinant virus. Three of the 
four recombinants had regained the Xbal site at 0.6 3 but 
still lacked the site at 0.0 7 map units. The simplest 
generation of this recombinant would have been by a 
crossover anywhere between 0.0 7 and 0.6 3 map units. Two of 
the three recombinants could have been clonally related as 
they came from the same superinfected flask. The third 
came from a separate epithelial culture which had been 
treated with ACG. The fourth recombinant isolated from 
epithelial cells had gained a new Xbal site at 0.74 map 
units. This may have been generated by illegitimate 
recombination and the insertion of an existing Xbal site 
from one of four places into a novel position at 0.7 4 map 
units. To determine whether there has been insertion of 
sequences from other parts of the genome appropriate
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experiments were carried out. The results indicated that 
the new site had not arisen from one of the existing Xbal 
sites unless it was within an insert of less than 150 base 
pairs. Other possibilities are that there has either been 
a spontaneous mutation generating a new Xbal site or that 
the site is derived from a host insert. There is no 
evidence so far in HSV of host insertion. The new Xbal 
site lies within the BamHI b fragment (0.7 35-0.81 map 
units). From the 0 .735 map unit end of BamHI b to the 0.81 
map unit end there are 1 0  potential sequences in which a 
single base change could generate an Xbal site. However in 
the course of isolating deletion mutants of HSV-1 and HSV-2 
the^JDNAjpf over 10^ single plaques has been analysed (Brown, 
Harland, MacLean, personal communication) , and only one new 
Xbal site at 0.16 map units has been identified in a plaque 
stock of HG52 (M. Y. l&ha, personal communication).
It was possible that by superinfecting immediately on 
transfer to 3 7°C, virus was being reactivated which would 
have been released spontaneously and that superinfection was 
merely speeding up the process. To determine whether 
cultures which had failed to shed virus after 14 days at 
37°C contained virus genomes, similar superinfection 
experiments were carried out on day 29 post infection. As 
a random sample the DNAs from 9 6 single plaques from ACG and 
non ACG treated epithelial cultures and 9 6 from equivalent 
keratocyte cultures were analysed. The superinfecting X2 
profile was present in 92 of the plaques from epithelial 
cells, 2 had a wild type profile, 1 had a recombinant 
profile with the 0.63 site regained and one had a 
recombinant profile with the 0.07 site regained. A single 
crossover between the resident and superinfecting genomes
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would generate a recombinant containing the 0.0 7 site. The 
two recombinants, with the 0.07 or 0 . 6  3 map unit sites 
regained are generated by reciprocal recombination and could 
have been generated by a single crossover event. The 9 6 
plaques analysed from the keratocyte cultures, all had the 
superinfecting X2 profile.
It is evident therefore that after removal from the 
conditions inducing latency, corneal epithelial cells are 
capable of continuing to harbour HSV-1 in a latent form for 
at least 14 days without shedding infectious virus. The 
genomes cannot be present as persistent intact infectious 
virus but the DNA must be in a state where it can readily 
make infectious particles as evidenced by the isolation of 
virus with the wild type profile, at least a proportion of 
which is assumed to be reactivated input virus. In 
addition the isolation of recombinants suggests that the 
resident DNA readily interacts with the superinfecting 
genomes. The way in which the single plaques have been 
isolated and their DNA analysed precludes the generation of 
recombinants outwith the corneal cells. The data does not 
distinguish between the HSV-1 DNA being in the cells as 
episomes, concatamers or integrated into the host 
chromosomes.
It could be argued that the regaining of the sites at 
0.07 and 0 . 6  3 is due to spontanous reversion at these sites. 
The loss of the 0.6 3 site is due to a 150 base pair deletion 
so spontaneous reversion does not come into question. The 
0.0 7 site could be regained by a base change but the DNA 
analysis of several thousand single plaque stocks of X2 has 
not brought to light a single revertant for the 0.0 7 site 
(A. MacLean - personal communication).
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It is apparent that ACG has no effect on the 
superinfection experiment. Resident and recombinant 
genomes were isolated from treated and untreated cultures.
Intertypic recombinants have been isolated from rat 
embryo transformed cells (Park et al. , 1980) but this is the 
first isolation of recombinants from latently infected 
cultured cells. The use of intratypic R.E. site deletion 
mutants greatly facilitated the study. Plaques were picked 
at random and identification of reactivants or recombinants 
was based on subsequent screening for unselected markers. 
Infecting at a m.o.i. of 0.0 01 pfu/cell, the maximum number 
of cells infected would be 10^. Superinfecting at a m.o.i. 
of J}. 0 1  jgfu/cell would mean that 1 in 1 0  ^ cells would be
doubly infected. The calculation is theoretical and does
not take into account the actual number of cells which would 
be infected initially or on superinfection; the 
particlespfu ratios of the stocks; or any virus replication 
taking place at 4 2°C. In 10^ cells, 10 at maximum would be
doubly infected. For every 1 doubly infected cell 10^ will
be infected with X2. Resident input virus i.e. wild type 
for Xbal sites has been isolated at a frequency of 2% in 
epithelial cells. This is 2 0 fold higher than expected. 
There are several possible explanations for the relatively 
high frequency of reactivation.
(1) The ts+ virus has a growth advantage over X2. This is 
unlikely as one step growth experiments have shown that X2 
and its parental virus have equivalent growth rates (Brown 
et al., 19 84).
(2) Reactivation of the wild type virus does not require the 
superinfecting virus to be in the same cell but is dependent 
on a viral product synthesised by the superinfecting virus
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in surrounding cells.
(3) Assuming that both resident and superinfecting virus 
require to be in the same cell for reactivation to occur 
there has to be limited replication of the original input 
virus at 4 2°C such that the number of doubly infected cells 
is 2 0 fold higher than calculated from the initial m.o.i.
The frequency of isolation of recombinant virus was also 
about 2%. For recombination to occur both genomes must be 
in the same cell. It would appear therefore that there has 
been limited replication of the original infecting virus at 
42°C.
(4) It has been shown that non-infectious particles make a 
conjtribution to complementation in ts mutant infections 
(L. I. lVfesser, PhD thesis 1978). It is possible therefore 
that the particle:pfu ratios of the virus stocks, may affect 
the number of cells both initially infected and 
superinfected. Our strain 17 stock had a particle:pfu 
ratio of 10:1 and the X2 stock a particle:pfu ratio of 3 5:1. 
The contribution made by non infectious particles could be 
important.
(5) If the original infecting genome is integrated into the 
host chromosome or is episomal and there is some cell 
division then the number of cells containing HSV would be 
higher than expected. Corneal epithelial cells divide and 
we have shown previously that they are capable of division 
at 41.5°C (Cook and Brown, 1986). Credence could be given 
to this argument by the fact that we have been unable to 
demonstrate reactivation or recombination from keratocyte 
cultures. The fact that keratocytes behave as epithelial 
cells in .being able to shed virus after 14 days at 4 2°c 
suggests that the original genomes should be present.
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If the original genomes are integrated, there must be rapid 
release fom integration to be available for recombination.
(6 ) After reactivation there is time for a round of viral 
replication within 24 hours.
(7) Another explanation would be that variation in the 
physiological and metabolic state of individual cells 
determines differences in the rate of virus release.
Southern blotting with whole HSV-1 genomes or with 
joint fragments failed to detect HSV information in latently 
infected cells. In reconstruction experiments HSV was 
detectable at input m.o.i.s of 5 and 1 pfu/cell but not at 
0.001 pfu/cell. The Southern blotting experiments were not 
as.sensitive as superinfection in detecting resident 
genomes. This contrasts with the results of Wigdahl et al. 
(19 84a) who were able to detect HSV DNA in neurones in an in 
vitro latency system. Several important differences are 
present between their system and the corneal cell latency 
system. The m.o.i. used fcy Wigdahl et al. (19 82a, 19 84a) 
was considerably higher (2.5 pfu/cell). Interferon and 
antiviral agents were used to induce the latent infection 
and temperature elevation was used to maintain the latent 
state.
Other workers have found the limit of sensitivity of 
Southern blotting to be around 0.01-0.1 copies of viral 
DNA/cell (Efstathiou et al. , 1986). This level of 
sensitivity is inadequate to detect viral genomes present 
in our system where cells are infected at a very low m.o.i.
The ability of rabbit corneal epithelial cells to 
support a latent infection gives credence to the possibility 
that in man recurrent episodes of herpes keratitis may be 
due to reactivation of virus from a latent state in the
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cornea itself in addition to reactivation from dorsal root 
ganglia. In conjunction with evidence from the mouse model 
system where HSV has been shown to be latent in the skin of 
the footpad (Al-Saadi et al., 1983) this work supports the 
hypothesis that HSV does not require cells of neurological 
origin in order to establish and maintain a latent 
infection.
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FUTURE PROSPECTS
Few of the variable biological characteristics of HSV 
with the notable exceptions of neurovirulence, which has 
been mapped to the region of the genome between 0.71 and 
0.74 map units (Thompson et al. , 1983, 1985) and the 
property of reactivation which has been excluded from the 
regions of the genome between 0 . 3 5- 0 . 5  6 and/or 0 . 8  2- 1 . 0  map 
units (Batra, 1987), have been mapped. Accurate 
characterization of HSV types with differences in biological 
properties, like the clinical signs of primary disease 
and/or frequency of induced reactivation e.g. HSV-1 strain 
McKrae and HSV-2 strain HG52, will allow the construction of 
intertypic recombinants. The novel recombinants can be 
tested and compared to the parental strains in animal 
experiments. By this painstaking technique biological 
properties may be assigned to a region of the genome. 
Pitfalls can be easily foreseen as a single gene may not be 
totally responsible for reactivation. Other biological 
variables i.e. primary disease may be similarly controlled. 
Further caution in the interpretation of results will be 
required as no virus strain is likely to be absolutely 
negative for a biological characteristic.
Recent in situ hybridization results have detected 
latency related HSV-1 RNAs in the trigeminal ganglia of 
rabbits, mice and man (Rock et al. , 1987a; Spivak and 
Fraser, 1987; and Croen et al. , 1987). More than one 
latency related RNA transcript was detected, and the genes 
for the latency related RNAs mapped in the region of the I El 
gene which encodes the polypeptide VmwEI110. The latent 
HSV-1 RNAs-were found to be transcribed in the direction 
opposite to that of IElmRNA. These results confirmed the
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work of Stevens et al. (1987).
Rock et al. (1987b) performed similar in situ 
hybridization experiments using bovine herpes virus type 1, 
and found that the latency related RNAs mapped to
0.734-0.748 map units of the viral genome. This area is 
abundantly transcribed at immediate early times in 
infection, but precise mapping data is not available.
The precise role of the latency related RNAs has yet to 
be elucidated, the anti-sense RNA may regulate the IEl gene 
or it may encode a regulatory protein capable of suppressing 
the HSV-1 lytic cycle or interacting with cellular 
transcription factors.
Within the confines of this thesis future work could 
determine whether a similar pattern of RNA expression occurs 
in latent infections in vitro. Does the in vitro latency 
system have any relevance to the in vivo situation? Just 
how essential is the IEl gene for latency? G.B. Clements 
and N.D. Stow (unpublished results) have shown that the dl 
1403 HSV-1 mutant can establish a latent infection in mice 
which can be reactivated after co-cultivation. The mutant 
synthesises a truncated form of VmwIEllO and it is possible 
that the truncated RNA is adequate for the establishment and 
maintenance of latency.
Further confirmation of the cornea as a site of 
peripheral latency could be obtained by in situ 
hybridization experiments on human and animal corneas, after 
herpetic keratitis.
Current evidence points to viral DNA being present 
during latency in concatameric or circularized forms.
However it.remains unknown whether the DNA undergoes 
rearrangements or is integrated with cellular DNA or exists
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in an episomal form.
In conclusion medical practitioners have potent 
antiviral agents which permit acute and recurrent infections 
to be treated. However treatment is unable to prevent the 
establishment or reactivation of latent infections. Until 
such times as the mechanisms of latency and reactivation are 
understood, medical therapy will be directed towards 
containment of disease rather than prevention.
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